false 2021 Q2 0001006837--12-31 1 1 1 1 1 1 1 1 1 5 5 5 5 5 5 5 5 5 1 1 1 1 5 5 5 5 0.2342971 http://fasb.org/us-gaap/2021-01-31#OtherAssets http://fasb.org/us-gaap/2021-01-31#OtherAssets http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2021-01-31#DebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2021-01-31#DebtAndCapitalLeaseObligations P2D P2D 0001006837 2021-01-01 2021-06-30 xbrli:shares 0001006837 2021-07-30 iso4217:USD 0001006837 2021-04-01 2021-06-30 0001006837 2020-04-01 2020-06-30 0001006837 2020-01-01 2020-06-30 iso4217:USD xbrli:shares 0001006837 2021-06-30 0001006837 2020-12-31 0001006837 us-gaap:CommonStockMember 2021-03-31 0001006837 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001006837 us-gaap:TreasuryStockMember 2021-03-31 0001006837 us-gaap:RetainedEarningsUnappropriatedMember 2021-03-31 0001006837 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001006837 us-gaap:ParentMember 2021-03-31 0001006837 us-gaap:NoncontrollingInterestMember 2021-03-31 0001006837 2021-03-31 0001006837 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001006837 us-gaap:ParentMember 2021-04-01 2021-06-30 0001006837 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001006837 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001006837 us-gaap:RetainedEarningsUnappropriatedMember 2021-04-01 2021-06-30 0001006837 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001006837 us-gaap:CommonStockMember 2021-06-30 0001006837 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001006837 us-gaap:TreasuryStockMember 2021-06-30 0001006837 us-gaap:RetainedEarningsUnappropriatedMember 2021-06-30 0001006837 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001006837 us-gaap:ParentMember 2021-06-30 0001006837 us-gaap:NoncontrollingInterestMember 2021-06-30 0001006837 us-gaap:CommonStockMember 2020-12-31 0001006837 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001006837 us-gaap:TreasuryStockMember 2020-12-31 0001006837 us-gaap:RetainedEarningsUnappropriatedMember 2020-12-31 0001006837 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001006837 us-gaap:ParentMember 2020-12-31 0001006837 us-gaap:NoncontrollingInterestMember 2020-12-31 0001006837 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0001006837 us-gaap:ParentMember 2021-01-01 2021-06-30 0001006837 us-gaap:TreasuryStockMember 2021-01-01 2021-06-30 0001006837 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001006837 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-06-30 0001006837 us-gaap:RetainedEarningsUnappropriatedMember 2021-01-01 2021-06-30 0001006837 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-06-30 0001006837 us-gaap:CommonStockMember 2020-03-31 0001006837 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001006837 us-gaap:TreasuryStockMember 2020-03-31 0001006837 us-gaap:RetainedEarningsUnappropriatedMember 2020-03-31 0001006837 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001006837 us-gaap:ParentMember 2020-03-31 0001006837 us-gaap:NoncontrollingInterestMember 2020-03-31 0001006837 2020-03-31 0001006837 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001006837 us-gaap:ParentMember 2020-04-01 2020-06-30 0001006837 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001006837 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0001006837 us-gaap:RetainedEarningsUnappropriatedMember 2020-04-01 2020-06-30 0001006837 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001006837 us-gaap:CommonStockMember 2020-06-30 0001006837 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001006837 us-gaap:TreasuryStockMember 2020-06-30 0001006837 us-gaap:RetainedEarningsUnappropriatedMember 2020-06-30 0001006837 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001006837 us-gaap:ParentMember 2020-06-30 0001006837 us-gaap:NoncontrollingInterestMember 2020-06-30 0001006837 2020-06-30 0001006837 us-gaap:CommonStockMember 2019-12-31 0001006837 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001006837 us-gaap:TreasuryStockMember 2019-12-31 0001006837 us-gaap:RetainedEarningsUnappropriatedMember 2019-12-31 0001006837 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001006837 us-gaap:ParentMember 2019-12-31 0001006837 us-gaap:NoncontrollingInterestMember 2019-12-31 0001006837 2019-12-31 0001006837 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-06-30 0001006837 us-gaap:ParentMember 2020-01-01 2020-06-30 0001006837 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0001006837 us-gaap:TreasuryStockMember 2020-01-01 2020-06-30 0001006837 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-06-30 0001006837 us-gaap:RetainedEarningsUnappropriatedMember 2020-01-01 2020-06-30 0001006837 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-06-30 hchc:segment xbrli:pure 0001006837 hchc:DBMGlobalIncMember 2021-06-30 0001006837 hchc:GenovelOrthopedicsIncMember 2021-06-30 0001006837 hchc:R2DermatologyInc.Member 2021-06-30 0001006837 hchc:MedibeaconInc.andTripleRingTechnologiesIncMember 2021-06-30 0001006837 hchc:HC2BroadcastingHoldingsIncMember 2021-06-30 0001006837 hchc:DTVAmericaMember 2021-06-30 0001006837 hchc:MinorityHoldersMember 2021-06-30 0001006837 hchc:InsuranceCompaniesMember 2021-06-30 0001006837 hchc:GlobalMarineSystemsLimitedMember 2021-06-30 0001006837 hchc:HuawaeiMarineNetworkMember 2021-06-30 0001006837 us-gaap:SegmentDiscontinuedOperationsMember 2020-12-31 0001006837 us-gaap:SegmentDiscontinuedOperationsMember 2021-06-30 0001006837 us-gaap:SegmentDiscontinuedOperationsMember 2021-04-01 2021-06-30 0001006837 us-gaap:SegmentDiscontinuedOperationsMember 2020-04-01 2020-06-30 0001006837 us-gaap:SegmentDiscontinuedOperationsMember 2021-01-01 2021-06-30 0001006837 us-gaap:SegmentDiscontinuedOperationsMember 2020-01-01 2020-06-30 0001006837 us-gaap:SegmentDiscontinuedOperationsMember hchc:CGIMember 2021-06-30 0001006837 us-gaap:SegmentDiscontinuedOperationsMember hchc:CGIMember 2021-01-01 2021-06-30 0001006837 us-gaap:SegmentDiscontinuedOperationsMember hchc:GlobalMarineSystemsLimitedMember 2020-02-28 2020-02-28 0001006837 us-gaap:SegmentDiscontinuedOperationsMember hchc:GlobalMarineSystemsLimitedMember 2020-10-01 2020-12-31 0001006837 us-gaap:SegmentDiscontinuedOperationsMember hchc:GlobalMarineSystemsLimitedMember 2021-01-01 2021-03-31 0001006837 us-gaap:SegmentDiscontinuedOperationsMember hchc:RevolvingCreditAgreementMember hchc:GlobalMarineSystemsLimitedMember 2020-02-28 2020-02-28 0001006837 hchc:A115SeniorSecuredNotesMember hchc:GlobalMarineSystemsLimitedMember 2020-02-28 0001006837 hchc:RevolvingCreditAgreementMember hchc:GlobalMarineSystemsLimitedMember 2020-02-28 2020-02-28 0001006837 us-gaap:SegmentDiscontinuedOperationsMember hchc:RevolvingCreditAgreementMember hchc:GlobalMarineSystemsLimitedMember 2021-04-01 2021-06-30 0001006837 us-gaap:SegmentDiscontinuedOperationsMember hchc:RevolvingCreditAgreementMember hchc:GlobalMarineSystemsLimitedMember 2020-04-01 2020-06-30 0001006837 us-gaap:SegmentDiscontinuedOperationsMember hchc:RevolvingCreditAgreementMember hchc:GlobalMarineSystemsLimitedMember 2021-01-01 2021-06-30 0001006837 us-gaap:SegmentDiscontinuedOperationsMember hchc:RevolvingCreditAgreementMember hchc:GlobalMarineSystemsLimitedMember 2020-01-01 2020-06-30 0001006837 hchc:SecuredIndentureMember hchc:GlobalMarineSystemsLimitedMember 2020-02-28 0001006837 us-gaap:SegmentDiscontinuedOperationsMember hchc:SecuredIndentureMember hchc:GlobalMarineSystemsLimitedMember 2021-04-01 2021-06-30 0001006837 us-gaap:SegmentDiscontinuedOperationsMember hchc:SecuredIndentureMember hchc:GlobalMarineSystemsLimitedMember 2020-04-01 2020-06-30 0001006837 us-gaap:SegmentDiscontinuedOperationsMember hchc:SecuredIndentureMember hchc:GlobalMarineSystemsLimitedMember 2021-01-01 2021-06-30 0001006837 us-gaap:SegmentDiscontinuedOperationsMember hchc:SecuredIndentureMember hchc:GlobalMarineSystemsLimitedMember 2020-01-01 2020-06-30 0001006837 us-gaap:SegmentDiscontinuedOperationsMember hchc:InternationalCarrierServicesMember 2020-10-31 2020-10-31 0001006837 hchc:Beyond6Member us-gaap:SegmentDiscontinuedOperationsMember 2021-01-15 2021-01-15 0001006837 hchc:Beyond6Member hchc:A2020RevolvingCreditAgreementMember 2021-01-15 2021-01-15 0001006837 hchc:Beyond6Member hchc:A115SeniorSecuredNotesMember 2021-01-15 2021-01-15 0001006837 hchc:Beyond6Member us-gaap:SegmentDiscontinuedOperationsMember hchc:A2020RevolvingCreditAgreementMember 2021-04-01 2021-06-30 0001006837 hchc:Beyond6Member us-gaap:SegmentDiscontinuedOperationsMember hchc:A2020RevolvingCreditAgreementMember 2020-04-01 2020-06-30 0001006837 hchc:Beyond6Member us-gaap:SegmentDiscontinuedOperationsMember hchc:A2020RevolvingCreditAgreementMember 2021-01-01 2021-06-30 0001006837 hchc:Beyond6Member us-gaap:SegmentDiscontinuedOperationsMember hchc:A2020RevolvingCreditAgreementMember 2020-01-01 2020-06-30 0001006837 hchc:Beyond6Member us-gaap:SegmentDiscontinuedOperationsMember hchc:A115SeniorSecuredNotesMember 2021-04-01 2021-06-30 0001006837 hchc:Beyond6Member us-gaap:SegmentDiscontinuedOperationsMember hchc:A115SeniorSecuredNotesMember 2020-04-01 2020-06-30 0001006837 hchc:Beyond6Member us-gaap:SegmentDiscontinuedOperationsMember hchc:A115SeniorSecuredNotesMember 2021-01-01 2021-06-30 0001006837 hchc:Beyond6Member us-gaap:SegmentDiscontinuedOperationsMember hchc:A115SeniorSecuredNotesMember 2020-01-01 2020-06-30 0001006837 hchc:SpectrumSegmentMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember us-gaap:OperatingSegmentsMember 2021-04-01 2021-06-30 0001006837 hchc:InfrastructureSegmentMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0001006837 hchc:InfrastructureSegmentMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-06-30 0001006837 hchc:InfrastructureSegmentMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0001006837 hchc:SpectrumSegmentMember us-gaap:OperatingSegmentsMember 2021-04-01 2021-06-30 0001006837 hchc:SpectrumSegmentMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0001006837 hchc:SpectrumSegmentMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-06-30 0001006837 hchc:SpectrumSegmentMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0001006837 hchc:LifeSciencesMember us-gaap:OperatingSegmentsMember 2021-04-01 2021-06-30 0001006837 hchc:LifeSciencesMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0001006837 hchc:LifeSciencesMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-06-30 0001006837 hchc:LifeSciencesMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0001006837 hchc:InfrastructureSegmentMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember 2020-12-31 0001006837 hchc:SpectrumSegmentMember 2020-12-31 0001006837 hchc:LifeSciencesSegmentMember 2021-06-30 0001006837 hchc:LifeSciencesSegmentMember 2020-12-31 0001006837 hchc:InfrastructureSegmentMember hchc:CommercialRevenueMember 2021-04-01 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:CommercialRevenueMember 2020-04-01 2020-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:CommercialRevenueMember 2021-01-01 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:CommercialRevenueMember 2020-01-01 2020-06-30 0001006837 hchc:IndustrialRevenueMember hchc:InfrastructureSegmentMember 2021-04-01 2021-06-30 0001006837 hchc:IndustrialRevenueMember hchc:InfrastructureSegmentMember 2020-04-01 2020-06-30 0001006837 hchc:IndustrialRevenueMember hchc:InfrastructureSegmentMember 2021-01-01 2021-06-30 0001006837 hchc:IndustrialRevenueMember hchc:InfrastructureSegmentMember 2020-01-01 2020-06-30 0001006837 hchc:TransportationRevenueMember hchc:InfrastructureSegmentMember 2021-04-01 2021-06-30 0001006837 hchc:TransportationRevenueMember hchc:InfrastructureSegmentMember 2020-04-01 2020-06-30 0001006837 hchc:TransportationRevenueMember hchc:InfrastructureSegmentMember 2021-01-01 2021-06-30 0001006837 hchc:TransportationRevenueMember hchc:InfrastructureSegmentMember 2020-01-01 2020-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:GovernmentRevenueMember 2021-04-01 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:GovernmentRevenueMember 2020-04-01 2020-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:GovernmentRevenueMember 2021-01-01 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:GovernmentRevenueMember 2020-01-01 2020-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:LeisureRevenueMember 2021-04-01 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:LeisureRevenueMember 2020-04-01 2020-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:LeisureRevenueMember 2021-01-01 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:LeisureRevenueMember 2020-01-01 2020-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:HealthcareRevenueMember 2021-04-01 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:HealthcareRevenueMember 2020-04-01 2020-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:HealthcareRevenueMember 2021-01-01 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:HealthcareRevenueMember 2020-01-01 2020-06-30 0001006837 hchc:ConventionRevenueMember hchc:InfrastructureSegmentMember 2021-04-01 2021-06-30 0001006837 hchc:ConventionRevenueMember hchc:InfrastructureSegmentMember 2020-04-01 2020-06-30 0001006837 hchc:ConventionRevenueMember hchc:InfrastructureSegmentMember 2021-01-01 2021-06-30 0001006837 hchc:ConventionRevenueMember hchc:InfrastructureSegmentMember 2020-01-01 2020-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:OtherRevenueMember 2021-04-01 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:OtherRevenueMember 2020-04-01 2020-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:OtherRevenueMember 2021-01-01 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:OtherRevenueMember 2020-01-01 2020-06-30 0001006837 hchc:InfrastructureSegmentMember 2021-04-01 2021-06-30 0001006837 hchc:InfrastructureSegmentMember 2020-04-01 2020-06-30 0001006837 hchc:InfrastructureSegmentMember 2021-01-01 2021-06-30 0001006837 hchc:InfrastructureSegmentMember 2020-01-01 2020-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:BankerSteelAcquisitionMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember 2021-07-01 hchc:CommercialRevenueMember hchc:RevenueRemainingPerformanceObligationPeriodOneMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember 2021-07-01 hchc:CommercialRevenueMember hchc:RevenueRemainingPerformanceObligationPeriodTwoMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:CommercialRevenueMember 2021-06-30 0001006837 hchc:IndustrialRevenueMember hchc:InfrastructureSegmentMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodOneMember 2021-06-30 0001006837 hchc:IndustrialRevenueMember hchc:InfrastructureSegmentMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodTwoMember 2021-06-30 0001006837 hchc:IndustrialRevenueMember hchc:InfrastructureSegmentMember 2021-06-30 0001006837 hchc:TransportationRevenueMember hchc:InfrastructureSegmentMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodOneMember 2021-06-30 0001006837 hchc:TransportationRevenueMember hchc:InfrastructureSegmentMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodTwoMember 2021-06-30 0001006837 hchc:TransportationRevenueMember hchc:InfrastructureSegmentMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember 2021-07-01 hchc:GovernmentRevenueMember hchc:RevenueRemainingPerformanceObligationPeriodOneMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember 2021-07-01 hchc:GovernmentRevenueMember hchc:RevenueRemainingPerformanceObligationPeriodTwoMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:GovernmentRevenueMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:LeisureRevenueMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodOneMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:LeisureRevenueMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodTwoMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:LeisureRevenueMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember 2021-07-01 hchc:HealthcareRevenueMember hchc:RevenueRemainingPerformanceObligationPeriodOneMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember 2021-07-01 hchc:HealthcareRevenueMember hchc:RevenueRemainingPerformanceObligationPeriodTwoMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:HealthcareRevenueMember 2021-06-30 0001006837 hchc:ConventionRevenueMember hchc:InfrastructureSegmentMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodOneMember 2021-06-30 0001006837 hchc:ConventionRevenueMember hchc:InfrastructureSegmentMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodTwoMember 2021-06-30 0001006837 hchc:ConventionRevenueMember hchc:InfrastructureSegmentMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:OtherRevenueMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodOneMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:OtherRevenueMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodTwoMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:OtherRevenueMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodOneMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodTwoMember 2021-06-30 0001006837 hchc:LifeSciencesMember hchc:SystemsRevenueMember 2021-04-01 2021-06-30 0001006837 hchc:LifeSciencesMember hchc:SystemsRevenueMember 2020-04-01 2020-06-30 0001006837 hchc:LifeSciencesMember hchc:SystemsRevenueMember 2021-01-01 2021-06-30 0001006837 hchc:LifeSciencesMember hchc:SystemsRevenueMember 2020-01-01 2020-06-30 0001006837 hchc:LifeSciencesMember 2021-04-01 2021-06-30 0001006837 hchc:LifeSciencesMember 2020-04-01 2020-06-30 0001006837 hchc:LifeSciencesMember 2021-01-01 2021-06-30 0001006837 hchc:LifeSciencesMember 2020-01-01 2020-06-30 0001006837 hchc:AdvertisingRevenueMember hchc:SpectrumSegmentMember 2021-04-01 2021-06-30 0001006837 hchc:AdvertisingRevenueMember hchc:SpectrumSegmentMember 2020-04-01 2020-06-30 0001006837 hchc:AdvertisingRevenueMember hchc:SpectrumSegmentMember 2021-01-01 2021-06-30 0001006837 hchc:AdvertisingRevenueMember hchc:SpectrumSegmentMember 2020-01-01 2020-06-30 0001006837 hchc:SpectrumSegmentMember hchc:BroadcastStationRevenueMember 2021-04-01 2021-06-30 0001006837 hchc:SpectrumSegmentMember hchc:BroadcastStationRevenueMember 2020-04-01 2020-06-30 0001006837 hchc:SpectrumSegmentMember hchc:BroadcastStationRevenueMember 2021-01-01 2021-06-30 0001006837 hchc:SpectrumSegmentMember hchc:BroadcastStationRevenueMember 2020-01-01 2020-06-30 0001006837 hchc:SpectrumSegmentMember hchc:NetworkDistributionRevenueMember 2021-04-01 2021-06-30 0001006837 hchc:SpectrumSegmentMember hchc:NetworkDistributionRevenueMember 2020-04-01 2020-06-30 0001006837 hchc:SpectrumSegmentMember hchc:NetworkDistributionRevenueMember 2021-01-01 2021-06-30 0001006837 hchc:SpectrumSegmentMember hchc:NetworkDistributionRevenueMember 2020-01-01 2020-06-30 0001006837 hchc:SpectrumSegmentMember hchc:OtherRevenueMember 2021-04-01 2021-06-30 0001006837 hchc:SpectrumSegmentMember hchc:OtherRevenueMember 2020-04-01 2020-06-30 0001006837 hchc:SpectrumSegmentMember hchc:OtherRevenueMember 2021-01-01 2021-06-30 0001006837 hchc:SpectrumSegmentMember hchc:OtherRevenueMember 2020-01-01 2020-06-30 0001006837 hchc:SpectrumSegmentMember 2021-04-01 2021-06-30 0001006837 hchc:SpectrumSegmentMember 2020-04-01 2020-06-30 0001006837 hchc:SpectrumSegmentMember 2021-01-01 2021-06-30 0001006837 hchc:SpectrumSegmentMember 2020-01-01 2020-06-30 0001006837 hchc:AdvertisingRevenueMember hchc:SpectrumSegmentMember 2021-07-01 2021-06-30 0001006837 hchc:SpectrumSegmentMember hchc:BroadcastStationRevenueMember 2021-07-01 2021-06-30 0001006837 hchc:SpectrumSegmentMember hchc:OtherRevenueMember 2021-07-01 2021-06-30 0001006837 hchc:SpectrumSegmentMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodOneMember 2021-06-30 0001006837 hchc:SpectrumSegmentMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodTwoMember 2021-06-30 0001006837 hchc:AdvertisingRevenueMember hchc:SpectrumSegmentMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodOneMember 2021-06-30 0001006837 hchc:SpectrumSegmentMember hchc:OtherRevenueMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodOneMember 2021-06-30 0001006837 hchc:SpectrumSegmentMember hchc:BroadcastStationRevenueMember 2021-07-01 hchc:RevenueRemainingPerformanceObligationPeriodOneMember 2021-06-30 0001006837 hchc:SpectrumSegmentMember 2022-07-01 hchc:RevenueRemainingPerformanceObligationPeriodTwoMember 2021-06-30 0001006837 hchc:SpectrumSegmentMember 2022-07-01 hchc:OtherRevenueMember hchc:RevenueRemainingPerformanceObligationPeriodTwoMember 2021-06-30 0001006837 hchc:AdvertisingRevenueMember hchc:SpectrumSegmentMember 2022-07-01 hchc:RevenueRemainingPerformanceObligationPeriodTwoMember 2021-06-30 0001006837 hchc:SpectrumSegmentMember 2022-07-01 hchc:BroadcastStationRevenueMember hchc:RevenueRemainingPerformanceObligationPeriodTwoMember 2021-06-30 0001006837 hchc:BankerSteelAcquisitionMember 2021-05-27 0001006837 hchc:BankerSteelAcquisitionMember 2021-05-27 2021-05-27 0001006837 us-gaap:RevolvingCreditFacilityMember hchc:BankerSteelAcquisitionMember 2021-05-27 0001006837 hchc:TermLoanMember hchc:BankerSteelAcquisitionMember 2021-05-27 0001006837 us-gaap:NotesPayableOtherPayablesMember hchc:BankerSteelAcquisitionMember 2021-05-27 hchc:company 0001006837 us-gaap:CustomerRelationshipsMember hchc:BankerSteelAcquisitionMember 2021-05-27 0001006837 us-gaap:CustomerRelationshipsMember hchc:BankerSteelAcquisitionMember 2021-05-27 2021-05-27 0001006837 us-gaap:TradeNamesMember hchc:BankerSteelAcquisitionMember 2021-05-27 0001006837 us-gaap:TradeNamesMember hchc:BankerSteelAcquisitionMember 2021-05-27 2021-05-27 0001006837 us-gaap:CustomerContractsMember hchc:BankerSteelAcquisitionMember 2021-05-27 0001006837 us-gaap:CustomerContractsMember hchc:BankerSteelAcquisitionMember 2021-05-27 2021-05-27 0001006837 us-gaap:LeaseAgreementsMember hchc:BankerSteelAcquisitionMember 2021-05-27 0001006837 hchc:DBMGlobalIncMember 2021-05-27 2021-05-27 0001006837 hchc:BankerSteelAcquisitionMember 2021-04-01 2021-06-30 0001006837 hchc:BankerSteelAcquisitionMember 2021-01-01 2021-06-30 0001006837 hchc:BankerSteelAcquisitionMember 2020-04-01 2020-06-30 0001006837 hchc:BankerSteelAcquisitionMember 2020-01-01 2020-06-30 0001006837 hchc:DTVAmericaMember 2021-03-31 0001006837 hchc:MinorityHoldersMember 2021-03-31 0001006837 hchc:CGIMember 2021-03-29 0001006837 hchc:CGIMember 2021-03-29 2021-03-29 0001006837 hchc:NewSaxon2019LimitedMember 2020-01-30 0001006837 hchc:GlobalMarineSystemsLimitedMember 2020-01-30 2020-01-30 0001006837 hchc:GlobalMarineSystemsLimitedMember 2020-01-30 0001006837 hchc:GlobalMarineSystemsLimitedMember 2020-02-28 2020-02-28 0001006837 us-gaap:NoncontrollingInterestMember hchc:GlobalMarineSystemsLimitedMember 2020-02-28 2020-02-28 0001006837 hchc:NoncontrollingInterestRedeemableMember hchc:GlobalMarineSystemsLimitedMember 2020-02-28 2020-02-28 0001006837 hchc:GlobalMarineSystemsLimitedMember 2020-01-01 2020-03-31 0001006837 hchc:GlobalMarineSystemsLimitedMember 2020-10-01 2020-12-31 0001006837 hchc:GlobalMarineSystemsLimitedMember 2021-01-01 2021-03-31 0001006837 hchc:HuaweiMarineNetworksMember 2019-10-30 2019-10-30 0001006837 hchc:HuaweiMarineNetworksMember 2019-10-30 0001006837 hchc:GlobalMarineSystemsLimitedMember 2019-10-30 0001006837 hchc:GlobalMarineSystemsLimitedMember 2019-10-30 0001006837 hchc:GlobalMarineSystemsLimitedMember 2020-05-12 0001006837 hchc:NewSaxon2019LimitedMember 2020-05-12 0001006837 hchc:GlobalMarineSystemsLimitedMember 2020-04-01 2020-06-30 0001006837 us-gaap:NoncontrollingInterestMember hchc:GlobalMarineSystemsLimitedMember 2020-04-01 2020-06-30 0001006837 hchc:NoncontrollingInterestRedeemableMember hchc:GlobalMarineSystemsLimitedMember 2020-04-01 2020-06-30 0001006837 hchc:GlobalMarineSystemsLimitedMember 2021-01-01 2021-06-30 0001006837 us-gaap:PutOptionMember hchc:GlobalMarineSystemsLimitedMember 2021-01-01 2021-06-30 0001006837 hchc:Beyond6Member 2021-01-15 0001006837 hchc:Beyond6Member 2021-01-15 2021-01-15 0001006837 hchc:EquipmentFurnitureAndFixturesMember 2021-06-30 0001006837 hchc:EquipmentFurnitureAndFixturesMember 2020-12-31 0001006837 hchc:BuildingAndLeaseholdImprovementsMember 2021-06-30 0001006837 hchc:BuildingAndLeaseholdImprovementsMember 2020-12-31 0001006837 us-gaap:LandMember 2021-06-30 0001006837 us-gaap:LandMember 2020-12-31 0001006837 hchc:PlantAndTransportationEquipmentMember 2021-06-30 0001006837 hchc:PlantAndTransportationEquipmentMember 2020-12-31 0001006837 us-gaap:ConstructionInProgressMember 2021-06-30 0001006837 us-gaap:ConstructionInProgressMember 2020-12-31 0001006837 hchc:FCCLicensesMember 2021-06-30 0001006837 hchc:FCCLicensesMember 2020-12-31 0001006837 hchc:StateLicensesMember 2021-06-30 0001006837 hchc:StateLicensesMember 2020-12-31 0001006837 hchc:FCCLicensesMember 2021-01-01 2021-06-30 0001006837 us-gaap:TradeNamesMember 2021-01-01 2021-06-30 0001006837 us-gaap:TradeNamesMember 2021-06-30 0001006837 us-gaap:TradeNamesMember 2020-12-31 0001006837 us-gaap:CustomerRelationshipsMember 2021-01-01 2021-06-30 0001006837 us-gaap:CustomerRelationshipsMember 2021-06-30 0001006837 us-gaap:CustomerRelationshipsMember 2020-12-31 0001006837 hchc:ChannelSharingArrangementMember 2021-01-01 2021-06-30 0001006837 hchc:ChannelSharingArrangementMember 2021-06-30 0001006837 hchc:ChannelSharingArrangementMember 2020-12-31 0001006837 us-gaap:OtherIntangibleAssetsMember 2021-01-01 2021-06-30 0001006837 us-gaap:OtherIntangibleAssetsMember 2021-06-30 0001006837 us-gaap:OtherIntangibleAssetsMember 2020-12-31 0001006837 us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:DBMGlobalCreditFacilitiesMember hchc:SeniorNotesDue20235.85Member 2021-01-01 2021-06-30 0001006837 us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:RealEstateTermAdvanceMember hchc:SeniorNotesDue20235.85Member 2021-06-30 0001006837 us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:RealEstateTermAdvanceMember hchc:SeniorNotesDue20235.85Member 2020-06-30 0001006837 hchc:SeniorNotesDue20231.5Member us-gaap:RevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:RealEstateTermAdvanceMember hchc:DBMGlobalCreditFacilitiesMember 2021-01-01 2021-06-30 0001006837 hchc:SeniorNotesDue20231.5Member us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:RealEstateTermAdvanceMember 2021-06-30 0001006837 hchc:SeniorNotesDue20231.5Member us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:RealEstateTermAdvanceMember 2020-06-30 0001006837 us-gaap:RevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:SeniorNotesDue2026325Member hchc:RealEstateTermAdvanceMember hchc:DBMGlobalCreditFacilitiesMember 2021-01-01 2021-06-30 0001006837 us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:SeniorNotesDue2026325Member hchc:RealEstateTermAdvanceMember 2021-06-30 0001006837 us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:SeniorNotesDue2026325Member hchc:RealEstateTermAdvanceMember 2020-06-30 0001006837 us-gaap:RevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:LineOfCredit215Member hchc:RealEstateTermAdvanceMember hchc:DBMGlobalCreditFacilitiesMember 2021-01-01 2021-06-30 0001006837 us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:LineOfCredit215Member hchc:RealEstateTermAdvanceMember 2021-06-30 0001006837 us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:LineOfCredit215Member hchc:RealEstateTermAdvanceMember 2020-06-30 0001006837 hchc:TrancheASeniorNotesDue2024400Member hchc:InfrastructureSegmentMember 2021-06-30 0001006837 hchc:TrancheASeniorNotesDue2024400Member us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:RealEstateTermAdvanceMember 2021-06-30 0001006837 hchc:TrancheASeniorNotesDue2024400Member us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:RealEstateTermAdvanceMember 2020-06-30 0001006837 hchc:InfrastructureSegmentMember hchc:TrancheBSeniorNotesDue2024800Member 2021-06-30 0001006837 us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:RealEstateTermAdvanceMember hchc:TrancheBSeniorNotesDue2024800Member 2021-06-30 0001006837 us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:RealEstateTermAdvanceMember hchc:TrancheBSeniorNotesDue2024800Member 2020-06-30 0001006837 us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:RealEstateTermAdvanceMember hchc:NotesPayableRevolvingLinesofCreditVariousMaturitIesMember 2021-06-30 0001006837 us-gaap:LondonInterbankOfferedRateLIBORMember hchc:InfrastructureSegmentMember hchc:RealEstateTermAdvanceMember hchc:NotesPayableRevolvingLinesofCreditVariousMaturitIesMember 2020-06-30 0001006837 hchc:InfrastructureSegmentMember 2020-06-30 0001006837 hchc:SpectrumSegmentMember hchc:TrancheASeniorNotesDue2021850Member 2021-06-30 0001006837 hchc:SpectrumSegmentMember hchc:TrancheASeniorNotesDue2021850Member 2020-06-30 0001006837 hchc:SpectrumSegmentMember hchc:TrancheBSeniorNotesDue20211050Member 2021-06-30 0001006837 hchc:SpectrumSegmentMember hchc:TrancheBSeniorNotesDue20211050Member 2020-06-30 0001006837 hchc:SpectrumSegmentMember hchc:NotesPayableRevolvingLinesofCreditVariousMaturitIesMember 2021-06-30 0001006837 hchc:SpectrumSegmentMember hchc:NotesPayableRevolvingLinesofCreditVariousMaturitIesMember 2020-06-30 0001006837 hchc:SpectrumSegmentMember 2020-06-30 0001006837 hchc:NonOperatingCorporateMember hchc:SeniorNotesDue202111.5Member 2021-06-30 0001006837 hchc:NonOperatingCorporateMember hchc:SeniorNotesDue202111.5Member 2020-06-30 0001006837 hchc:NonOperatingCorporateMember hchc:SeniorNotesDue2026850Member 2021-06-30 0001006837 hchc:NonOperatingCorporateMember hchc:SeniorNotesDue2026850Member 2020-06-30 0001006837 hchc:NonOperatingCorporateMember hchc:ConvertibleSeniorNotesDue20227.5Member 2021-06-30 0001006837 hchc:NonOperatingCorporateMember hchc:ConvertibleSeniorNotesDue20227.5Member 2020-06-30 0001006837 hchc:NonOperatingCorporateMember hchc:ConvertibleSeniorNotesDue2026750Member 2021-06-30 0001006837 hchc:NonOperatingCorporateMember hchc:ConvertibleSeniorNotesDue2026750Member 2020-06-30 0001006837 hchc:NonOperatingCorporateMember hchc:LineOfCredit575Member 2021-01-01 2021-06-30 0001006837 hchc:NonOperatingCorporateMember hchc:LineOfCredit575Member 2021-06-30 0001006837 hchc:NonOperatingCorporateMember hchc:LineOfCredit575Member 2020-06-30 0001006837 srt:MinimumMember 2021-01-01 2021-06-30 0001006837 srt:MaximumMember 2021-01-01 2021-06-30 0001006837 hchc:TermLoanMember hchc:UMBBankMember 2021-05-31 0001006837 us-gaap:RevolvingCreditFacilityMember hchc:UMBBankMember 2021-05-31 0001006837 us-gaap:RevolvingCreditFacilityMember us-gaap:PrimeRateMember hchc:UMBBankMember 2021-05-31 2021-05-31 0001006837 us-gaap:RevolvingCreditFacilityMember hchc:TWCAssetManagementCompanyLLCMember 2021-05-27 2021-05-27 0001006837 hchc:NonOperatingCorporateMember hchc:SeniorNotesDue2026850Member 2021-02-01 2021-02-01 0001006837 hchc:NonOperatingCorporateMember hchc:SeniorNotesDue2026850Member 2021-02-01 0001006837 hchc:NonOperatingCorporateMember hchc:ConvertibleSeniorNotesDue20227.5Member 2021-02-01 0001006837 hchc:NonOperatingCorporateMember hchc:ConvertibleSeniorNotesDue20227.5Member 2021-02-01 2021-02-01 0001006837 hchc:NonOperatingCorporateMember hchc:SeniorNotesDue202111.5Member 2021-02-01 2021-02-01 0001006837 hchc:SeniorNotesDue2026850Member 2021-02-01 0001006837 hchc:ConvertibleSeniorNotesDue2026750Member 2021-02-01 0001006837 hchc:HC2BroadcastingHoldingsIncMember hchc:ConvertibleSeniorNotesDue2026750Member 2021-02-01 0001006837 hchc:NonOperatingCorporateMember hchc:ConvertibleSeniorNotesDue2026750Member 2021-02-01 2021-02-01 0001006837 hchc:ConvertibleSeniorNotesDue2026750Member 2021-06-30 0001006837 hchc:ConvertibleSeniorNotesDue2026750Member 2021-01-01 2021-06-30 0001006837 hchc:NonOperatingCorporateMember hchc:LineOfCredit575Member 2021-02-23 2021-02-23 0001006837 us-gaap:RevolvingCreditFacilityMember hchc:RevolvingCreditAgreementMember us-gaap:LineOfCreditMember 2021-02-23 0001006837 hchc:NonOperatingCorporateMember srt:MinimumMember hchc:LineOfCredit575Member 2021-02-23 2021-02-23 0001006837 srt:MaximumMember hchc:NonOperatingCorporateMember hchc:LineOfCredit575Member 2021-02-23 2021-02-23 0001006837 us-gaap:RevolvingCreditFacilityMember hchc:RevolvingCreditAgreementMember us-gaap:LineOfCreditMember 2021-05-31 0001006837 hchc:ConvertibleSeniorNotesDue2026750Member 2021-02-01 2021-02-01 0001006837 us-gaap:CommonStockMember 2021-06-30 0001006837 us-gaap:CommonStockMember 2020-12-31 0001006837 us-gaap:PreferredStockMember 2021-06-30 0001006837 us-gaap:PreferredStockMember 2020-12-31 0001006837 us-gaap:FixedMaturitiesMember 2021-06-30 0001006837 us-gaap:FixedMaturitiesMember 2020-12-31 0001006837 us-gaap:CorporateJointVentureMember 2021-06-30 0001006837 us-gaap:CorporateJointVentureMember 2020-12-31 0001006837 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-06-30 0001006837 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-06-30 0001006837 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel1Member 2021-06-30 0001006837 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel2Member 2021-06-30 0001006837 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel3Member 2021-06-30 0001006837 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-12-31 0001006837 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-12-31 0001006837 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0001006837 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001006837 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0001006837 us-gaap:DomesticCountryMember 2020-12-31 0001006837 us-gaap:ForeignCountryMember 2020-12-31 0001006837 us-gaap:ForeignCountryMember hchc:EnergySegmentMember 2021-03-31 0001006837 2020-01-01 2020-12-31 0001006837 hchc:CoronavirusAidReliefAndEconomicSecurityCARESActMember 2021-06-30 0001006837 hchc:CoronavirusAidReliefAndEconomicSecurityCARESActMember us-gaap:AccruedLiabilitiesMember 2021-06-30 0001006837 hchc:CoronavirusAidReliefAndEconomicSecurityCARESActMember us-gaap:OtherLiabilitiesMember 2021-06-30 hchc:plaintiff 0001006837 hchc:DTVAmericaCorporationStockholdersMember 2021-03-15 2021-03-15 0001006837 hchc:DTVAmericaCorporationStockOptionHoldersMember 2021-03-15 2021-03-15 0001006837 us-gaap:RestrictedStockMember 2019-12-31 0001006837 us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0001006837 us-gaap:RestrictedStockMember 2020-12-31 0001006837 us-gaap:RestrictedStockMember 2021-01-01 2021-06-30 0001006837 us-gaap:RestrictedStockMember 2021-06-30 0001006837 us-gaap:EmployeeStockOptionMember 2021-06-30 0001006837 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-06-30 0001006837 us-gaap:SeriesAPreferredStockMember 2021-06-30 0001006837 us-gaap:SeriesAPreferredStockMember 2020-12-31 0001006837 hchc:SeriesA2PreferredStockMember 2021-06-30 0001006837 hchc:SeriesA2PreferredStockMember 2020-12-31 0001006837 us-gaap:SeriesAPreferredStockMember us-gaap:CorporateMember hchc:CGIMember 2018-12-20 0001006837 hchc:SeriesATwoPreferredStockMember us-gaap:CorporateMember hchc:CGIMember 2019-01-11 2019-01-11 0001006837 us-gaap:SeriesAPreferredStockMember hchc:CGIMember 2018-12-20 0001006837 us-gaap:SeriesAPreferredStockMember hchc:CGIMember 2018-12-18 0001006837 hchc:DGValuePartnersLPandDGValuePartnersIIMasterFundsLPMember us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001006837 hchc:SeriesATwoPreferredStockMember hchc:CGIMember 2019-01-11 2019-01-11 0001006837 hchc:CGIMember us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001006837 hchc:CorribMasterFundLtd.Member us-gaap:SeriesAPreferredStockMember 2016-08-02 2016-08-02 0001006837 hchc:SeriesA1PreferredStockMember hchc:LuxorCapitalPartnersLPMember 2016-08-02 2016-08-02 0001006837 hchc:CorribMasterFundLtd.andLuxorCapitalPartnersLPMember 2021-01-01 2021-06-30 0001006837 us-gaap:SeriesAPreferredStockMember hchc:LuxorCapitalPartnersLPMember 2021-01-01 2021-06-30 0001006837 hchc:CorribMasterFundLtd.Member us-gaap:SeriesAPreferredStockMember 2021-01-01 2021-06-30 0001006837 us-gaap:SeriesAPreferredStockMember hchc:LuxorCapitalPartnersLPMember 2020-01-01 2020-06-30 0001006837 hchc:CorribMasterFundLtd.Member us-gaap:SeriesAPreferredStockMember 2020-01-01 2020-06-30 0001006837 us-gaap:CommonStockMember 2021-05-29 2021-05-29 0001006837 hchc:CGIMember 2021-05-29 0001006837 hchc:TripleRingMember srt:AffiliatedEntityMember 2021-04-01 2021-06-30 0001006837 hchc:TripleRingMember srt:AffiliatedEntityMember 2020-04-01 2020-06-30 0001006837 hchc:TripleRingMember srt:AffiliatedEntityMember 2021-01-01 2021-06-30 0001006837 hchc:TripleRingMember srt:AffiliatedEntityMember 2020-01-01 2020-06-30 0001006837 2018-09-01 2018-09-30 hchc:space 0001006837 srt:AffiliatedEntityMember hchc:OfficeSpaceMember hchc:BankerSteelMember 2021-01-01 2021-06-30 0001006837 srt:AffiliatedEntityMember hchc:OfficeSpaceMember hchc:BankerSteelMember 2021-06-30 0001006837 srt:AffiliatedEntityMember hchc:OfficeSpaceMember hchc:BankerSteelMember 2021-04-01 2021-06-30 0001006837 srt:AffiliatedEntityMember hchc:OfficeSpaceMember hchc:BankerSteelMember 2020-04-01 2020-06-30 0001006837 srt:AffiliatedEntityMember hchc:OfficeSpaceMember hchc:BankerSteelMember 2020-01-01 2020-06-30 hchc:plane 0001006837 hchc:PlanesMember srt:AffiliatedEntityMember hchc:BankerSteelMember 2021-05-01 2021-05-31 0001006837 hchc:PlanesMember srt:AffiliatedEntityMember hchc:BankerSteelMember 2021-01-01 2021-06-30 0001006837 hchc:PlanesMember srt:AffiliatedEntityMember hchc:BankerSteelMember 2021-06-30 0001006837 hchc:PlanesMember srt:AffiliatedEntityMember hchc:BankerSteelMember 2021-04-01 2021-06-30 0001006837 hchc:PlanesMember srt:AffiliatedEntityMember hchc:BankerSteelMember 2020-04-01 2020-06-30 0001006837 hchc:PlanesMember srt:AffiliatedEntityMember hchc:BankerSteelMember 2020-01-01 2020-06-30 0001006837 hchc:BankerSteelAcquisitionMember us-gaap:SubordinatedDebtMember 2021-06-30 0001006837 hchc:BankerSteelAcquisitionMember us-gaap:SubordinatedDebtMember 2021-05-27 2021-05-27 0001006837 us-gaap:SubordinatedDebtMember 2021-04-01 2021-06-30 0001006837 us-gaap:SubordinatedDebtMember 2020-04-01 2020-06-30 0001006837 us-gaap:SubordinatedDebtMember 2021-01-01 2021-06-30 0001006837 us-gaap:SubordinatedDebtMember 2020-01-01 2020-06-30 0001006837 us-gaap:AllOtherSegmentsMember us-gaap:OperatingSegmentsMember 2021-04-01 2021-06-30 0001006837 us-gaap:AllOtherSegmentsMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0001006837 us-gaap:AllOtherSegmentsMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-06-30 0001006837 us-gaap:AllOtherSegmentsMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0001006837 us-gaap:CorporateNonSegmentMember 2021-04-01 2021-06-30 0001006837 us-gaap:CorporateNonSegmentMember 2020-04-01 2020-06-30 0001006837 us-gaap:CorporateNonSegmentMember 2021-01-01 2021-06-30 0001006837 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-06-30 0001006837 hchc:InfrastructureSegmentMember us-gaap:OperatingSegmentsMember 2021-06-30 0001006837 hchc:InfrastructureSegmentMember us-gaap:OperatingSegmentsMember 2020-12-31 0001006837 hchc:LifeSciencesMember us-gaap:OperatingSegmentsMember 2021-06-30 0001006837 hchc:LifeSciencesMember us-gaap:OperatingSegmentsMember 2020-12-31 0001006837 us-gaap:AllOtherSegmentsMember us-gaap:OperatingSegmentsMember 2021-06-30 0001006837 us-gaap:AllOtherSegmentsMember us-gaap:OperatingSegmentsMember 2020-12-31 0001006837 hchc:SpectrumSegmentMember us-gaap:OperatingSegmentsMember 2021-06-30 0001006837 hchc:SpectrumSegmentMember us-gaap:OperatingSegmentsMember 2020-12-31 0001006837 us-gaap:OperatingSegmentsMember hchc:InsuranceServicesMember 2021-06-30 0001006837 us-gaap:OperatingSegmentsMember hchc:InsuranceServicesMember 2020-12-31 0001006837 us-gaap:CorporateNonSegmentMember 2021-06-30 0001006837 us-gaap:CorporateNonSegmentMember 2020-12-31 0001006837 us-gaap:IntersegmentEliminationMember 2021-06-30 0001006837 us-gaap:IntersegmentEliminationMember 2020-12-31 0001006837 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:SubsequentEventMember hchc:ContinentalGeneralInsuranceCompanyAndContinentalLTCIncMember 2021-07-01 2021-07-01 0001006837 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:SubsequentEventMember hchc:ContinentalGeneralInsuranceCompanyAndContinentalLTCIncMember 2021-07-01 0001006837 hchc:MichaelGorzynskMember us-gaap:SubsequentEventMember 2021-07-01 0001006837 hchc:NonCoreAssetsMember us-gaap:SubsequentEventMember 2021-07-14 0001006837 hchc:NonCoreAssetsMember us-gaap:SubsequentEventMember 2021-08-02 0001006837 hchc:R2DermatologyInc.Member us-gaap:SubsequentEventMember 2021-07-21 2021-07-21 0001006837 hchc:R2DermatologyInc.Member us-gaap:SubsequentEventMember 2021-07-21
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended June 30, 2021
OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File No. 001-35210

HC2 HOLDINGS, INC. (Exact name of registrant as specified in its charter)

Delaware |  | 54-1708481
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
295 Madison Avenue, 12th Floor, New York, NY |  | 10017
(Address of principal executive offices) |  | (Zip Code)

(212) 235-2690
(Registrant’s telephone number, including area code)
_____________________________________________________________________________________________________________________
Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol | Name of each exchange on which registered
Common Stock, par value $0.001 per share | HCHC | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act.:

Large accelerated filer | ☐ | Accelerated filer | ☒
Non-accelerated filer | ☐ | Smaller reporting company | ☒
Emerging growth company | ☐ |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ý
As of July 30, 2021, 77,819,782 shares of common stock, par value $0.001, were outstanding.
F-1

HC2 HOLDINGS, INC.
INDEX TO FORM 10-Q

PART I - FINANCIAL INFORMATION
Item 1. Financial Statement s (unaudited) | 1
Condensed Consolidated Statements of Operations | 2
Condensed Consolidated Statements of Comprehensive Income (Los s) | 3
Condensed Consolidated Balance Sheets | 4
Condensed Consolidated Statements of Stockholders’ Equity | 5
Condensed Consolidated Statements of Cash Flows | 7
Notes to Condensed Consolidated Financial Statements | 8
(1) Organization and Business | 8
(2) Summary of Significant Accounting Policies | 9
(3) Discontinued Operations | 11
(4) Revenue | 13
(5) Business Combinations | 15
(6) Accounts Receivable | 18
(7) Property, Plant and Equipment, net | 19
(8) Goodwill and Intangible Assets | 19
(9) Debt Obligations | 21
(10) Supplementary Financial Information | 22
(11) Leases | 24
(12) Income Taxes | 25
(13) Commitments and Contingencies | 25
(14) Share-based Compensation | 28
(15) Equity | 29
(16) Related Parties | 31
(17) Operating Segment and Related Information | 31
(18) Basic and Diluted Income (Loss) Per Common Share | 33
(19) Subsequent Events | 34
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations | 35
Item 4. Controls and Procedures | 57

| PART II. OTHER INFORMATION |
Item 1. | Legal Proceedings | 58
Item 1A. | Risk Factors | 58
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 58
Item 3. | Defaults Upon Senior Securities | 58
Item 4. | Mine Safety Disclosures | 58
Item 5. | Other Information | 58
Item 6. | Exhibits | 58

F-1

HC2 HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, in millions, except per share amounts)
PART I: FINANCIAL INFORMATION
Item 1. Financial Statements

| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Revenue | $ | 243.8 |  |  | $ | 181.8 |  |  | $ | 415.6 |  |  | $ | 368.4 |
Cost of revenue | 207.4 |  |  | 152.1 |  |  | 348.7 |  |  | 308.9 |
Gross profit | 36.4 |  |  | 29.7 |  |  | 66.9 |  |  | 59.5 |
Operating expenses: |  |  |  |  |  |  |
Selling, general and administrative | 39.5 |  |  | 36.4 |  |  | 76.6 |  |  | 75.3 |
Depreciation and amortization | 4.8 |  |  | 4.5 |  |  | 8.7 |  |  | 8.8 |
Other operating (income) loss | (0.2) |  |  | (2.3) |  |  | 0.2 |  |  | (2.1) |
Loss from operations | (7.7) |  |  | (8.9) |  |  | (18.6) |  |  | (22.5) |
Other (expense) income: |  |  |  |  |  |  |
Interest expense | (12.4) |  |  | (19.1) |  |  | (33.8) |  |  | (38.3) |
Loss on early extinguishment or restructuring of debt | (1.6) |  |  | (3.4) |  |  | (12.4) |  |  | (9.2) |
Income (loss) from equity investees | 0.2 |  |  | (0.2) |  |  | (1.9) |  |  | (2.7) |
Other income | 0.4 |  |  | 64.6 |  |  | 3.8 |  |  | 66.1 |
(Loss) income from continuing operations before income taxes | (21.1) |  |  | 33.0 |  |  | (62.9) |  |  | (6.6) |
Income tax expense | (2.6) |  |  | (12.0) |  |  | (3.7) |  |  | (2.3) |
(Loss) income from continuing operations | (23.7) |  |  | 21.0 |  |  | (66.6) |  |  | (8.9) |
(Loss) income from discontinued operations (including gain on disposal of $40.4 million and loss on disposal of $39.3 million for the six months ended June 30, 2021 and 2020, respectively) | (1.5) |  |  | 7.5 |  |  | 50.4 |  |  | (63.6) |
Net (loss) income | (25.2) |  |  | 28.5 |  |  | (16.2) |  |  | (72.5) |
Net income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest | 1.7 |  |  | (15.4) |  |  | 5.3 |  |  | 2.5 |
Net (loss) income attributable to HC2 Holdings, Inc. | (23.5) |  |  | 13.1 |  |  | (10.9) |  |  | (70.0) |
Less: Preferred dividends and deemed dividends from conversions | 0.2 |  |  | 0.4 |  |  | 0.6 |  |  | 0.8 |
Net (loss) income attributable to common stock and participating preferred stockholders | $ | (23.7) |  |  | $ | 12.7 |  |  | $ | (11.5) |  |  | $ | (70.8) |
(Loss) income per common share - continuing operations |  |  |  |  |  |  |
Basic | $ | (0.29) |  |  | $ | 0.11 |  |  | $ | (0.82) |  |  | $ | (0.48) |
Diluted | $ | (0.29) |  |  | $ | 0.11 |  |  | $ | (0.82) |  |  | $ | (0.48) |
(Loss) income per common share - discontinued operations |  |  |  |  |  |  |
Basic | $ | (0.02) |  |  | $ | 0.15 |  |  | $ | 0.67 |  |  | $ | (1.06) |
Diluted | $ | (0.02) |  |  | $ | 0.14 |  |  | $ | 0.67 |  |  | $ | (1.06) |
(Loss) income per share - Net (loss) income attributable to common stock and participating preferred stockholders |  |  |  |  |  |  |
Basic | $ | (0.31) |  |  | $ | 0.26 |  |  | $ | (0.15) |  |  | $ | (1.54) |
Diluted | $ | (0.31) |  |  | $ | 0.25 |  |  | $ | (0.15) |  |  | $ | (1.54) |
Weighted average common shares outstanding: |  |  |  |  |  |  |
Basic | 77.0 |  |  | 46.8 |  |  | 77.1 |  |  | 45.9 |
Diluted | 77.0 |  |  | 48.8 |  |  | 77.1 |  |  | 45.9 |

See notes to Condensed Consolidated Financial Statements
F-2

HC2 HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited, in millions)

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Net (loss) income |  | $ | (25.2) |  |  | $ | 28.5 |  |  | $ | (16.2) |  |  | $ | (72.5) |
Other comprehensive income (loss) |  |  |  |  |  |  |  |
Foreign currency translation adjustment |  | (0.4) |  |  | 3.8 |  |  | (1.2) |  |  | 4.0 |
Unrealized income (loss) on available-for-sale securities |  | 123.5 |  |  | 283.8 |  |  | (57.7) |  |  | 7.8 |
Dispositions |  | — |  |  | (0.7) |  |  | — |  |  | 22.1 |
Other comprehensive income (loss) |  | 123.1 |  |  | 286.9 |  |  | (58.9) |  |  | 33.9 |
Comprehensive income (loss) |  | 97.9 |  |  | 315.4 |  |  | (75.1) |  |  | (38.6) |
Comprehensive (loss) income attributable to noncontrolling interests and redeemable noncontrolling interests |  | (1.7) |  |  | 16.2 |  |  | (5.4) |  |  | 7.3 |
Comprehensive income (loss) attributable to HC2 Holdings, Inc. |  | $ | 96.2 |  |  | $ | 331.6 |  |  | $ | (80.5) |  |  | $ | (31.3) |

See notes to Condensed Consolidated Financial Statements
F-3

HC2 HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited, in millions, except share amounts)

|  | June 30, 2021 |  | December 31, 2020
Assets |  |  |  |
Current assets |  |  |  |
Cash and cash equivalents |  | $ | 18.1 |  |  | $ | 43.8 |
Accounts receivable, net |  | 364.6 |  |  | 184.7 |
Costs and recognized earnings in excess of billings on uncompleted contracts |  | 63.7 |  |  | 55.6 |
Assets held for sale |  | 5,812.4 |  |  | 5,942.1 |
Other current assets |  | 28.9 |  |  | 20.1 |
Total current assets |  | 6,287.7 |  |  | 6,246.3 |
Investments |  | 53.1 |  |  | 55.4 |
Deferred tax asset |  | 2.0 |  |  | 3.0 |
Property, plant and equipment, net |  | 173.3 |  |  | 112.8 |
Goodwill |  | 121.1 |  |  | 111.0 |
Intangibles, net |  | 222.0 |  |  | 172.1 |
Other assets |  | 76.7 |  |  | 42.2 |
Total assets |  | $ | 6,935.9 |  |  | $ | 6,742.8 |
Liabilities, temporary equity and stockholders’ equity |  |  |  |
Current liabilities |  |  |  |
Accounts payable |  | $ | 135.1 |  |  | $ | 69.7 |
Accrued liabilities |  | 101.9 |  |  | 77.1 |
Current portion of debt obligations |  | 70.2 |  |  | 433.6 |
Billings in excess of costs and recognized earnings on uncompleted contracts |  | 146.8 |  |  | 52.2 |
Liabilities held for sale |  | 5,261.6 |  |  | 5,306.7 |
Other current liabilities |  | 18.7 |  |  | 12.9 |
Total current liabilities |  | 5,734.3 |  |  | 5,952.2 |
Deferred tax liability |  | 7.0 |  |  | 7.0 |
Debt obligations |  | 606.3 |  |  | 127.9 |
Other liabilities |  | 70.6 |  |  | 39.8 |
Total liabilities |  | 6,418.2 |  |  | 6,126.9 |
Commitments and contingencies |  |  |  |
Temporary equity |  |  |  |
Preferred stock |  | — |  |  | 10.4 |
Redeemable noncontrolling interest |  | 6.2 |  |  | 5.3 |
Total temporary equity |  | 6.2 |  |  | 15.7 |
Stockholders’ equity |  |  |  |
Common stock, $0.001 par value |  | 0.1 |  |  | 0.1 |
Shares authorized: 160,000,000 at June 30, 2021 and December 31, 2020, respectively |  |  |  |
Shares issued: 79,208,998 and 77,836,586 at June 30, 2021 and December 31, 2020, respectively |  |  |  |
Shares outstanding: 77,823,942 and 76,726,835 at June 30, 2021 and December 31, 2020, respectively |  |  |  |
Additional paid-in capital |  | 354.8 |  |  | 355.7 |
Treasury stock, at cost: 1,385,056 and 1,109,751 shares at June 30, 2021 and December 31, 2020, respectively |  | (5.2) |  |  | (4.2) |
Accumulated deficit |  | (199.6) |  |  | (188.7) |
Accumulated other comprehensive income |  | 338.2 |  |  | 396.9 |
Total HC2 Holdings, Inc. stockholders’ equity |  | 488.3 |  |  | 559.8 |
Noncontrolling interest |  | 23.2 |  |  | 40.4 |
Total stockholders’ equity |  | 511.5 |  |  | 600.2 |
Total liabilities, temporary equity and stockholders’ equity |  | $ | 6,935.9 |  |  | $ | 6,742.8 |

See notes to Condensed Consolidated Financial Statements
F-4

HC2 HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited, in millions)

|  | Common Stock |  | Additional Paid-In Capital |  | Treasury Stock |  | Accumulated Deficit |  | Accumulated Other Comprehensive Income (Loss) |  | Total HC2 Stockholders' Equity |  | Non- controlling Interest |  | Total Stockholders’ Equity |  | Temporary Equity
|  | Shares |  | Amount |  |  |
Balance as of March 31, 2021 |  | 77.6 |  |  | $ | 0.1 |  |  | $ | 355.7 |  |  | $ | (5.2) |  |  | $ | (176.1) |  |  | $ | 215.1 |  |  | $ | 389.6 |  |  | $ | 23.9 |  |  | $ | 413.5 |  |  | $ | 18.0 |
Share-based compensation |  | — |  |  | — |  |  | 0.6 |  |  | — |  |  | — |  |  | — |  |  | 0.6 |  |  | — |  |  | 0.6 |  |  | — |
Fair value adjustment of redeemable noncontrolling interest |  | — |  |  | — |  |  | (0.1) |  |  | — |  |  | — |  |  | — |  |  | (0.1) |  |  | — |  |  | (0.1) |  |  | 0.1 |
Preferred stock dividend |  | — |  |  | — |  |  | (0.1) |  |  | — |  |  | — |  |  | — |  |  | (0.1) |  |  | — |  |  | (0.1) |  |  | — |
Issuance of common stock |  | 0.2 |  |  | — |  |  | 0.5 |  |  | — |  |  | — |  |  | — |  |  | 0.5 |  |  | — |  |  | 0.5 |  |  | — |
Purchase of preferred stock by subsidiary |  | — |  |  | — |  |  | (0.2) |  |  | — |  |  | — |  |  | — |  |  | (0.2) |  |  | — |  |  | (0.2) |  |  | — |
Redemption of Series A and A-2 Preferred Stock |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (10.4) |
Transactions with noncontrolling interests |  | — |  |  | — |  |  | (1.6) |  |  | — |  |  | — |  |  | — |  |  | (1.6) |  |  | (0.5) |  |  | (2.1) |  |  | — |
Net loss |  | — |  |  | — |  |  | — |  |  | — |  |  | (23.5) |  |  | — |  |  | (23.5) |  |  | (0.2) |  |  | (23.7) |  |  | (1.5) |
Other comprehensive income |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 123.1 |  |  | 123.1 |  |  | — |  |  | 123.1 |  |  | — |
Balance as of June 30, 2021 |  | 77.8 |  |  | $ | 0.1 |  |  | $ | 354.8 |  |  | $ | (5.2) |  |  | $ | (199.6) |  |  | $ | 338.2 |  |  | $ | 488.3 |  |  | $ | 23.2 |  |  | $ | 511.5 |  |  | $ | 6.2 |

|  | Common Stock |  | Additional Paid-In Capital |  | Treasury Stock |  | Accumulated Deficit |  | Accumulated Other Comprehensive Income (Loss) |  | Total HC2 Stockholders' Equity |  | Non- controlling Interest |  | Total Stockholders’ Equity |  | Temporary Equity
|  | Shares |  | Amount |  |  |
Balance as of December 31, 2020 |  | 76.7 |  |  | $ | 0.1 |  |  | $ | 355.7 |  |  | $ | (4.2) |  |  | $ | (188.7) |  |  | $ | 396.9 |  |  | $ | 559.8 |  |  | $ | 40.4 |  |  | $ | 600.2 |  |  | $ | 15.7 |
Share-based compensation |  | — |  |  | — |  |  | 1.3 |  |  | — |  |  | — |  |  | — |  |  | 1.3 |  |  | — |  |  | 1.3 |  |  | — |
Fair value adjustment of redeemable noncontrolling interest |  | — |  |  | — |  |  | (0.3) |  |  | — |  |  | — |  |  | — |  |  | (0.3) |  |  | — |  |  | (0.3) |  |  | 0.3 |
Taxes paid in lieu of shares issued for share-based compensation |  | — |  |  | — |  |  | — |  |  | (1.0) |  |  | — |  |  | — |  |  | (1.0) |  |  | — |  |  | (1.0) |  |  | — |
Preferred stock dividend |  | — |  |  | — |  |  | (0.3) |  |  | — |  |  | — |  |  | — |  |  | (0.3) |  |  | — |  |  | (0.3) |  |  | — |
Issuance of common stock |  | 1.1 |  |  | — |  |  | 0.7 |  |  | — |  |  | — |  |  | — |  |  | 0.7 |  |  | — |  |  | 0.7 |  |  | — |
Purchase of preferred stock by subsidiary |  | — |  |  | — |  |  | (0.2) |  |  | — |  |  | — |  |  | — |  |  | (0.2) |  |  | — |  |  | (0.2) |  |  | — |
Redemption of Series A and A-2 Preferred Stock |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (10.4) |
Transactions with noncontrolling interests |  | — |  |  | — |  |  | 0.8 |  |  | — |  |  | — |  |  | — |  |  | 0.8 |  |  | (15.0) |  |  | (14.2) |  |  | 3.8 |
Other |  | — |  |  | — |  |  | (2.9) |  |  | — |  |  | — |  |  | — |  |  | (2.9) |  |  | — |  |  | (2.9) |  |  | — |
Net loss |  | — |  |  | — |  |  | — |  |  | — |  |  | (10.9) |  |  | — |  |  | (10.9) |  |  | (2.1) |  |  | (13.0) |  |  | (3.2) |
Other comprehensive loss |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (58.7) |  |  | (58.7) |  |  | (0.1) |  |  | (58.8) |  |  | — |
Balance as of June 30, 2021 |  | 77.8 |  |  | $ | 0.1 |  |  | $ | 354.8 |  |  | $ | (5.2) |  |  | $ | (199.6) |  |  | $ | 338.2 |  |  | $ | 488.3 |  |  | $ | 23.2 |  |  | $ | 511.5 |  |  | $ | 6.2 |

See notes to Condensed Consolidated Financial Statements
F-5

HC2 HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited, in millions)

|  | Common Stock |  | Additional Paid-In Capital |  | Treasury Stock |  | Accumulated Deficit |  | Accumulated Other Comprehensive Income (Loss) |  | Total HC2 Stockholders' Equity |  | Non- controlling Interest |  | Total Stockholders’ Equity |  | Temporary Equity
|  | Shares |  | Amount |  |  |
Balance as of March 31, 2020 |  | 46.5 |  |  | $ | — |  |  | $ | 282.7 |  |  | $ | (4.2) |  |  | $ | (179.8) |  |  | $ | (84.6) |  |  | $ | 14.1 |  |  | $ | 46.4 |  |  | $ | 60.5 |  |  | $ | 18.6 |
Share-based compensation |  | — |  |  | — |  |  | 0.3 |  |  | — |  |  | — |  |  | — |  |  | 0.3 |  |  | — |  |  | 0.3 |  |  | — |
Fair value adjustment of redeemable noncontrolling interest |  | — |  |  | — |  |  | 2.9 |  |  | — |  |  | — |  |  | — |  |  | 2.9 |  |  | — |  |  | 2.9 |  |  | (2.9) |
Preferred stock dividend |  | — |  |  | — |  |  | (0.2) |  |  | — |  |  | — |  |  | — |  |  | (0.2) |  |  | — |  |  | (0.2) |  |  | — |
Issuance of common stock |  | 0.1 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Transactions with noncontrolling interests |  | — |  |  | — |  |  | 2.8 |  |  | — |  |  | — |  |  | — |  |  | 2.8 |  |  | (15.2) |  |  | (12.4) |  |  | 1.5 |
Net income |  | — |  |  | — |  |  | — |  |  | — |  |  | 13.1 |  |  | — |  |  | 13.1 |  |  | 14.0 |  |  | 27.1 |  |  | 1.4 |
Other comprehensive income |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 286.3 |  |  | 286.3 |  |  | 0.7 |  |  | 287.0 |  |  | 0.1 |
Balance as of June 30, 2020 |  | 46.6 |  |  | $ | — |  |  | $ | 288.5 |  |  | $ | (4.2) |  |  | $ | (166.7) |  |  | $ | 201.7 |  |  | $ | 319.3 |  |  | $ | 45.9 |  |  | $ | 365.2 |  |  | $ | 18.7 |

|  | Common Stock |  | Additional Paid-In Capital |  | Treasury Stock |  | Accumulated Deficit |  | Accumulated Other Comprehensive Income (Loss) |  | Total HC2 Stockholders' Equity |  | Non- controlling Interest |  | Total Stockholders’ Equity |  | Temporary Equity
|  | Shares |  | Amount |  |  |
Balance as of December 31, 2019 |  | 46.1 |  |  | $ | — |  |  | $ | 281.1 |  |  | $ | (3.3) |  |  | $ | (96.7) |  |  | $ | 168.7 |  |  | $ | 349.8 |  |  | $ | 93.8 |  |  | $ | 443.6 |  |  | $ | 21.6 |
Share-based compensation |  | — |  |  | — |  |  | 2.9 |  |  | — |  |  | — |  |  | — |  |  | 2.9 |  |  | — |  |  | 2.9 |  |  | — |
Fair value adjustment of redeemable noncontrolling interest |  | — |  |  | — |  |  | (1.2) |  |  | — |  |  | — |  |  | — |  |  | (1.2) |  |  | — |  |  | (1.2) |  |  | 1.2 |
Taxes paid in lieu of shares issued for share-based compensation |  | (0.4) |  |  | — |  |  | — |  |  | (0.9) |  |  | — |  |  | — |  |  | (0.9) |  |  | — |  |  | (0.9) |  |  | — |
Preferred stock dividend |  | — |  |  | — |  |  | (0.4) |  |  | — |  |  | — |  |  | — |  |  | (0.4) |  |  | — |  |  | (0.4) |  |  | — |
Issuance of common stock |  | 0.9 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Transactions with noncontrolling interests |  | — |  |  | — |  |  | 6.1 |  |  | — |  |  | — |  |  | — |  |  | 6.1 |  |  | (55.3) |  |  | (49.2) |  |  | (4.0) |
Net loss |  | — |  |  | — |  |  | — |  |  | — |  |  | (70.0) |  |  | — |  |  | (70.0) |  |  | (1.0) |  |  | (71.0) |  |  | (1.5) |
Other comprehensive income |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 33.0 |  |  | 33.0 |  |  | 8.4 |  |  | 41.4 |  |  | 1.4 |
Balance as of June 30, 2020 |  | 46.6 |  |  | $ | — |  |  | $ | 288.5 |  |  | $ | (4.2) |  |  | $ | (166.7) |  |  | $ | 201.7 |  |  | $ | 319.3 |  |  | $ | 45.9 |  |  | $ | 365.2 |  |  | $ | 18.7 |

See notes to Condensed Consolidated Financial Statements
F-6

HC2 HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in millions)

|  | Six Months Ended June 30,
|  | 2021 |  | 2020
Cash flows from operating activities |  |  |  |
Net loss |  | $ | (16.2) |  |  | $ | (72.5) |
Less: Income (loss) from discontinued operations, net of tax |  | 50.4 |  |  | (63.6) |
|  | (66.6) |  |  | (8.9) |
Adjustments to reconcile net loss to cash provided by operating activities |  |  |  |
Share-based compensation expense |  | 1.3 |  |  | 1.7 |
Depreciation and amortization |  | 13.8 |  |  | 13.4 |
Amortization of deferred financing costs and debt discount |  | 8.3 |  |  | 7.0 |
Loss on extinguishment of debt |  | 12.4 |  |  | 9.2 |
Loss from equity investees |  | 1.9 |  |  | 2.7 |
Asset impairment expense |  | 2.2 |  |  | 0.1 |
Net realized and unrealized gains on investments |  | — |  |  | (72.5) |
Deferred income taxes |  | 1.3 |  |  | — |
Other operating activities |  | (4.6) |  |  | 1.2 |
Changes in assets and liabilities, net of acquisitions: |  |  |  |
Accounts receivable |  | (67.9) |  |  | 23.3 |
Costs and recognized earnings in excess of billings on uncompleted contracts |  | (6.1) |  |  | (7.2) |
Other current assets |  | 0.5 |  |  | (8.2) |
Other assets |  | 5.5 |  |  | 3.1 |
Accounts payable |  | 24.6 |  |  | 6.5 |
Accrued liabilities |  | 25.3 |  |  | 12.0 |
Billings in excess of costs and recognized earnings on uncompleted contracts |  | 39.6 |  |  | 17.5 |
Other current liabilities |  | (26.0) |  |  | (17.1) |
Other liabilities |  | (0.2) |  |  | 8.1 |
Cash used in operating activities |  | (34.7) |  |  | (8.1) |
Cash provided by discontinued operating activities |  | 34.3 |  |  | 55.9 |
Cash (used in) provided by continuing operating activities |  | (0.4) |  |  | 47.8 |
Cash flows from investing activities |  |  |  |
Purchase of property, plant and equipment |  | (8.0) |  |  | (10.0) |
Proceeds from disposal of property, plant and equipment |  | 1.1 |  |  | 0.6 |
Sale of investments |  | — |  |  | 85.5 |
Cash received from dispositions, net of cash disposed |  | 71.2 |  |  | 144.0 |
Cash paid for acquisitions, net of cash acquired |  | (128.5) |  |  | — |
Other investing activities |  | 1.4 |  |  | 3.5 |
Cash (used in) provided by investing activities |  | (62.8) |  |  | 223.6 |
Cash (used in) provided by discontinued investing activities |  | 31.6 |  |  | (84.7) |
Cash (used in) provided by continuing investing activities |  | (31.2) |  |  | 138.9 |
Cash flows from financing activities |  |  |  |
Proceeds from debt obligations |  | 528.2 |  |  | (0.7) |
Principal payments on debt obligations |  | (446.1) |  |  | (154.2) |
Cash received by subsidiary to issue preferred stock |  | 10.0 |  |  | 10.0 |
Redemption of preferred stock |  | (10.4) |  |  | — |
Transactions with noncontrolling interests |  | (6.9) |  |  | (62.1) |
Other financing activities |  | (1.2) |  |  | (4.2) |
Cash (used in) provided by financing activities |  | 73.6 |  |  | (211.2) |
Cash (used in) provided by discontinued financing activities |  | (7.6) |  |  | (11.4) |
Cash (used in) provided by continuing financing activities |  | 66.0 |  |  | (222.6) |
Effects of exchange rate changes on cash, cash equivalents and restricted cash |  | (0.7) |  |  | 0.6 |
Net increase (decrease) in cash and cash equivalents, including cash classified within assets held for sale |  | 33.7 |  |  | (35.3) |
Less: Net increase (decrease) in cash and cash equivalents from discontinued operations |  | 58.3 |  |  | (35.7) |
Net change in cash, cash equivalents and restricted cash |  | (24.6) |  |  | 0.4 |
Cash, cash equivalents and restricted cash, beginning of period |  | 45.3 |  |  | 24.7 |
Cash, cash equivalents and restricted cash, end of period |  | $ | 20.7 |  |  | $ | 25.1 |

See notes to Condensed Consolidated Financial Statements
F-7

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Organization and Business
HC2 Holdings, Inc. ("HC2" and, together with its consolidated subsidiaries, the "Company", "we" and "our") is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. We seek to grow these businesses so that they can generate long-term sustainable free cash flow and attractive returns in order to maximize value for all stakeholders. While the Company generally intends to acquire controlling equity interests in its operating subsidiaries, the Company may invest to a limited extent in a variety of debt instruments or noncontrolling equity interest positions. The Company’s shares of common stock trade on the NYSE under the symbol "HCHC".
The Company currently has four reportable segments, plus our Other segment, based on management’s organization of the enterprise- Infrastructure, Life Sciences, Spectrum, Insurance, and Other which includes businesses that do not meet the separately reportable segment thresholds.
1.Our Infrastructure segment is comprised of DBM Global Inc. ("DBMG") and its wholly-owned subsidiaries. DBMG is a fully integrated Industrial Construction, Structural Steel and Facility Maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services and also fabricates trusses and girders and specializes in the fabrication and erection of large-diameter water pipe and water storage tanks, as well as 3-D Building Information Modeling (“BIM”) and detailing. DBMG provides these services on commercial, industrial, and infrastructure construction projects such as high- and low-rise buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills and power plants. Through GrayWolf, DBMG provides integrated solutions for digital engineering, modeling and detailing, construction, heavy equipment installation and facility services including maintenance, repair, and installation to a diverse range of end markets. Through Aitken Manufacturing, DBMG manufactures pollution control scrubbers, tunnel liners, pressure vessels, strainers, filters, separators and a variety of customized products. Through the recently acquired Banker Steel, DBMG provides fabricated structural steel and erection services primarily for the East Coast and Southeast commercial and industrial construction market. The Company maintains an approximately 92% controlling interest in DBMG.
2.Our Life Sciences segment is comprised of Pansend Life Sciences, LLC ("Pansend"). Pansend maintains controlling interests of approximately 80% in Genovel Orthopedics, Inc. ("Genovel"), which seeks to develop products to treat early osteoarthritis of the knee and approximately 51% in R2 Technologies, Inc. ("R2"), which develops aesthetic and medical technologies for the skin. Pansend also invests in other early stage or developmental stage healthcare companies including an approximately 47% interest in MediBeacon Inc. ("MediBeacon"), and an investment in Triple Ring Technologies, Inc ("Triple Ring").
3.Our Spectrum segment is comprised of HC2 Broadcasting Holdings Inc. ("HC2 Broadcasting") and its subsidiaries. HC2 Broadcasting strategically acquires and operates over-the-air broadcasting stations across the United States. In addition, HC2 Broadcasting, through its wholly-owned subsidiary, HC2 Network Inc. ("Network"), operates Azteca America, a Spanish-language broadcast network offering high quality Hispanic content to a diverse demographic across the United States. The Company maintains an approximately 98% controlling interest in HC2 Broadcasting and maintains a controlling interest of 76%, inclusive of approximately 15% proxy rights from minority holders of DTV America Corporation ("DTV").
4.Our Insurance segment is comprised of the discontinued operations of Continental Insurance Group Ltd. ("CIG") and its wholly-owned subsidiaries Continental General Insurance Company ("CGI") and Continental LTC, Inc. CGI provides long-term care, life, annuity, and other accident and health coverage that help protect policy and certificate holders from the financial hardships associated with illness, injury, loss of life, or income continuation. The Company maintains a 100% interest in CIG which was sold subsequent to quarter end on July 1, 2021.
5.Our Other segment represents all other businesses or investments that do not meet the definition of a segment individually or in the aggregate. Included in the Other segment is the former Marine Services segment, which includes its holding company, Global Marine Holdings, LLC ("GMH"), in which the Company maintains approximately 73% controlling interest. GMH results include the current and prior year equity investment in Huawei Marine Networks Co., Limited (“HMN”), its 19% equity method investment with Huawei Technologies Co., Ltd., and the discontinued operations of Global Marine Systems Limited ("GMSL"). Also included in the Other segment is the discontinued operations of Beyond6, Inc. ("Beyond6") and PTGi International Carrier Services, Inc. and its subsidiaries ("ICS").
F-8

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
2. Summary of Significant Accounting Policies
Principles of Consolidation
The Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries and all other subsidiaries over which the Company exerts control. All intercompany profits, transactions and balances have been eliminated in consolidation. As of June 30, 2021, the results of DBMG, Genovel, R2, HC2 Broadcasting, CIG, GMH and Beyond6 have been consolidated into the Company’s results based on guidance from the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC" 810, Consolidation). The remaining interests not owned by the Company are presented as a noncontrolling interest component of total equity.
Basis of Presentation
The accompanying unaudited Condensed Consolidated Financial Statements of the Company included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). The financial statements reflect all adjustments that are, in the opinion of management, necessary for a fair statement of such information. All such adjustments are of a normal recurring nature. Certain information and note disclosures, including a description of significant accounting policies normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"), have been condensed or omitted pursuant to such rules and regulations. Certain prior amounts have been reclassified or combined to conform to the current year presentation.
These interim financial statements should be read in conjunction with the Company’s annual Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed with the SEC on March 10, 2021. The results of operations for the three and six months ended June 30, 2021 are not necessarily indicative of the results for any subsequent periods or the entire fiscal year ending December 31, 2021.
Use of Estimates and Assumptions
The preparation of the Company’s Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions used.
Liquidity
At this time, we believe that we will be able to continue to meet our liquidity requirements and fund our fixed obligations (such as debt service and operating leases) and other cash needs for our operations for at least the next twelve months from the issuance of the Condensed Consolidated Financial Statements through a combination of available cash, distributions from our subsidiaries, raising of additional debt or equity, refinancing of certain of our subsidiary indebtedness or preferred stock, other financing arrangements and/or the sale of assets and certain investments. Historically, we have chosen to reinvest cash and receivables into the growth of our various businesses, and therefore have not kept a large amount of cash on hand at the holding company level. The ability of HC2’s subsidiaries to make distributions to HC2 is subject to numerous factors, including restrictions contained in each subsidiary’s financing agreements, regulatory requirements, availability of sufficient funds at each subsidiary and the approval of such payment by each subsidiary’s board of directors, which must consider various factors, including general economic and business conditions, tax considerations, strategic plans, financial results and condition, expansion plans, any contractual, legal or regulatory restrictions on the payment of dividends, and such other factors each subsidiary’s board of directors considers relevant. Although the Company believes that it will be able to raise additional equity capital, refinance indebtedness or preferred stock, enter into other financing arrangements or engage in asset sales and sales of certain investments sufficient to fund any cash needs that we are not able to satisfy with the funds on hand or expected to be provided by our subsidiaries, there can be no assurance that it will be able to do so on terms satisfactory to the Company, if at all. Such financing options, if pursued, may also ultimately have the effect of negatively impacting our liquidity profile and prospects over the long-term. Our ability to sell assets and certain of our investments to meet our existing financing needs may also be limited by our existing financing instruments. In addition, the sale of assets or the Company’s investments may also make the Company less attractive to potential investors or future financing partners.
COVID-19
There are many uncertainties regarding the current coronavirus ("COVID-19") pandemic, and the Company continues to closely monitor the impact of the COVID-19 pandemic, including the effectiveness of the vaccine programs, on all aspects of its business, including how it will impact its customers, employees, suppliers, vendors, business partners and distribution channels and any potential prolonging or worsening of the pandemic due to COVID-19 variants. We are unable to predict the impact that COVID-19 will have on its financial position and operating results due to numerous uncertainties, however as the pandemic continues, it may have an adverse effect on the Company’s results of operations, financial condition, or liquidity for fiscal year 2021. The Company expects to continue to assess the evolving impact of the COVID-19 pandemic.
F-9

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
Statement of Cash Flows
The following table provides a reconciliation of cash and cash equivalents and restricted cash to amounts reported within the Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Cash Flows (in millions):

|  | June 30,
|  | 2021 |  | 2020
Cash and cash equivalents, beginning of period |  | $ | 43.8 |  |  | $ | 23.3 |
Restricted cash included in other assets |  | 1.5 |  |  | 1.4 |
Total cash and cash equivalents and restricted cash |  | $ | 45.3 |  |  | $ | 24.7 |
Cash and cash equivalents, end of period |  | $ | 18.1 |  |  | $ | 23.7 |
Restricted cash included in other assets |  | 2.6 |  |  | 1.4 |
Total cash and cash equivalents and restricted cash |  | $ | 20.7 |  |  | $ | 25.1 |
Cash and cash equivalents classified in Assets held for sale, beginning of period |  | $ | 195.2 |  |  | $ | 216.0 |
Restricted cash classified in Assets held for sale |  | 0.2 |  |  | 0.2 |
Total cash and cash equivalents and restricted cash classified in Assets held for sale |  | $ | 195.4 |  |  | $ | 216.2 |
Cash and cash equivalents classified in Assets held for sale, end of period |  | $ | 253.7 |  |  | $ | 180.3 |
Restricted cash classified in Assets held for sale |  | — |  |  | 0.2 |
Total cash and cash equivalents and restricted cash classified in Assets held for sale |  | $ | 253.7 |  |  | $ | 180.5 |
Supplemental cash flow information: |  |  |  |
Cash paid for interest |  | $ | 12.3 |  |  | $ | 33.0 |
Cash paid for taxes, net of refunds |  | $ | 2.6 |  |  | $ | 8.0 |
Non-cash investing and financing activities: |  |  |  |
Property, plant and equipment included in accounts payable |  | $ | 2.1 |  |  | $ | 4.9 |
Investments included in accounts receivable |  | $ | — |  |  | $ | 20.0 |
Investments included in accounts payable |  | $ | — |  |  | $ | 8.5 |
Extinguishment of convertible note in exchange |  | $ | 51.8 |  |  | $ | — |
Issuance of convertible note in exchange |  | $ | (51.8) |  |  | $ | — |
Debt assumed in acquisitions |  | $ | 6.3 |  |  | $ | — |

Reclassification
Certain previous year amounts have been reclassified to conform with current year presentations, as related to the reporting of new balance sheet line items:
•The recast of Beyond6, ICS, and CIG's results to discontinued operations. Further, the reclassification of prior period assets and liabilities have been classified as held for sale. See Note 3. Discontinued Operations for further information;
•As a result of the sale of ICS, and in accordance with ASC 280, the Company no longer considers the results of operations and Balance Sheets of the retained ICS entities as a separate segment. Formerly the Telecommunications segment, these entities have been reclassified to the Other segment. See Note 17. Operating Segment and Related Information for further information;
•As a result of the sale of Beyond6, and in accordance with ASC 280, the Company no longer considers the results of operations and Balance Sheets of Beyond6 as a separate segment. Formerly the Clean Energy segment, this entity has been reclassified to the Other segment. See Note 17. Operating Segment and Related Information for further information; and
•The recast of prior year earnings per share as a result of the discontinued operations noted above. This includes presenting EPS for Net income (loss) from continuing operations, Net income (loss) from discontinuing operations, and Net income (loss). See Note 18. Basic and Diluted Income (Loss) Per Common Share for further details.
•Certain 2021 statement of cash flow items have been reclassified to conform to the current financial statement presentation. These reclassifications have no effect on previously reported net income.
F-10

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
Accounting Pronouncements Adopted in the Current Year
Accounting for Debt with Conversion Options
ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, was issued by the FASB in August 2020. This ASU (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock; (2) revises the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification; and (3) revises the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares. The standard is effective on January 1, 2024, but early adoption was elected as of January 1, 2021. A modified retrospective method of transition was applied, which resulted in no impact to the Company.
Accounting Pronouncements to be Adopted Subsequent to December 31, 2021
Credit Loss Standard
ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments, was issued by FASB in June 2016. This standard is effective January 1, 2020 (with early adoption permitted). This new standard changes the impairment model for most financial assets that are measured at amortized cost and certain other instruments, including trade receivables, from an incurred loss model to an expected loss model and adds certain new required disclosures. Under the expected loss model, entities will recognize estimated credit losses over the entire contractual term of the instrument rather than delaying recognition of credit losses until it is probable the loss has been incurred. The FASB has voted to delay the effective date of ASU 2016-13 to January 1, 2023 for smaller reporting companies with a revised ASU in the fourth quarter of 2019. The Company will not be required to adopt Topic 326 until January 1, 2023. Currently, the Company continues to evaluate the potential impact of the new standard on its financial results.
Subsequent Events
ASC 855, Subsequent Events requires the Company to evaluate events that occur after the balance sheet date as of which the financial statements are issued, and to determine whether adjustments to or additional disclosures in the financial statements are necessary. See Note 19. Subsequent Events for the summary of the subsequent events.
3. Discontinued Operations
The results of GMSL, ICS, Beyond6, and CIG and the related expenses directly attributable to the entities were reported as discontinued operations. Summarized operating results of the discontinued operations are as follows (in millions):

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Revenue |  | $ | — |  |  | $ | 117.5 |  |  | $ | 1.7 |  |  | $ | 331.6 |
Life, accident and health earned premiums, net |  | 27.3 |  |  | 29.5 |  |  | 55.7 |  |  | 58.2 |
Net investment income |  | 48.5 |  |  | 48.4 |  |  | 92.4 |  |  | 100.3 |
Realized/unrealized (losses) gains on investments |  | (4.4) |  |  | (0.5) |  |  | 5.1 |  |  | (19.5) |
Total revenue |  | 71.4 |  |  | 194.9 |  |  | 154.9 |  |  | 470.6 |
Cost of revenue |  | — |  |  | 110.1 |  |  | 0.8 |  |  | 317.5 |
Policy benefits, changes in reserves, and commissions |  | 69.9 |  |  | 63.0 |  |  | 126.0 |  |  | 135.4 |
Selling, general and administrative |  | 8.7 |  |  | 11.8 |  |  | 21.1 |  |  | 39.0 |
Depreciation and amortization |  | (5.1) |  |  | (3.3) |  |  | (11.0) |  |  | (3.3) |
(Loss) income from operations |  | (2.1) |  |  | 13.3 |  |  | 18.0 |  |  | (18.0) |
Interest expense |  | (0.1) |  |  | (2.3) |  |  | (0.5) |  |  | (8.0) |
Gain (loss) on sale and liquidation of subsidiaries |  | — |  |  | — |  |  | 40.4 |  |  | (39.3) |
Income from equity investees |  | — |  |  | — |  |  | — |  |  | 0.5 |
Other (loss) income |  | — |  |  | (0.2) |  |  | (3.1) |  |  | 1.7 |
Pre-tax income (loss) from discontinued operations |  | (2.2) |  |  | 10.8 |  |  | 54.8 |  |  | (63.1) |
Income tax benefit (expense) |  | 0.7 |  |  | (3.3) |  |  | (4.4) |  |  | (0.5) |
(Loss) income from discontinued operations |  | $ | (1.5) |  |  | $ | 7.5 |  |  | $ | 50.4 |  |  | $ | (63.6) |

F-11

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
Sale of CGI
On March 29, 2021, the Company announced the entry into a definitive agreement (the "Stock Purchase Agreement") to sell its Insurance segment to Continental General Holdings LLC, an entity controlled by Michael Gorzynski, a director of the Company and, as of June 30, 2021, a beneficial owner of approximately 6.6% of the Company's outstanding common stock who has also served as executive chairman of Continental since October 2020. The transaction value is approximately $90.0 million, inclusive of $65.0 million in cash plus certain assets of CGI. As of the first quarter of 2021, the Insurance segment met the held-for-sale criteria under ASC 205-20 and has been presented in discontinued operations. The sale closed on July 1, 2021, subsequent to quarter end. See Note 19. Subsequent Events for further information.
Sale of GMSL
The sale of GMSL closed on February 28, 2020. At the time of the sale, the Company recorded a $39.3 million loss on the sale and recognized $31.3 million of Accumulated other comprehensive loss. During the fourth quarter of 2020, the Company recognized a gain on sale of $2.4 million as a result of the cash collateralized bonding facility release. During the first quarter of 2021, the Company recognized a gain of $1.2 million as a result of an indemnity release.
The net proceeds from the sale of GMSL were used to repay $15.0 million of the then outstanding balance under the Revolving Credit Agreement and redeem $76.9 million aggregate principal amount of the Company's 11.5% senior secured notes due 2021 (the "2021 Senior Secured Notes"), plus accrued and unpaid interest since December 1, 2019 (the last regularly scheduled interest payment date).
As a result of the repayment of $15.0 million Revolving Credit Agreement, the Company allocated the following interest and the amortization of deferred financing costs for the three and six months ended June 30, 2021 and 2020 associated with the principal prepayment from continuing operations to discontinued operations on the Company’s Condensed Consolidated Statement of Operations:

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Interest expense |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 0.2 |
Amortization of deferred financing costs and original issuance discount |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 0.1 |

As a result of the mandatory redemption of $76.9 million of 2021 Senior Secured Notes, the Company allocated the following pro-rata interest and amortization of deferred financing costs and original issuance discount for the three and six months ended June 30, 2021 and 2020, from continuing operations to discontinued operations on the Company’s Condensed Consolidated Statements of Operations:

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Interest expense |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 2.2 |
Amortization of deferred financing costs and original issuance discount |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 0.2 |

Sale of ICS
The sale of ICS and its subsidiary, Go2 Tel, Inc., closed on October 31, 2020. The Company recorded a $0.9 million gain on the sale and recognized $8.2 million of accumulated other comprehensive loss related to the realization of foreign currency translation of PTGi International Carrier Services Ltd., which was essentially liquidated in conjunction with the sale. The proceeds were used for general corporate purposes.
Sale of Beyond6
On December 31, 2020, the Company announced a plan to sell Beyond6 to an affiliate of Mercuria Investments US, Inc., pursuant to an Agreement and Plan of Merger (the "Merger Agreement") among Beyond6, Greenfill, Inc., a Delaware corporation ("Parent"), Greenfill Merger Inc., a newly-formed Delaware corporation and wholly-owned subsidiary of Parent, and an affiliate of HC2 as the Stockholder Representative for the Beyond6 stockholders. The sale closed on January 15, 2021. The Company recognized a $39.2 million gain on the sale.
A portion of the proceeds from the sale of Beyond6 were used to repay $15.0 million of the then outstanding balance under the Revolving Credit Agreement and repay $27.9 million of the Company's 2021 Senior Secured Notes.
F-12

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
As a result of the repayment of $15.0 million Revolving Credit Agreement, the Company allocated the following interest for the three and six months ended June 30, 2021 and 2020 associated with the principal prepayment from continuing operations to discontinued operations on the Company’s Condensed Consolidated Statements of Operations:

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Interest expense |  | $ | — |  |  | $ | 0.2 |  |  | $ | 0.1 |  |  | $ | 0.2 |

As a result of the repayment of $27.9 million of the 2021 Senior Secured Notes, the Company allocated the following pro-rata interest and amortization of deferred financing costs and original issuance discount for the three and six months ended June 30, 2021 and 2020, from continuing operations to discontinued operations on the Company’s Condensed Consolidated Statements of Operations:

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Interest expense |  | $ | — |  |  | $ | 0.8 |  |  | $ | 0.3 |  |  | $ | 1.6 |
Amortization of deferred financing costs and original issuance discount |  | $ | — |  |  | $ | 0.1 |  |  | $ | — |  |  | $ | 0.2 |

Summarized assets and liabilities of the discontinued operations are as follows (in millions):

|  | June 30, 2021 |  | December 31, 2020
Assets |  |  |  |
Current assets |  |  |  |
Cash and cash equivalents |  | $ | 253.7 |  |  | $ | 195.2 |
Accounts receivable, net |  | — |  |  | 13.6 |
Other current assets |  | 6.7 |  |  | 8.7 |
Total current assets |  | 260.4 |  |  | 217.5 |
Investments |  | 4,483.7 |  |  | 4,610.2 |
Recoverable from reinsurers |  | 1,015.2 |  |  | 957.5 |
Deferred tax asset |  | — |  |  | 1.4 |
Property, plant and equipment, net |  | 1.4 |  |  | 90.5 |
Goodwill |  | — |  |  | 2.1 |
Intangibles, net |  | 2.5 |  |  | 11.7 |
Other assets |  | 44.0 |  |  | 51.2 |
Total assets held for sale |  | $ | 5,807.2 |  |  | $ | 5,942.1 |
Liabilities |  |  |  |
Current liabilities |  |  |  |
Accounts payable |  | $ | — |  |  | $ | 2.6 |
Accrued liabilities |  | 8.8 |  |  | 35.8 |
Current portion of debt obligations |  | — |  |  | 5.7 |
Other current liabilities |  | 3.6 |  |  | 7.4 |
Total current liabilities |  | 12.4 |  |  | 51.5 |
Life, accident and health reserves |  | 4,711.7 |  |  | 4,627.5 |
Annuity reserves |  | 225.8 |  |  | 228.8 |
Value of business acquired |  | 188.3 |  |  | 199.8 |
Deferred tax liability |  | 114.8 |  |  | 136.5 |
Debt obligations |  | — |  |  | 50.6 |
Other liabilities |  | 8.6 |  |  | 12.0 |
Total liabilities held for sale |  | $ | 5,261.6 |  |  | $ | 5,306.7 |

In addition, as of June 30, 2021, the Company had $5.2 million of assets from its Spectrum segment classified as Assets held for sale in continuing operations related to certain station licenses and assets.
4. Revenue
Revenue from contracts with customers consist of the following (in millions):
F-13

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Revenue |  |  |  |  |  |  |  |
Infrastructure |  | $ | 232.0 |  |  | $ | 172.3 |  |  | $ | 393.3 |  |  | $ | 348.8 |
Spectrum |  | 10.6 |  |  | 9.5 |  |  | 21.1 |  |  | 19.6 |
Life Sciences |  | 1.2 |  |  | — |  |  | 1.2 |  |  | — |
Total revenue |  | $ | 243.8 |  |  | $ | 181.8 |  |  | $ | 415.6 |  |  | $ | 368.4 |

Accounts receivables, net from contracts with customers consist of the following (in millions):

|  | June 30, 2021 |  | December 31, 2020
Accounts receivables with customers |  |  |  |
Infrastructure |  | $ | 343.7 |  |  | $ | 168.5 |
Spectrum |  | 8.5 |  |  | 7.3 |
Life Sciences |  | 0.1 |  |  | — |
Total accounts receivables with customers |  | $ | 352.3 |  |  | $ | 175.8 |

Infrastructure Segment
The following table disaggregates DBMG's revenue by market (in millions):

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Commercial |  | $ | 84.8 |  |  | $ | 54.0 |  |  | $ | 134.3 |  |  | $ | 116.8 |
Industrial |  | 79.0 |  |  | 59.6 |  |  | 119.2 |  |  | 118.4 |
Transportation |  | 10.8 |  |  | 23.5 |  |  | 24.7 |  |  | 39.9 |
Government |  | 17.2 |  |  | 11.1 |  |  | 38.5 |  |  | 19.7 |
Leisure |  | 4.7 |  |  | 11.3 |  |  | 12.2 |  |  | 27.3 |
Healthcare |  | 11.1 |  |  | 4.7 |  |  | 20.0 |  |  | 12.6 |
Convention |  | 18.8 |  |  | 1.4 |  |  | 28.2 |  |  | 3.8 |
Other |  | 5.6 |  |  | 6.1 |  |  | 16.2 |  |  | 9.7 |
Total revenue from contracts with customers |  | 232.0 |  |  | 171.7 |  |  | 393.3 |  |  | 348.2 |
Other revenue |  | — |  |  | 0.6 |  |  | — |  |  | 0.6 |
Total Infrastructure segment revenue |  | $ | 232.0 |  |  | $ | 172.3 |  |  | $ | 393.3 |  |  | $ | 348.8 |

Contract assets and contract liabilities consisted of the following (in millions):

|  | June 30, 2021 |  | December 31, 2020
Costs and recognized earnings in excess of billings on uncompleted contracts |  | $ | 63.7 |  |  | $ | 55.6 |
Billings in excess of costs and recognized earnings on uncompleted contracts |  | $ | (146.8) |  |  | $ | (52.2) |

The change in contract assets is a result of the recording of $35.6 million of costs in excess of billings on uncompleted contracts driven by new commercial projects and $1.9 million of costs in excess of billings on uncompleted contracts for projects acquired in the Banker Steel acquisition, offset by $29.4 million of costs in excess of billings on uncompleted contracts transferred to receivables from contract assets recognized at the beginning of the period. The change in contract liabilities is a result of periodic billing in excess of costs on uncompleted contracts of $114.4 million driven largely by new commercial projects and $55.0 million of billings in excess of costs on uncompleted contracts for projects acquired as a result of the Banker Steel acquisition, offset by revenue recognized that was included in the contract liability balance at the beginning of the period in the amount of $74.8 million.
F-14

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
The transaction price allocated to remaining unsatisfied performance obligations consisted of the following (in millions):

|  | Within one year |  | Within five years |  |  |  | Total
Commercial |  | $ | 580.5 |  |  | $ | 620.2 |  |  |  |  | $ | 1,200.7 |
Industrial |  | 201.3 |  |  | — |  |  |  |  | 201.3 |
Transportation |  | 41.5 |  |  | 17.2 |  |  |  |  | 58.7 |
Government |  | 47.3 |  |  | — |  |  |  |  | 47.3 |
Leisure |  | 7.0 |  |  | — |  |  |  |  | 7.0 |
Healthcare |  | 51.1 |  |  | — |  |  |  |  | 51.1 |
Convention |  | 52.7 |  |  | — |  |  |  |  | 52.7 |
Other |  | 5.6 |  |  | — |  |  |  |  | 5.6 |
Remaining unsatisfied performance obligations | $ | 987.0 |  |  | $ | 637.4 |  |  |  |  | $ | 1,624.4 |

DBMG includes an additional $10.0 million in its backlog that is not included in the remaining unsatisfied performance obligations noted above. This backlog represents commitments under master service agreements that are estimated amounts of work to be performed based on customer communications, historic experience and knowledge of our customers' intentions.
Life Sciences Segment
The following table disaggregates the Life Sciences segment's revenue by type (in millions):

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Systems revenue |  | $ | 1.2 |  |  | $ | — |  |  | $ | 1.2 |  |  | $ | — |
Total Life Sciences segment revenue |  | $ | 1.2 |  |  | $ | — |  |  | $ | 1.2 |  |  | $ | — |

Spectrum Segment
The following table disaggregates the Spectrum segment's revenue by type (in millions):

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Network advertising |  | $ | 4.8 |  |  | $ | 4.0 |  |  | $ | 9.5 |  |  | $ | 9.0 |
Broadcast station |  | 4.5 |  |  | 3.8 |  |  | 8.9 |  |  | 7.3 |
Network distribution |  | 0.7 |  |  | 1.0 |  |  | 1.6 |  |  | 2.1 |
Other |  | 0.6 |  |  | 0.7 |  |  | 1.1 |  |  | 1.2 |
Total Spectrum segment revenue |  | $ | 10.6 |  |  | $ | 9.5 |  |  | $ | 21.1 |  |  | $ | 19.6 |

The transaction price allocated to remaining unsatisfied performance obligations consisted of $1.7 million, $6.9 million, and $0.1 million of network advertising, broadcasting station revenues, and other revenues, respectively, of which $5.6 million is expected to be recognized within one year and $3.1 million is expected to be recognized within five years.
5. Acquisitions, Dispositions, and Deconsolidations
Infrastructure Segment
Banker Steel Acquisition
On March 15, 2021, the Company announced that DBMG entered into an agreement to acquire 100% of Banker Steel Holdco LLC ("Banker Steel") for $145.0 million, which closed on May 27, 2021. The acquisition was financed with $64.1 million from a partial draw on a new $110.0 million revolving credit facility, $49.6 million of sellers' notes, $6.3 million of assumed debt of Banker Steel, and $25.0 million in cash received from HC2 in the settlement of certain intercompany balances.
Banker Steel provides fabricated structural steel and erection services primarily for the East Coast and Southeast commercial and industrial construction market. Banker Steel consists of six operating companies: Banker Steel Co., LLC; NYC Constructors, LLC; Memco LLC; Derr & Isbell Construction LLC; Innovative detailing and Engineering Solutions; and Lynchburg Freight and Specialty LLC.
The transaction was accounted for as business acquisition. The preliminary allocation of the fair value of consideration transferred among the identified assets acquired, liabilities assumed, intangibles and residual goodwill are summarized as follows (in millions):
F-15

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

Purchase Consideration at Fair Value |  |
Partial draw on new $110.0 million revolving credit facility |  | $ | 64.1 |
Sellers' notes |  | 49.6 |
Bankers Steel debt - assumed |  | 6.3 |
Cash |  | 25.0 |
Gross consideration |  | 145.0 |
Less: Transaction costs |  | 0.4 |
Less: Bankers debt - assumed |  | 6.3 |
Less: R&W premium paid by seller |  | 0.5 |
Net consideration |  | $ | 137.8 |
Cash and cash equivalents |  | $ | 9.3 |
Accounts receivable, net |  | 111.3 |
Costs recognized in earnings in excess of billings on uncompleted contracts |  | 1.9 |
Assets held for sale |  | 0.7 |
Other current assets |  | 7.3 |
Property, plant, and equipment, net |  | 62.6 |
Other assets |  | 40.2 |
Intangibles, net |  | 58.5 |
Goodwill |  | 10.3 |
Total assets to be acquired |  | 302.1 |
Accounts Payable |  | 39.1 |
Billings in excess of costs and recognized earnings on uncompleted contracts |  | 55.0 |
Other current liabilities |  | 29.6 |
Other liabilities |  | 34.2 |
Long-term debt, less current portion |  | 6.4 |
Total liabilities to be assumed |  | 164.3 |
Total net assets acquired |  | $ | 137.8 |

The size and breadth of the Banker Steel acquisition necessitates use of the allowable measurement period to adequately analyze all the factors used in establishing the asset and liability fair values as of the acquisition date. The preliminary acquisition accounting is based upon the Company’s estimates of fair value. The primary areas of the preliminary acquisition accounting that are not yet finalized include the following: (i) finalizing the review and valuation of property and equipment (including the models, key assumptions, estimates and inputs used), (ii) finalizing the review and valuation of related intangible assets (including key assumptions, inputs and estimates), (iii) finalizing the valuation of certain in-place contracts or contractual relationships (including but not limited to leases), (iv) finalizing our review of certain assets acquired and liabilities assumed, (v) finalizing our estimate of the impact of acquisition accounting on deferred income taxes or liabilities. As the initial acquisition accounting is based on our preliminary assessments, actual values may differ (possibly materially) when final information becomes available that differs from our current estimates. We will continue to evaluate these items, until they are satisfactorily resolved and adjust our acquisition accounting accordingly, within the allowable measurement period (not to exceed one year from the date of acquisition), as defined by ASC 805.
Goodwill was determined based on the residual differences between fair value of consideration transferred and the value assigned to acquired assets and liabilities. Among the factors that contributed to goodwill was approximately $58.5 million assigned to intangibles, including customer relationships of $34.0 million with a useful life of 18 years, trade names of $7.4 million with a useful life of 15 years, existing customer contracts of $15.1 million with a useful life of 2 years and leasehold interests of $2.0 million with varying useful life. Goodwill is not amortized and is not deductible for tax purposes.
Acquisition costs incurred by DBMG in connection with the acquisition of Banker Steel were approximately $1.5 million, which were included in selling, general and administrative expenses. The acquisition costs were primarily related to legal, accounting and valuation services.
The following schedule presents the unaudited results of operations data for the three and six months ended June 30, 2021 for Banker Steel since the date of acquisition (in millions):
F-16

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

| Three Months Ended June 30, 2021 |  | Six Months Ended June 30, 2021
Revenue | $ | 39.5 |  |  | $ | 39.5 |
Net income from operations | $ | 1.3 |  |  | $ | 1.3 |
Net income attributable to HC2 Holdings | $ | 0.6 |  |  | $ | 0.6 |

Pro Forma Adjusted Summary
The following schedule presents unaudited consolidated pro forma results of operations data as if the acquisition of Banker Steel had occurred on January 1, 2020. This information does not purport to be indicative of the actual results that would have occurred if the acquisitions had actually been completed on the date indicated, nor is it necessarily indicative of the future operating results or the financial position of the combined company (in millions):

| Three Months Ended June 30, 2021 |  | Three Months Ended June 30, 2020 |  | Six Months Ended June 30, 2021 |  | Six Months Ended June 30, 2020
Revenue | $ | 326.1 |  |  | $ | 252.5 |  |  | $ | 613.1 |  |  | $ | 517.0 |
Income (loss) from operations | $ | 1.5 |  |  | $ | (7.3) |  |  | $ | (7.1) |  |  | $ | (16.7) |
Net income (loss) attributable to HC2 Holdings | $ | (15.7) |  |  | $ | 10.5 |  |  | $ | (2.6) |  |  | $ | (70.3) |

Spectrum Segment
During the six months ended June 30, 2021, the Company increased its controlling interest in DTV from 60%, inclusive of approximately 10% proxy and voting rights from minority holders, to approximately 76%, inclusive of 15% proxy and voting rights from minority holders, from private purchases and proxy voting rights.
Insurance Segment
Sale of CGI
On March 29, 2021, the Company announced the entry into the Stock Purchase Agreement to sell its Insurance segment to Continental General Holdings LLC, an entity controlled by Michael Gorzynski, a director of the Company and, as of June 30, 2021, a beneficial owner of approximately 6.6% of the Company's outstanding common stock who has also served as executive chairman of Continental since October 2020. The transaction value is approximately $90.0 million, inclusive of $65.0 million in cash plus certain assets of CGI. The sale closed on July 1, 2021, subsequent to quarter end. See Note 19. Subsequent Events for further information.
Other Segment
Sale of GMSL
On January 30, 2020, the Company announced that, through its indirect subsidiary GMH in which the Company holds an approximately 73% controlling interest, the Company entered into a definitive agreement to sell 100% of the shares of GMSL to Trafalgar AcquisitionCo, Ltd. and an affiliate of J.F. Lehman & Company, LLC. The total base consideration was $250.0 million, subject to customary purchase price adjustments, working capital adjustments, and a potential earn-out of up to $12.5 million at such time, if any, if J.F. Lehman & Company, LLC and its investment affiliates achieve a specified multiple of their invested capital.
The purchase price is subject to customary potential downward or upward post-closing adjustments based on net working capital, cash, unpaid transaction expenses, indebtedness and certain of the Company’s pre-closing paid capital expenditures. The Share Purchase Agreement contained customary representations, warranties and covenants for a transaction of this nature.
The transaction closed on February 28, 2020. GMH received approximately $144.0 million of net proceeds from the sale, of which $36.8 million and $5.5 million were paid to noncontrolling interest holders and redeemable noncontrolling interest holders, respectively. HC2 received net proceeds of approximately $100.8 million. In connection with the closing of the transaction, the purchaser deposited (i) $1.25 million of the base price into an escrow fund for the purpose of securing certain indemnification obligations for losses payable in the first twelve months after closing and (ii) $1.91 million of the base price into an escrow fund for the purpose of securing a purchase price adjustment, if any, in favor of purchaser. Following the closing, the purchaser paid an amount equal to $2.4 million on the earlier of December 31, 2020 and the date on which a cash collateralized bonding facility was released.
In the first quarter of 2020, the Company recorded a $39.3 million loss on the sale and recognized a $31.3 million of Accumulated other comprehensive loss. During the fourth quarter of 2020, the Company recognized a gain on sale of $2.4 million as a result of the cash collateralized bonding facility release. During the first quarter of 2021, the Company recognized a gain of $1.2 million as a result of indemnity release.
F-17

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
Sale of HMN
On October 30, 2019, the Company announced the sale of its stake in HMN, its 49% joint venture with Huawei Technologies Co., Ltd., to Hengtong Optic-Electric Co Ltd. The sale valued HMN at $285 million, and GMH's 49% stake, through New Saxon, at approximately $140 million.
Under the terms of the Sale and Purchase Agreement, the sale of New Saxon’s 49% interest in HMN will be affected in two tranches. The sale of the portion of New Saxon’s 30% interest of HMN, closed on May 12, 2020 (the "First HMN Close"). The remaining 19% interest of HMN is retained by New Saxon and subject to a put option agreement by New Saxon, exercisable starting on the second year anniversary of the closing date of the First HMN Close at a price equal to the greater of the share price paid for the 30% interest or fair market value as of the exercisable date.
For the three months ended June 30, 2020, in conjunction with the first tranche of the sale, the Company received $85.5 million in cash, of which $17.5 million and $2.1 million were paid to noncontrolling interest holders and redeemable noncontrolling interest holders, respectively. On the close date, New Saxon recorded a $71.1 million gain, included in Other income (loss) in the Condensed Consolidated Statements of Operations. The gain recognized includes $11.3 million related to the fair value of the put option. In addition, on the close date, the Company recorded a $7.2 million tax expense related to a foreign tax payment when the first tranche closed.
Sale of ICS
The sale of ICS and its subsidiary, Go2 Tel, Inc., closed on October 31, 2020. The Company recorded a $0.9 million gain on the sale and recognized $8.2 million of Accumulated other comprehensive loss related to the realization of foreign currency translation of PTGi International Carrier Services Ltd., which was essentially liquidated in conjunction with the sale. The proceeds were used for general corporate purposes.
Sale of Beyond6
On December 31, 2020, the Company announced a plan to sell Beyond6 to an affiliate of Mercuria Investments US, Inc., pursuant to an Agreement and Plan of Merger (the "Merger Agreement") among Beyond6, Greenfill, Inc., a Delaware Corporation ("Parent"), Greenfill Merger Inc., a newly-formed Delaware corporation and wholly-owned subsidiary of the Parent, and an affiliate of HC2 as the Stockholder Representative for the Beyond6 stockholders, for a total purchase price, net of Beyond6's debt and transaction expenses, customary purchase price adjustments and escrow arrangements, of approximately $106.5 million. Net proceeds received by HC2 at closing was cash consideration of approximately $70.0 million. The sale closed on January 15, 2021. The Company recognized a $39.2 million gain on the sale.
See Note 3. Discontinued Operations for further details.
6. Accounts Receivable, net
Accounts receivable, net consist of the following (in millions):

|  | June 30, 2021 |  | December 31, 2020
Contracts in progress |  | $ | 250.5 |  |  | $ | 118.6 |
Unbilled retentions |  | 93.8 |  |  | 50.3 |
Trade receivables |  | 8.6 |  |  | 7.5 |
Other receivables |  | 12.2 |  |  | 8.9 |
Allowance for doubtful accounts |  | (0.5) |  |  | (0.6) |
Total |  | $ | 364.6 |  |  | $ | 184.7 |

F-18

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
7. Property, Plant and Equipment, net
Property, plant and equipment, net consists of the following (in millions):

|  | June 30, 2021 |  | December 31, 2020
Equipment, furniture and fixtures, and software |  | $ | 170.4 |  |  | $ | 113.7 |
Building and leasehold improvements |  | 43.4 |  |  | 41.0 |
Land |  | 24.1 |  |  | 24.1 |
Plant and transportation equipment |  | 10.6 |  |  | 4.4 |
Construction in progress |  | 7.6 |  |  | 3.1 |
|  | 256.1 |  |  | 186.3 |
Less: Accumulated depreciation |  | 82.8 |  |  | 73.5 |
Total |  | $ | 173.3 |  |  | $ | 112.8 |

Depreciation expense was $5.3 million and $5.2 million for the three months ended June 30, 2021 and 2020, respectively. These amounts included $2.8 million and $2.3 million of depreciation expense recognized within cost of revenue for each of the three months ended June 30, 2021 and 2020.
Depreciation expense was $10.0 million and $10.3 million for the six months ended June 30, 2021 and 2020, respectively. These amounts included $5.0 million and $4.6 million of depreciation expense recognized within cost of revenue for each of the six months ended June 30, 2021 and 2020.
8. Goodwill and Intangibles, net
Goodwill
The carrying amount of goodwill by segment was as follows (in millions):

|  | Infrastructure |  | Spectrum |  | Total
Balance at December 31, 2020 |  | $ | 89.6 |  |  | $ | 21.4 |  |  | $ | 111.0 |
Acquisitions |  | 10.3 |  |  | — |  |  | 10.3 |
Translation |  | (0.2) |  |  | — |  |  | (0.2) |
Balance at June 30, 2021 |  | $ | 99.7 |  |  | $ | 21.4 |  |  | $ | 121.1 |

Indefinite-lived Intangible Assets
The carrying amount of indefinite-lived intangible assets was as follows (in millions):

|  | June 30, 2021 |  | December 31, 2020
FCC licenses |  | $ | 107.5 |  |  | $ | 113.0 |
Other |  | — |  |  | — |
Total |  | $ | 107.5 |  |  | $ | 113.0 |

For the six months ended June 30, 2021, FCC licenses decreased $5.5 million predominately related to the reclassification to held-for-sale as a result of our Spectrum segment entering into certain agreements to sell non-core FCC licenses.
F-19

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
Definite Lived Intangible Assets
The gross carrying amount and accumulated amortization of amortizable intangible assets by major intangible asset class were as follows (in millions):

|  | Weighted-Average Original Useful Life |  | June 30, 2021 |  | December 31, 2020
|  |  | Gross Carrying Amount | Accumulated Amortization | Net |  | Gross Carrying Amount | Accumulated Amortization | Net
Trade names |  | 14 years |  | $ | 25.4 |  |  | $ | (5.4) |  |  | $ | 20.0 |  |  | $ | 18.0 |  |  | $ | (4.6) |  |  | $ | 13.4 |
Customer relationships and contracts |  | 11 years |  | 85.4 |  |  | (14.5) |  |  | 70.9 |  |  | 36.4 |  |  | (12.1) |  |  | 24.3 |
Channel sharing arrangements |  | 35 years |  | 20.1 |  |  | (1.9) |  |  | 18.2 |  |  | 20.2 |  |  | (1.6) |  |  | 18.6 |
Other |  | 8 years |  | 8.4 |  |  | (3.0) |  |  | 5.4 |  |  | 5.5 |  |  | (2.7) |  |  | 2.8 |
Total |  |  |  | $ | 139.3 |  |  | $ | (24.8) |  |  | $ | 114.5 |  |  | $ | 80.1 |  |  | $ | (21.0) |  |  | $ | 59.1 |

Amortization expense for definite lived intangible assets was $2.3 million and $1.5 million for the three months ended June 30, 2021 and 2020, respectively, and was included in Depreciation and amortization in our Condensed Consolidated Statements of Operations.
Amortization expense for definite lived intangible assets was $3.8 million and $3.0 million for the six months ended June 30, 2021 and 2020, respectively, and was included in Depreciation and amortization in our Condensed Consolidated Statements of Operations.
Amortization
Excluding the impact of any future acquisitions, dispositions or change in foreign currency, the Company estimates the annual amortization expense of amortizable intangible assets for the next five fiscal years will be as follows (in millions):

|  | Estimated Amortization
2021 |  | $ | 7.8 |
2022 |  | 15.6 |
2023 |  | 11.1 |
2024 |  | 8.0 |
2025 |  | 7.3 |
Thereafter |  | 64.7 |
Total |  | $ | 114.5 |

F-20

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
9. Debt Obligations
Debt obligations consist of the following (in millions):

|  | June 30, 2021 |  | December 31, 2020
Infrastructure |  |
LIBOR plus 5.85% Note, due 2023 |  | $ | — |  |  | $ | 71.6 |
LIBOR plus 1.50% Line of Credit |  | — |  |  | 38.7 |
LIBOR plus 3.25% Note, due 2026 |  | 109.6 |  |  | — |
LIBOR plus 2.15% Line of Credit |  | 71.1 |  |  | — |
4.00% Note due 2024 |  | 27.5 |  |  | — |
8.00% Note due 2024 |  | 19.6 |  |  | — |
Other, various maturity dates |  | 6.5 |  |  | — |
Obligations under finance leases |  | 0.1 |  |  | 0.2 |
Spectrum |  |  |  |
8.50% Note due 2021 |  | 19.3 |  |  | 19.3 |
10.50% Note due 2021 |  | 32.9 |  |  | 32.9 |
Other, various maturity dates |  | 2.9 |  |  | 2.9 |
Obligations under finance leases |  | 0.1 |  |  | 0.6 |
Non-Operating Corporate |  |  |  |
11.50% Senior Secured Notes, due 2021 |  | — |  |  | 340.4 |
8.50% Senior Secured Notes, due 2026 |  | 330.0 |  |  | — |
7.50% Convertible Senior Notes, due 2022 |  | 3.2 |  |  | 55.0 |
7.50% Convertible Senior Notes, due 2026 |  | 51.8 |  |  | — |
LIBOR plus 5.75% Line of Credit |  | 5.0 |  |  | 15.0 |
|  | 679.6 |  |  | 576.6 |
Unamortized issuance discount, issuance premium, and deferred financing costs |  | (3.1) |  |  | (15.1) |
Less: current portion of debt obligations |  | (70.2) |  |  | (433.6) |
Debt obligations |  | $ | 606.3 |  |  | $ | 127.9 |

Aggregate finance lease and debt payments, including interest are as follows (in millions):

|  | Finance Leases |  | Debt |  | Total
2021 |  | $ | 0.2 |  |  | $ | 71.5 |  |  | $ | 71.7 |
2022 |  | — |  |  | 57.6 |  |  | 57.6 |
2023 |  | — |  |  | 57.1 |  |  | 57.1 |
2024 |  | — |  |  | 142.2 |  |  | 142.2 |
2025 |  | — |  |  | 40.2 |  |  | 40.2 |
Thereafter |  | — |  |  | 507.5 |  |  | 507.5 |
Total minimum principal and interest payments |  | 0.2 |  |  | 876.1 |  |  | 876.3 |
Less: Amount representing interest |  | — |  |  | (196.7) |  |  | (196.7) |
Total aggregate finance lease and debt payments |  | $ | 0.2 |  |  | $ | 679.4 |  |  | $ | 679.6 |

The interest rates on the finance leases range from approximately 2.0% to 10.0%.
Infrastructure
In May 2021, DBMG repaid its revolving line of credit under the Credit and Security Agreement with Wells Fargo Bank ("Revolving Line") and its term loan under a financing agreement with TWC Asset Management Company LLC ("TWC Loan"). In addition, DBMG entered into a new credit facility with UMB Bank ("UMB"). Under the terms of the agreement, UMB agreed to a $110.0 million term loan ("UMB Term Loan") and $110.0 million revolving credit agreement ("UMB Revolving Line"). The UMB Term loan expires in 2026 and will bear interest at a rate of 3.25%. The UMB Revolving Line expires in 2024 and will bear interest at a rate of Prime Rate minus 1.10%. The proceeds were used to fully repay DBMG's existing debt obligations, fund a portion of the Banker Steel acquisition, and provide additional working capital capacity to DBMG.
The extinguishment of the Revolving Line and the TWC Loan yielded a loss on extinguishment of $1.6 million included in Loss on early extinguishment or restructuring of debt in the Condensed Consolidated Statement of Operations.
F-21

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
Non-Operating Corporate
On February 1, 2021, HC2 repaid its 2021 Senior Secured Notes and issued $330.0 million aggregate principal amount of 8.5% senior secured notes due 2026 (the "2026 Senior Secured Notes"). In addition, the Company entered into exchange agreements with certain holders of approximately $51.8 million aggregate principal amount of its existing $55.0 million 7.5% convertible senior notes due 2022 (the "2022 Convertible Notes"), pursuant to which the Company exchanged such holders' 2022 Convertible Notes for newly issued 7.5% convertible notes due 2026 (the "2026 Convertible Notes"). The 2026 Senior Secured Notes were issued in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
The Company accounted for the transactions under the debt extinguishment model as the present value of cash flows under the terms of the 2026 Senior Secured Notes and 2026 Convertible Notes was at least 10% different from the present value of the remaining cash flows under the 2021 Senior Secured Notes and the 2022 Convertible Notes.
The extinguishment of the 2021 Senior Secured Notes yielded a loss on extinguishment of $4.5 million. The extinguishment of the $51.8 million of 2022 Convertible Notes yielded a loss on extinguishment of $5.4 million, an acceleration of the amortization of discount of $5.3 million, and extinguishment of the bifurcated conversion option classified as equity of $7.7 million.
Senior Secured Notes
The 2026 Senior Secured Notes were issued under an indenture dated February 1, 2021, by and among the Company, the guarantors party thereto and U.S. Bank National Association, a national banking association ("U.S. Bank"), as trustee (the "Secured Indenture"). The 2026 Senior Secured Notes were issued at 100% of par.
Convertible Notes
The 2026 Convertible Notes were issued under a separate indenture dated February 1, 2021, between the Company and U.S. Bank, as trustee (the "Convertible Indenture"). The 2026 Convertible Notes were issued at 100% of par.
Each $1,000 of principal of the 2026 Convertible Notes will initially be convertible into 234.2971 shares of our common stock, which is equivalent to an initial conversion price of approximately $4.27 per share, subject to adjustment upon the occurrence of specified events.
The fair value of the embedded conversion feature contained in the 2026 Convertible Notes had a fair value of $12.3 million, which was recorded as a premium on the 2026 Convertible Notes. The 2026 Convertible Notes have an effective interest rate of 3.21%, which reflects the $12.3 million premium and $1.1 million of deferred financing fees.
At June 30, 2021, the 2026 Convertible Notes had a carrying value of $62.2 million and an unamortized premium of $11.4 million. Based on the closing price of our common stock of $3.98 on June 30, 2021, the if-converted value of the 2026 Convertible Notes did not exceed its principal value.
For the six months ended June 30, 2021, interest cost recognized for the period relating to both the contractual interest coupon and amortization of discount net of premium was $1.6 million and $0.8 million, respectively.
Line of Credit
On February 23, 2021, the Company entered into a third amendment (the "Amendment") of the 6.75% line of credit with MSD PCOF Partners IX, LLC ("Revolving Credit Agreement"). Among other things, the Amendment (i) increases the aggregate principal amount of the Revolving Credit Agreement to $20.0 million, (ii) extends the maturity date of the Revolving Credit Amendment to February 23, 2024, (iii) updates the affirmative and negative covenants contained in the Amended Credit Agreement so that they are substantially consistent with the affirmative and negative covenants contained in the indenture that governs the 2026 Senior Secured Notes and (iv) reduces the interest rate margin applicable to loans borrowed under the Amended Credit Agreement to 5.75% from the 6.75% described above. Except as modified by the Amendment, the terms of the Revolving Credit Agreement remain in effect.
In May 2021, HC2 drew $5.0 million of the Revolving Credit Agreement. The Company used the proceeds to fund the redemption of the Company's Series A and A-2 Preferred Stock.
HC2 is in compliance with its debt covenants as of June 30, 2021.
10. Supplementary Financial Information
Contracts in Progress
Costs and recognized earnings in excess of billings on uncompleted contracts and billings in excess of costs and recognized earnings on uncompleted contracts consist of the following:
F-22

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

|  | June 30, 2021 |  | December 31, 2020
Costs incurred on contracts in progress |  | $ | 1,611.6 |  |  | $ | 752.9 |
Estimated earnings |  | 254.0 |  |  | 139.0
|  | 1,865.6 |  |  | 891.9
Less progress billings |  | 1,948.7 |  |  | 888.5
|  | $ | (83.1) |  |  | $ | 3.4 |
The above is included in the accompanying condensed consolidated balance sheet under the following line items:
Costs and recognized earnings in excess of billings on uncompleted contracts |  | $ | 63.7 |  |  | $ | 55.6 |
Billings in excess of costs and recognized earnings on uncompleted contracts |  | (146.8) |  |  | (52.2) |
|  | $ | (83.1) |  |  | $ | 3.4 |

Investments
Carrying values of other invested assets were as follows (in millions):

|  | June 30, 2021 |  | December 31, 2020
|  | Measurement Alternative |  | Equity Method |  | Total |  | Measurement Alternative |  | Equity Method |  | Total
Common stock |  | $ | — |  |  | $ | 2.5 |  |  | $ | 2.5 |  |  | $ | — |  |  | $ | 2.5 |  |  | $ | 2.5 |
Preferred stock |  | — |  |  | 12.1 |  |  | 12.1 |  |  | — |  |  | 15.4 |  |  | 15.4 |
Fixed maturities |  | 0.5 |  |  | — |  |  | 0.5 |  |  | 0.5 |  |  | — |  |  | 0.5 |
Other |  | 11.3 |  |  | 26.7 |  |  | 38.0 |  |  | 11.3 |  |  | 25.7 |  |  | 37.0 |
Total |  | $ | 11.8 |  |  | $ | 41.3 |  |  | $ | 53.1 |  |  | $ | 11.8 |  |  | $ | 43.6 |  |  | $ | 55.4 |

Fair Value of Financial Instruments Not Measured at Fair Value
The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments, which were not measured at fair value on a recurring basis. The table excludes carrying amounts for cash and cash equivalents, accounts receivable, accounts payable and other current liabilities, and other assets and liabilities that approximate fair value due to relatively short periods to maturity (in millions):

June 30, 2021 |  |  |  |  |  | Fair Value Measurement Using:
| Carrying Value |  | Estimated Fair Value |  | Level 1 |  | Level 2 |  | Level 3
Assets |  |  |  |  |  |  |  |  |  |
Other invested assets |  | $ | 11.3 |  |  | $ | 11.3 |  |  | $ | — |  |  | $ | — |  |  | $ | 11.3 |
Total assets not accounted for at fair value |  | $ | 11.3 |  |  | $ | 11.3 |  |  | $ | — |  |  | $ | — |  |  | $ | 11.3 |
Liabilities |  |  |  |  |  |  |  |  |  |
Debt obligations (1) |  | $ | 676.3 |  |  | $ | 692.7 |  |  | $ | — |  |  | $ | 692.7 |  |  | $ | — |
Total liabilities not accounted for at fair value |  | $ | 676.3 |  |  | $ | 692.7 |  |  | $ | — |  |  | $ | 692.7 |  |  | $ | — |

December 31, 2020 |  |  |  |  |  | Fair Value Measurement Using:
| Carrying Value |  | Estimated Fair Value |  | Level 1 |  | Level 2 |  | Level 3
Assets |  |  |  |  |  |  |  |  |  |
Other invested assets |  | $ | 11.3 |  |  | $ | 11.3 |  |  | $ | — |  |  | $ | — |  |  | $ | 11.3 |
Total assets not accounted for at fair value |  | $ | 11.3 |  |  | $ | 11.3 |  |  | $ | — |  |  | $ | — |  |  | $ | 11.3 |
Liabilities |  |  |  |  |  |  |  |  |  |
Debt obligations (1) |  | $ | 560.7 |  |  | $ | 579.2 |  |  | $ | — |  |  | $ | 579.2 |  |  | $ | — |
Total liabilities not accounted for at fair value |  | $ | 560.7 |  |  | $ | 579.2 |  |  | $ | — |  |  | $ | 579.2 |  |  | $ | — |

(1) Excludes certain lease obligations accounted for under ASC 842, Leases.
Debt Obligations. The fair value of the Company’s long-term obligations was determined using Bloomberg Valuation Service BVAL. The methodology combines direct market observations from contributed sources with quantitative pricing models to generate evaluated prices and classified as Level 2.
F-23

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
Other Non-Current Assets
The following tables provide information relating to Other non-current assets (in millions):

|  | June 30, 2021 |  | December 31, 2020
Right of use asset |  | $ | 72.2 |  |  | $ | 39.8 |
Other |  | 4.5 |  |  | 2.4 |
Total other non-current assets |  | $ | 76.7 |  |  | $ | 42.2 |

Accrued Liabilities
Accrued liabilities consist of the following (in millions):

|  | June 30, 2021 |  | December 31, 2020
Accrued expenses and other current liabilities |  | $ | 42.2 |  |  | $ | 27.9 |
Accrued payroll and employee benefits |  | 32.6 |  |  | 34.7 |
Accrued interest |  | 26.7 |  |  | 13.9 |
Accrued income taxes |  | 0.4 |  |  | 0.6 |
Total accrued liabilities |  | $ | 101.9 |  |  | $ | 77.1 |

Other Non-Current Liabilities
The following tables provide information relating to Other non-current liabilities (in millions):

|  | June 30, 2021 |  | December 31, 2020
Lease liability, net of current portion |  | $ | 60.4 |  |  | $ | 31.6 |
Other |  | 10.2 |  |  | 8.2 |
Total other non-current liabilities |  | $ | 70.6 |  |  | $ | 39.8 |

11. Leases
Operating lease right-of-use-assets and finance leases are recognized in the Condensed Consolidated Balance Sheets within Other assets and Property, plant and equipment, net, respectively. Operating lease liability and finance lease liability are recognized in the Condensed Consolidated Balance Sheets within Other liabilities and Debt obligations, respectively. As of June 30, 2021 and December 31, 2020, lease right-of-use assets and lease liabilities consist of the following (in millions):

|  | June 30, 2021 |  | December 31, 2020
Right-of-use assets: |  |  |  |
Operating lease (Other non-current assets) |  | $ | 72.2 |  |  | $ | 39.8 |
Finance lease (Property, plant and equipment, net) |  | 0.3 |  |  | 0.9 |
Total right-of-use assets |  | $ | 72.5 |  |  | $ | 40.7 |
Lease liabilities: |  |  |  |
Current portion of operating lease (Other current liabilities) |  | $ | 16.2 |  |  | $ | 11.2 |
Non-current portion of operating lease (Other non-current liabilities) |  | 60.4 |  |  | 31.6 |
Finance lease (Debt obligations) |  | 0.2 |  |  | 0.8 |
Total lease liabilities |  | $ | 76.8 |  |  | $ | 43.6 |

The tables below present financial information associated with the Company's leases. This information is presented as of, and for the three and six months ended June 30, 2021 and 2020. The Company has entered into operating and finance lease agreements primarily for land, office space, equipment and vehicles, expiring between 2021 and 2045.
F-24

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
The following table summarizes the components of lease expense for the three and six months ended June 30, 2021 and 2020 (in millions):

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Finance lease cost: |  |  |  |  |  |  |  |
Amortization of right-of-use assets |  | $ | 0.3 |  |  | $ | 0.3 |  |  | $ | 0.6 |  |  | $ | 0.6 |
Interest on lease liabilities |  | — |  |  | — |  |  | — |  |  | 0.1 |
Net finance lease cost |  | 0.3 |  |  | 0.3 |  |  | 0.6 |  |  | 0.7 |
Operating lease cost |  | 4.3 |  |  | 3.5 |  |  | 7.8 |  |  | 7.2 |
Variable lease cost |  | 0.1 |  |  | 0.1 |  |  | 0.2 |  |  | 0.2 |
Total lease cost |  | $ | 4.7 |  |  | $ | 3.9 |  |  | $ | 8.6 |  |  | $ | 8.1 |

Cash flow information related to leases for the three and six months ended June 30, 2021and 2020 is as follows (in millions):

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |  |  |  |
Operating cash flows from finance leases |  | $ | — |  |  | $ | 0.1 |  |  | $ | — |  |  | $ | 0.1 |
Financing cash flows from finance leases |  | $ | 0.2 |  |  | $ | 0.3 |  |  | $ | 0.5 |  |  | $ | 0.5 |
Operating cash flows from operating leases |  | $ | 4.2 |  |  | $ | 3.6 |  |  | $ | 7.9 |  |  | $ | 7.1 |
Right-of-use assets obtained in exchange for new lease liabilities |  |  |  |  |  |  |  |
Finance leases |  | $ | — |  |  | $ | 0.1 |  |  | $ | — |  |  | $ | 0.1 |
Operating leases |  | $ | 37.3 |  |  | $ | 3.6 |  |  | $ | 41.2 |  |  | $ | 12.1 |

As of June 30, 2021 and December 31, 2020, the weighted-average remaining lease term and the weighted-average discount rate for finance leases and operating leases are as follows:

|  | June 30, 2021 |  | December 31, 2020
Weighted-average remaining lease term (years) - operating lease |  | 8.0 |  | 4.4
Weighted-average remaining lease term (years) - finance lease |  | 1.0 |  | 0.9
Weighted-average discount rate - operating lease |  | 5.2 | % |  | 6.2 | %
Weighted-average discount rate - finance lease |  | 7.0 | % |  | 8.9 | %

As of June 30, 2021, undiscounted cash flows for finance and operating leases are as follows (in millions):

| Operating Leases |  | Finance Leases
2021 | $ | 19.6 |  |  | $ | 0.2 |
2022 | 16.6 |  |  | — |
2023 | 12.4 |  |  | — |
2024 | 8.9 |  |  | — |
2025 | 6.4 |  |  | — |
Thereafter | 29.8 |  |  | — |
Total future lease payments | 93.7 |  |  | 0.2 |
Less: Present values | (17.1) |  |  | — |
Total lease liability balance | $ | 76.6 |  |  | $ | 0.2 |

12. Income Taxes
The Company used the Annual Effective Tax Rate ("ETR") approach of ASC 740-270, Interim Reporting, to calculate its 2021 interim tax provision.
Income tax was an expense of $2.6 million and $12.0 million for the three months ended June 30, 2021 and 2020, respectively. The income tax expense recorded for the three months ended June 30, 2021 primarily relates to the projected expense as calculated under ASC 740 for tax paying entities. Additionally, the tax benefits associated with losses generated by the HC2 Holdings, Inc. U.S. consolidated income tax return and certain other businesses have been reduced by a full valuation allowance as we do not believe it is more-likely-than-not that the losses will be utilized prior to expiration. The income tax expense recorded for the three months ended June 30, 2020 primarily relates to tax expense incurred in China from the partial sale of HMN and projected expense as calculated under ASC 740 for tax paying entities.
F-25

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
Income tax was an expense of $3.7 million and $2.3 million for the six months ended June 30, 2021 and 2020, respectively. The income tax expense recorded for the six months ended June 30, 2021 primarily relates to the projected expense as calculated under ASC 740 for tax paying entities. Additionally, the tax benefits associated with losses generated by the HC2 Holdings, Inc. U.S. consolidated income tax return and certain other businesses have been reduced by a full valuation allowance as we do not believe it is more-likely-than-not that the losses will be utilized prior to expiration. The income tax expense recorded for the six months ended June 30, 2020 primarily relates to tax expense incurred in China from the partial sale of HMN and projected expense as calculated under ASC 740 for tax paying entities which was mostly offset by a tax benefit from the carryback of net operating losses at the Insurance segment as a result of the enactment of the CARES Act.
Net Operating Losses
At December 31, 2020, the Company had gross U.S. net operating loss carryforwards available to reduce future taxable income in the amount of $170.3 million, of which a portion is subject to annual limitation under IRC Sec. 382. Based on estimates as of June 30, 2021, the Company expects that approximately $96.0 million of the gross U.S. net operating loss carryforwards would be available to offset taxable income in 2021. This estimate may change based on changes to the quarterly forecasts and actual results reported on the 2020 U.S. tax return.
Additionally, at December 31, 2020, the Company had $112.6 million of gross U.S. net operating loss carryforwards from its subsidiaries that do not qualify to be included in the HC2 Holdings, Inc. U.S. consolidated income tax return. This balance includes $29.3 million from ANG which was sold during the first quarter of 2021.
Unrecognized Tax Benefits
The Company follows the provision of ASC 740-10, Income Taxes, which prescribes a comprehensive model for how a company should recognize, measure, present, and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on a tax return. The Company is subject to challenge from various taxing authorities relative to certain tax planning strategies, including certain intercompany transactions as well as regulatory taxes.
The Company did not have any unrecognized tax benefits as of December 31, 2020 related to uncertain tax positions that would impact the effective income tax rate if recognized. The Company has reduced the net operating loss carryforward by $69.6 million for uncertain tax positions based on our interpretation of tax laws and regulations that are subject to varied interpretation by the IRS.
Examinations
The Company conducts business globally, and as a result, the Company or one or more of its subsidiaries files income tax returns in the United States federal jurisdiction and various state and foreign jurisdictions. In the normal course of business the Company is subject to examination by taxing authorities throughout the world. The open tax years contain matters that could be subject to differing interpretations of applicable tax laws and regulations as they relate to the amount, character, timing or inclusion of revenue and expenses or the applicability of income tax credits for the relevant tax period. Given the nature of tax audits there is a risk that disputes may arise. Tax years 2002 - 2020 remain open for examination.
CARES Act Payroll Tax Deferral
Tax payment deferrals provided for under the CARES Act resulted in liabilities for deferred payroll tax payments. The Company elected to defer approximately $10.9 million of its employer payroll tax obligation as of June 30, 2021. The Company is required to remit 50 percent of the deferred tax balance on or before December 31, 2021 and the remaining 50 percent on or before December 31, 2022, resulting in $5.4 million included in Accrued liabilities and $5.5 million included in Other liabilities. We continue to monitor any effects that may result from the CARES Act.
13. Commitments and Contingencies
Litigation
The Company is subject to claims and legal proceedings that arise in the ordinary course of business. Such matters are inherently uncertain, and there can be no guarantee that the outcome of any such matter will be decided favorably to the Company or that the resolution of any such matter will not have a material adverse effect upon the Company’s Condensed Consolidated Financial Statements. The Company does not believe that any of such pending claims and legal proceedings will have a material adverse effect on its Condensed Consolidated Financial Statements. The Company records a liability in its Condensed Consolidated Financial Statements for these matters when a loss is known or considered probable and the amount can be reasonably estimated. The Company reviews these estimates each accounting period as additional information is known and adjusts the loss provision when appropriate. If a matter is both probable to result in a liability and the amount of loss can be reasonably estimated, the Company estimates and discloses the possible loss or range of loss to the extent necessary for its Condensed Consolidated Financial Statements not to be misleading. If the loss is not probable or cannot be reasonably estimated, a liability is not recorded in the Company's Condensed Consolidated Financial Statements.
F-26

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
Based on a review of the current facts and circumstances with counsel in each of the matters disclosed, management has provided for what is believed to be a reasonable estimate of loss exposure. While acknowledging the uncertainties of litigation, management believes that the ultimate outcome of litigation will not have a material effect on its financial position and will defend itself vigorously.
VAT assessment
On February 20, 2017, and on August 15, 2017, the Company's subsidiary, PTGi International Carrier Services Ltd., received notices from Her Majesty’s Revenue and Customs office in the U.K. (the "HMRC") indicating that it was required to pay certain Value-Added Taxes ("VAT") for the 2015 and 2016 tax years. The Company disagrees with HMRC’s assessments on technical and factual grounds and intends to dispute the assessed liabilities and vigorously defend its interests. We do not believe the assessment to be probable and expect to prevail based on the facts and merits of our existing VAT position.
Fair Value Investments Litigation
On October 1, 2020, Fair Value Investments Incorporated (“FVI”) filed a putative stockholder class action and derivative complaint in the Delaware Court of Chancery against HC2 and certain of DBMG’s current and former officers and directors, including current and former HC2 officers and directors AJ Stahl, Kenneth S. Courtis, Robert V. Leffler, Jr., Philip A. Falcone, Michael J. Sena, and Paul Voigt (together with HC2, the “HC2 Defendants”) styled Fair Value Investments Incorporated v. Roach, et al., C.A. No. 2020-0847-JTL (Del. Ch.) (the “FVI Action”). In the FVI Action, FVI alleges that HC2, in its capacity as DBMG’s controlling stockholder, and DBMG’s current and former officers and directors breached their fiduciary duties to DBMG and DBMG’s minority stockholders by approving certain transactions that allegedly provide disproportionate benefits to HC2. FVI challenges the following transactions: (i) DBMG’s payments to HC2 from 2016–present pursuant to a Tax Sharing Agreement between DBMG and HC2; (ii) DBMG acting as a guarantor or providing collateral for loans taken on by HC2; (iii) DBMG’s issuance of dividends to its common and preferred stockholders in 2017–2020; (iv) DBMG’s issuance of preferred stock to HC2 to finance DBMG’s 2018 acquisition of GrayWolf Industrial; and (v) HC2’s appointment of directors to DBMG’s board of directors by written consent in lieu of holding an annual stockholder meeting. On February 23, 2021, FVI filed an Amended Verified Stockholder Class Action Complaint (the "Amended Complaint"). In the Amended Complaint, FVI named two additional defendants: HC2’s Chief Executive Officer, Wayne Barr, and DBMG’s General Counsel, Scott D. Sherman. The Amended Complaint includes additional fact allegations in support of the largely similar claims raised in the original complaint. Defendants moved to dismiss the Amended Complaint on April 23, 2021. HC2 believes the allegations in the FVI Amended Complaint are without merit and the HC2-related defendants have filed a motion to dismiss the complaint, which continues to be pending. HC2 intends to vigorously defend this litigation.
DTV Derivative Litigation
On March 15, 2021, twenty-two DTV America Corporation (“DTV”) stockholders and eight holders of DTV stock options filed a stockholder class action and derivative complaint in the Delaware Court of Chancery in an action styled Bocock, et al., v. HC2 Holdings, Inc. et al., C.A. No. 2021-0224 (Del. Ch.). Plaintiffs named as defendants HC2 Holdings, Inc., HC2 Broadcasting Holdings, Inc., HC2 Broadcasting Inc., and Continental General Insurance Corporation (the “HC2 Entities”) and certain current and former officers and directors of the HC2 Entities and DTV, including Phillip Falcone, Michael Sena, Wayne Barr, Jr., Les Levi, Paul Voigt, Ivan Minkov, and Paul Robinson (the “Individual Defendants”). Plaintiffs principally allege that the defendants breached their fiduciary duties and/or aided and abetted breaches of fiduciary duty by participating in a “scheme” in which the HC2 Entities (i) acquired majority voting and operating control over DTV; (ii) exploited that control to misappropriate DTV’s assets and business opportunities for the benefit of the HC2 Entities; and (iii) purchased DTV stock at a discount to fair value and diminished the value of DTV stock options. Plaintiffs allege that the Individual Defendants (i) “prompted” the HC2 Entities to purchase more than 100 low-power television (“LPTV”) broadcast stations originally identified for potential acquisition by DTV, (ii) allowed the HC2 Entities to misappropriate DTV technology, known as “DTV Cast,” (iii) caused DTV to transfer unspecified LPTV broadcasting station licenses to HC2 affiliates “without paying any value,” and (iv) transferred to the HC2 Entities unspecified DTV broadcasting stations that had been “repacked” by the FCC. Defendants moved to dismiss the Complaint on May 19, 2021. On June 23, 2021, plaintiffs amended their complaint. In the amended complaint, plaintiffs assert the same claims they asserted in their initial complaint, added a claim for waste associated with DTV’s purported transfer of licenses and construction permits for less than fair value, and dropped Paul Robinson as a defendant. HC2 believes the allegations in the amended complaint are without merit and the HC2-related defendants intend to move to dismiss the amended complaint. HC2 intends to vigorously defend this litigation.
Separation from Philip A. Falcone
The Company has engaged in ongoing negotiations with Philip A. Falcone, the former Chairman, President and Chief Executive Officer of the Company, regarding his separation. On December 18, 2020, Mr. Falcone filed a demand for arbitration against the Company with the American Arbitration Association. The Company filed its Answering Statement and Counterclaims with the AAA on March 5, 2021. The Company contends that the claims in Mr. Falcone’s demand are without merit and that the Company has both factual and legal defenses. Mr. Falcone filed his Answer to the Company’s Counterclaims on March 19, 2021. The Company and Mr. Falcone mediated on July 14, 2021, and on July 19, 2021, both the Company and Mr. Falcone accepted the mediator’s proposal, and the Company has reserved for an amount consistent with the mediator’s proposal.
Books and Records Demand
On July 28, 2021, the Company received a demand from a company stockholder pursuant to 8 Del. C. § 220 to inspect books and records of the Company relating to, among other things, the Company's sale of its Insurance segment. The Company is currently evaluating a response, and cannot determine at this time if the books and records demand will lead to litigation.
F-27

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
Tax Matters
Currently, the Canada Revenue Agency ("CRA") is auditing a subsidiary previously held by the Company. The Company intends to cooperate in audit matters. To date, CRA has not proposed any specific adjustments and the audit is ongoing.
14. Share-based Compensation
Total share-based compensation expense recognized by the Company and its subsidiaries under all equity compensation arrangements was $1.1 million and $1.5 million for the six months ended June 30, 2021 and 2020, respectively.
All grants are time based and vest either immediately or over a period established at grant. The Company recognizes compensation expense for equity awards, reduced by actual forfeitures, using the straight-line basis.
Restricted Stock
A summary of HC2’s restricted stock activity is as follows:

|  | Shares |  | Weighted Average Grant Date Fair Value
Unvested - December 31, 2019 |  | 2,213,775 |  |  | $ | 5.12 |
Granted |  | 1,152,202 |  |  | $ | 2.74 |
Vested |  | (2,258,905) |  |  | $ | 4.08 |
Forfeited |  | (478,639) |  |  | $ | 5.87 |
Unvested - December 31, 2020 |  | 628,433 |  |  | $ | 3.93 |
Granted |  | 593,458 |  |  | $ | 3.81 |
Vested |  | (425,222) |  |  | $ | 3.74 |
Forfeited |  | (31,171) |  |  | $ | 2.62 |
Unvested - June 30, 2021 |  | 765,498 |  |  | $ | 4.00 |

At June 30, 2021, the total unrecognized stock-based compensation expense related to unvested restricted stock was $2.0 million. The unrecognized compensation cost is expected to be recognized over the remaining weighted average period of 2.2 years.
Stock Options
A summary of HC2’s stock option activity is as follows:

|  | Shares |  | Weighted Average Exercise Price
Outstanding - December 31, 2019 |  | 7,067,592 |  |  | $ | 6.52 |
Granted |  | 143,096 |  |  | $ | 2.62 |
Exercised |  | — |  |  | $ | — |
Forfeited |  | (142,503) |  |  | $ | 5.45 |
Expired |  | (2,328,327) |  |  | $ | 9.18 |
Outstanding - December 31, 2020 |  | 4,739,858 |  |  | $ | 5.13 |
Granted |  | — |  |  | $ | — |
Exercised |  | — |  |  | $ | — |
Forfeited |  | — |  |  | $ | — |
Expired |  | (21,599) |  |  | $ | 5.45 |
Outstanding - June 30, 2021 |  | 4,718,259 |  |  | $ | 5.13 |
Eligible for exercise |  | 4,716,909 |  |  | $ | 5.13 |

At June 30, 2021, the intrinsic value and average remaining life of the Company's outstanding options were $0.2 million and approximately 3.1 years, and intrinsic value and average remaining life of the Company's exercisable options were $0.2 million and approximately 3.1 years.
At June 30, 2021, the total unrecognized stock-based compensation expense related to unvested stock options was $0.1 million. The unrecognized compensation cost is expected to be recognized over the remaining weighted average period of 0.7 years. There are 1,350 unvested stock options expected to vest, with a weighted average remaining life of 7.7 years, a weighted average exercise price of $2.62, and an intrinsic value of $0.1 million.
F-28

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
15. Equity
Preferred Shares
The Company’s preferred shares authorized, issued and outstanding consisted of the following:

|  | June 30, 2021 |  | December 31, 2020
Preferred shares authorized, $0.001 par value |  | 20,000,000 |  |  | 20,000,000 |
Series A shares issued and outstanding(1) |  | — |  |  | 6,375 |
Series A-2 shares issued and outstanding(1) |  | — |  |  | 4,000 |

(1) CGI, a wholly owned subsidiary of the Company, owns 6,125 shares of Series A Preferred Stock and 10,000 shares of Series A-2 Preferred Stock which are eliminated in consolidation.
Preferred Share Activity
Series A Shares
CGI Purchase
On December 18, 2018, and December 20, 2018, CGI, a wholly owned subsidiary of the Company closed on the purchase of 6,125 shares of Series A Preferred Stock, which, as of June 30, 2021, is convertible into a total of 1,763,706 shares of the Company's common stock. The shares and dividends accrued related to the Series A Preferred Stock owned by CGI are eliminated in consolidation.
On January 11, 2019, CGI purchased 10,000 shares of Series A-2 Preferred Stock, which, as of June 30, 2021, is convertible into a total of 1,872,659 shares of the Company's common stock. The shares and dividends accrued related to the Series A-2 Preferred Stock owned by CGI are eliminated in consolidation.
Luxor and Corrib Conversions
On August 2, 2016, the Company entered into separate agreements with each of Corrib Master Fund, Ltd. ("Corrib"), then a holder of 1,000 shares of Series A Preferred Stock, and certain investment entities managed by Luxor Capital Group, LP ("Luxor"), that together then held 9,000 shares of Series A-1 Preferred Stock. In conjunction with the conversions, the Company agreed to provide the following two forms of additional consideration for as long as the Preferred Stock remained entitled to receive dividend payments (the "Additional Share Consideration"):
•The Company agreed that in the event that Corrib and Luxor would have been entitled to any Participating Dividends payable, had they not converted the Preferred Stock (as defined in the respective Series A and Series A-1 Certificate of Designation), after the date of their Preferred Share conversion, then the Company will issue to Corrib and Luxor, on the date such Participating Dividends become payable by the Company, in a transaction exempt from the registration requirements of the Securities Act the number of shares of common stock equal to (a) the value of the Participating Dividends Corrib or Luxor would have received pursuant to Sections (2)(c) and (2)(d) of the respective Series A and Series A-1 Certificates of Designation, divided by (b) the Thirty Day VWAP (as defined in the respective Series A and Series A-1 Certificates of Designation) for the period ending two business days prior to the underlying event or transaction that would have entitled Corrib or Luxor to such Participating Dividend had Corrib’s or Luxor’s Preferred Stock remain unconverted.
•The Company agreed that it will issue to Corrib and Luxor, on each quarterly anniversary commencing May 29, 2017 (or, if later, the date on which the corresponding dividend payment is made to the holders of the outstanding Preferred Stock), through and until the Maturity Date (as defined in the respective Series A and Series A-1 Certificates of Designation), in a transaction exempt from the registration requirements of the Securities Act the number of shares of common stock equal to (a) 1.875% the Accrued Value (as defined in the respective Series A and Series A-1 Certificates of Designation) of Corrib’s or Luxor’s Preferred Stock as of the Closing Date (as defined in applicable Voluntary Conversion Agreements) divided by (b) the Thirty Day VWAP (as defined in the respective Series A and Series A-1 Certificate of Designation) for the period ending two business days prior to the applicable Dividend Payment Date (as defined in the respective Series A and Series A-1 Certificate of Designation).
For the six months ended June 30, 2021, 119,784 and 13,477 shares of the Company's common stock have been issued to Luxor and Corrib, respectively, in conjunction with the conversion agreements. For the six months ended June 30, 2020, 159,400 and 17,933 shares of the Company's common stock have been issued to Luxor and Corrib, respectively, in conjunction with the conversion agreements.
The fair value of the Additional Share Consideration for the six months ended June 30, 2021 was valued by the Company at $0.3 million and for the six months ended June 30, 2020 was valued by the Company at $0.4 million on the date of issuance and was recorded within Preferred stock and deemed dividends from conversion line item of the Condensed Consolidated Statements of Operations as a deemed dividend.
On May 29, 2021, pursuant to the terms of the Additional Share Consideration, the final Participating Dividend payments were made to Luxor and Corrib.
F-29

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
Redemption and Conversion of Series A and A-2 Shares
On May 29, 2021, pursuant to the Certificate of Designation, holders of the Series A and A-2 Preferred Stock caused the Company to redeem the Series A and A-2 Preferred Stock at the accrued value per share plus accrued but unpaid dividends (to the extent not included in the accrued value of Series A and A-2 Preferred Stock), of which $10.4 million was paid in cash to holders of the Series A and A-2 Preferred Stock. Each share of Series A and A-2 Preferred Stock that was not so redeemed was automatically converted into shares of common stock at the conversion price then in effect, of which 50,410 shares of the Company's common stock were issued in lieu of cash to holders of the Series A Preferred Stock.
In connection with the Stock Purchase Agreement, CGI, a wholly owned subsidiary of the Company, entered into a letter agreement with Continental General Holdings, LLC to not redeem at maturity or seek redemption of the $16.1 million Preferred Stock. On July 1, 2021, subsequent to quarter end, CGI exchanged their Series A and Series A-2 Preferred Stock for new classes of Series A-3 and Series A-4 Preferred Stock with an extended maturity of July 1, 2026, with other terms substantially unchanged from the terms of the Series A and Series A-2 Preferred Stock.
Preferred Share Dividends
During the six months ended June 30, 2021 and 2020, HC2's Board of Directors declared cash dividends with respect to HC2’s issued and outstanding Preferred Stock, excluding Preferred Stock owned by CGI which is eliminated in consolidation, as presented in the following table (in millions):
2021

Declaration Date |  | March 31, 2021 |  | May 29, 2021
Holders of Record Date |  | March 31, 2021 |  | May 29, 2021
Payment Date |  | April 15, 2021 |  | June 4, 2021
Total Dividend |  | $ | 0.2 |  |  | $ | 0.1 |

2020

Declaration Date |  | March 31, 2020 |  | June 30, 2020
Holders of Record Date |  | March 31, 2020 |  | June 30, 2020
Payment Date |  | April 15, 2020 |  | July 15, 2020
Total Dividend |  | $ | 0.2 |  |  | $ | 0.2 |

F-30

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
16. Related Parties
Non-Operating Corporate
Pansend has an investment in Triple Ring Technologies, Inc. ("Triple Ring"). Various subsidiaries of HC2 utilize the services of Triple Ring, incurring zero and $0.3 million in services for the three months ended June 30, 2021 and 2020, and zero and $1.0 million in services for the six months ended June 30, 2021 and 2020, respectively.
In September 2018, the Company entered into a 75-month lease for office space. As part of the agreement, HC2 was able to pay a lower security deposit and lease payments, and received favorable lease terms as consideration for landlord required cross default language in the event of default of the shared space leased by Harbinger Capital Partners, formerly a related party, in the same building. With the adoption of ASC 842, as of January 1, 2019, this lease was recognized as a right of use asset and lease liability on the Condensed Consolidated Balance Sheets.
Infrastructure
Banker Steel, a subsidiary of DBMG, has leased two office spaces from 2940 Fulks St LLC, a related party that is owned by Donald Banker, CEO of Banker Steel and a related party, with monthly lease payments of $10 thousand and a total lease liability of $0.2 million. For the three months ended June 30, 2021, and 2020, DBMG incurred lease expense of $10 thousand and zero, respectively, and for the six months ended June 30, 2021, and 2020, DBMG incurred lease expense of $10 thousand and zero, respectively.
Banker Steel has leased two planes from Banker Aviation LLC, a related party that is owned by Donald Banker, a related party, with monthly lease payments of $0.2 million and a total lease liability of $4.5 million. For the three months ended June 30, 2021, and 2020, DBMG incurred lease expense of $0.2 million and zero, respectively, and for the six months ended June 30, 2021, and 2020, DBMG incurred lease expense of $0.2 million and zero, respectively.
Banker Steel also has a subordinated note payable of $6.3 million to Donald Banker, a related party, that has a maturity date of June 30, 2024 at a 11% interest rate. For the three months ended June 30, 2021, and 2020, DBMG incurred interest expense of $0.1 million and zero, respectively, and for the six months ended June 30, 2021, and 2020, DBMG incurred interest expense of $0.1 million and zero, respectively.
17. Operating Segment and Related Information
The Company currently has one primary reportable geographic segment - United States. The Company has four reportable operating segments, plus our Other segment, based on management’s organization of the enterprise - Infrastructure, Life Sciences, Spectrum, Insurance, and Other. We also have included a Non-operating Corporate segment. All inter-segment revenues are eliminated.
As a result of the sale of GMSL, ICS, and Beyond6, and in accordance with ASC 280, the Company no longer considers the results of operations and balance sheets of these entities and related subsidiaries as separate segments. Formerly part of the Marine Services, Telecommunications, and Clean Energy segments, these entities and the investment in HMN have been reclassified to the Other segment. In addition, as GMSL, ICS, Beyond6, and CIG are discontinued operations, all operating results of these entities have been reclassified to discontinued operations. This has been reflected in the tables below for both the current and historical periods presented.
Summary information with respect to the Company’s operating segments is as follows (in millions):

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020 |  |
Revenue |  |  |  |  |  |  |  |  |  |
Infrastructure |  | $ | 232.0 |  |  | $ | 172.3 |  |  | $ | 393.3 |  |  | $ | 348.8 |  |  |
Life Sciences |  | 1.2 |  |  | — |  |  | 1.2 |  |  | — |  |  |
Spectrum |  | 10.6 |  |  | 9.5 |  |  | 21.1 |  |  | 19.6 |  |  |
Total revenue |  | $ | 243.8 |  |  | $ | 181.8 |  |  | $ | 415.6 |  |  | $ | 368.4 |  |  |

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Income (loss) from operations |  |  |  |  |  |  |  |
Infrastructure |  | $ | 2.2 |  |  | $ | 4.5 |  |  | $ | 4.4 |  |  | $ | 7.1 |
Life Sciences |  | (4.5) |  |  | (3.5) |  |  | (9.3) |  |  | (6.7) |
Spectrum |  | 1.4 |  |  | (1.2) |  |  | 0.2 |  |  | (4.1) |
Other |  | (0.2) |  |  | (0.7) |  |  | (0.6) |  |  | (1.7) |
Non-operating Corporate |  | (6.6) |  |  | (8.0) |  |  | (13.3) |  |  | (17.1) |
Total loss from operations |  | $ | (7.7) |  |  | $ | (8.9) |  |  | $ | (18.6) |  |  | $ | (22.5) |

F-31

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED
A reconciliation of the Company's consolidated segment operating income to consolidated earnings before income taxes is as follows (in millions):

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Loss from operations |  | $ | (7.7) |  |  | $ | (8.9) |  |  | $ | (18.6) |  |  | $ | (22.5) |
Interest expense |  | (12.4) |  |  | (19.1) |  |  | (33.8) |  |  | (38.3) |
Loss on early extinguishment or restructuring of debt |  | (1.6) |  |  | (3.4) |  |  | (12.4) |  |  | (9.2) |
Income (loss) from equity investees |  | 0.2 |  |  | (0.2) |  |  | (1.9) |  |  | (2.7) |
Other income |  | 0.4 |  |  | 64.6 |  |  | 3.8 |  |  | 66.1 |
(Loss) income from continuing operations before income taxes |  | (21.1) |  |  | 33.0 |  |  | (62.9) |  |  | (6.6) |
Income tax expense |  | (2.6) |  |  | (12.0) |  |  | (3.7) |  |  | (2.3) |
(Loss) income from continuing operations |  | (23.7) |  |  | 21.0 |  |  | (66.6) |  |  | (8.9) |
(Loss) income from discontinued operations (including gain on disposal of $40.4 million and loss on disposal of $39.3 million for the six months ended June 30, 2021 and 2020, respectively) |  | (1.5) |  |  | 7.5 |  |  | 50.4 |  |  | (63.6) |
Net (loss) income |  | (25.2) |  |  | 28.5 |  |  | (16.2) |  |  | (72.5) |
Net income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest |  | 1.7 |  |  | (15.4) |  |  | 5.3 |  |  | 2.5 |
Net (loss) income attributable to HC2 Holdings, Inc. |  | (23.5) |  |  | 13.1 |  |  | (10.9) |  |  | (70.0) |
Less: Preferred dividends and deemed dividends from conversions |  | 0.2 |  |  | 0.4 |  |  | 0.6 |  |  | 0.8 |
Net (loss) income attributable to common stock and participating preferred stockholders |  | $ | (23.7) |  |  | $ | 12.7 |  |  | $ | (11.5) |  |  | $ | (70.8) |

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Depreciation and Amortization |  |  |  |  |  |  |  |
Infrastructure |  | $ | 3.3 |  |  | $ | 2.7 |  |  | $ | 5.7 |  |  | $ | 5.3 |
Life Sciences |  | 0.1 |  |  | 0.1 |  |  | 0.1 |  |  | 0.1 |
Spectrum |  | 1.4 |  |  | 1.7 |  |  | 2.9 |  |  | 3.4 |
Total |  | 4.8 |  |  | 4.5 |  |  | 8.7 |  |  | 8.8 |
Depreciation expense recognized within cost of revenue |  | 2.8 |  |  | 2.3 |  |  | 5.0 |  |  | 4.6 |
Total depreciation and amortization |  | $ | 7.6 |  |  | $ | 6.8 |  |  | $ | 13.7 |  |  | $ | 13.4 |

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Capital Expenditures (*) |  |  |  |  |  |  |  |
Infrastructure |  | $ | 3.9 |  |  | $ | 1.1 |  |  | $ | 5.5 |  |  | $ | 3.4 |
Life Sciences |  | 0.3 |  |  | 0.1 |  |  | 0.5 |  |  | 0.1 |
Spectrum |  | 0.6 |  |  | 3.7 |  |  | 2.0 |  |  | 6.4 |
Non-operating Corporate |  | — |  |  | 0.1 |  |  | — |  |  | 0.1 |
Total |  | $ | 4.8 |  |  | $ | 5.0 |  |  | $ | 8.0 |  |  | $ | 10.0 |

(*) The above capital expenditures exclude assets acquired under terms of capital lease and vendor financing obligations.

|  | June 30, 2021 |  | December 31, 2020
Investments |  |  |  |
Infrastructure |  | $ | 0.9 |  |  | $ | 0.9 |
Life Sciences |  | 15.1 |  |  | 18.4 |
Other |  | 37.1 |  |  | 36.1 |
Total |  | $ | 53.1 |  |  | $ | 55.4 |

F-32

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

|  | June 30, 2021 |  | December 31, 2020
Total Assets |  |  |  |
Infrastructure |  | $ | 858.9 |  |  | $ | 494.8 |
Life Sciences |  | 20.4 |  |  | 21.4 |
Spectrum |  | 206.0 |  |  | 213.6 |
Insurance |  | 5,849.0 |  |  | 5,854.0 |
Other |  | 40.8 |  |  | 167.3 |
Non-operating Corporate |  | 4.2 |  |  | 30.1 |
Eliminations |  | (43.4) |  |  | (38.4) |
Total |  | $ | 6,935.9 |  |  | $ | 6,742.8 |

18. Basic and Diluted Income (Loss) Per Common Share
Earnings per share ("EPS") is calculated using the two-class method, which allocates earnings among common stock and participating securities to calculate EPS when an entity's capital structure includes either two or more classes of common stock or common stock and participating securities. Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities. As such, shares of any unvested restricted stock of the Company are considered participating securities. The dilutive effect of options and their equivalents (including non-vested stock issued under stock-based compensation plans), is computed using the "treasury" method as this measurement was determined to be more dilutive between the two available methods in each period.
The Company had no dilutive common share equivalents during the six months ended June 30, 2021 and 2020 due to results from continuing operations being a loss, net of tax. The following table presents a reconciliation of net income (loss) used in basic and diluted EPS calculations (in millions, except per share amounts):

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
(Loss) income from continuing operations |  | $ | (23.7) |  |  | $ | 21.0 |  |  | $ | (66.6) |  |  | $ | (8.9) |
Income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest |  | 1.6 |  |  | (15.3) |  |  | 4.4 |  |  | (12.5) |
(Loss) income from continuing operations attributable to the Company |  | (22.1) |  |  | 5.7 |  |  | (62.2) |  |  | (21.4) |
Less: Preferred dividends, deemed dividends and repurchase gains |  | 0.2 |  |  | 0.4 |  |  | 0.6 |  |  | 0.8 |
(Loss) income from continuing operations attributable to HC2 common stockholders |  | (22.3) |  |  | 5.3 |  |  | (62.8) |  |  | (22.2) |
(Loss) income from discontinued operations |  | (1.5) |  |  | 7.5 |  |  | 50.4 |  |  | (63.6) |
(Loss) income attributable to noncontrolling interest and redeemable noncontrolling interest |  | 0.1 |  |  | (0.1) |  |  | 0.9 |  |  | 15.0 |
(Loss) income from discontinued operations, net of tax and noncontrolling interest |  | (1.4) |  |  | 7.4 |  |  | 51.3 |  |  | (48.6) |
Net (loss) income attributable to common stock and participating preferred stockholders |  | $ | (23.7) |  |  | $ | 12.7 |  |  | $ | (11.5) |  |  | $ | (70.8) |
Earnings allocable to common shares: |  |  |  |  |  |  |  |
Participating shares at end of period: |  |  |  |  |  |  |  |
Weighted-average common stock outstanding |  | 77.0 |  |  | 46.8 |  |  | 77.1 |  |  | 45.9 |
Unvested restricted stock |  |  |  | 0.3 |  |  |  |  |
Preferred stock (as-converted basis) |  |  |  | 2.1 |  |  |  |  |
Total |  | 77.0 |  |  | 49.2 |  |  | 77.1 |  |  | 45.9 |
Percentage of loss allocated to: |  |  |  |  |  |  |  |
Common stock |  | 100.0 | % |  | 95.1 | % |  | 100.0 | % |  | 100.0 | %
Unvested restricted stock |  | — | % |  | 0.6 | % |  | — | % |  | — | %
Preferred stock |  | — | % |  | 4.3 | % |  | — | % |  | — | %
Numerator for earnings per share, basic: |  |  |  |  |  |  |  |

F-33

HC2 HOLDINGS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

Net (loss) income from continuing operations attributable to common stock, basic |  | $ | (22.3) |  |  | $ | 5.0 |  |  | $ | (62.8) |  |  | $ | (22.2) |
Net (loss) income from discontinued operations attributable to common stock, basic |  | $ | (1.4) |  |  | $ | 7.1 |  |  | $ | 51.3 |  |  | $ | (48.6) |
Net (loss) income attributable to common stock, basic |  | $ | (23.7) |  |  | $ | 12.1 |  |  | $ | (11.5) |  |  | $ | (70.8) |
Earnings allocable to common shares, diluted: |  |  |  |  |  |  |  |
Numerator for earnings per share, diluted |  |  |  |  |  |  |  |
Effect of assumed shares under the if-converted method for convertible instruments |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Net (loss) income from continuing operations attributable to common stock, basic |  | $ | (22.3) |  |  | $ | 5.0 |  |  | $ | (62.8) |  |  | $ | (22.2) |
Net (loss) income from discontinued operations attributable to common stock, basic |  | $ | (1.4) |  |  | $ | 7.1 |  |  | $ | 51.3 |  |  | $ | (48.6) |
Net (loss) income attributable to common stock, basic |  | $ | (23.7) |  |  | $ | 12.1 |  |  | $ | (11.5) |  |  | $ | (70.8) |
Denominator for basic and dilutive earnings per share |  |  |  |  |  |  |  |
Weighted average common shares outstanding - basic |  | 77.0 |  |  | 46.8 |  |  | 77.1 |  |  | 45.9 |
Effect of assumed shares under treasury stock method for stock options and restricted shares and if-converted method for convertible instruments |  | — |  |  | 2.0 |  |  | — |  |  | — |
Weighted average common shares outstanding - diluted |  | 77.0 |  |  | 48.8 |  |  | 77.1 |  |  | 45.9 |
(Loss) income per share - continuing operations |  |  |  |  |  |  |  |
Basic |  | $ | (0.29) |  |  | $ | 0.11 |  |  | $ | (0.82) |  |  | $ | (0.48) |
Diluted |  | $ | (0.29) |  |  | $ | 0.11 |  |  | $ | (0.82) |  |  | $ | (0.48) |
(Loss) income per share - discontinued operations |  |  |  |  |  |  |  |
Basic |  | $ | (0.02) |  |  | $ | 0.15 |  |  | $ | 0.67 |  |  | $ | (1.06) |
Diluted |  | $ | (0.02) |  |  | $ | 0.14 |  |  | $ | 0.67 |  |  | $ | (1.06) |
(Loss) income per share - Net (loss) income attributable to common stock and participating preferred stockholders |  |  |  |  |  |  |  |
Basic |  | $ | (0.31) |  |  | $ | 0.26 |  |  | $ | (0.15) |  |  | $ | (1.54) |
Diluted |  | $ | (0.31) |  |  | $ | 0.25 |  |  | $ | (0.15) |  |  | $ | (1.54) |

19. Subsequent Events
On July 1, 2021, the Company completed the previously announced sale of its insurance segment, comprised of CIG and its wholly-owned subsidiaries, Continental General Insurance Company and Continental LTC Inc., to Continental General Holdings LLC, an entity controlled by Michael Gorzynski, a director of the Company and, as of June 30, 2021, a beneficial owner of approximately 6.6% of the Company's outstanding common stock who has also served as executive chairman of Continental since October 2020. The total transaction value of approximately $90.0 million consists of a combination of $65.0 million in cash plus securities plus certain assets at CGI.
On July 1, 2021, CGI exchanged their Series A and Series A-2 Preferred Stock for new classes of Series A-3 and A-4 Preferred Stock with an extended maturity of July 1, 2026 and a redemption option at the Company's discretion, with other terms substantially unchanged from the terms in the Series A and Series A-2 Preferred Stock. Concurrently with the sale of CGI and the exchange of the Series A and Series A-2 Preferred stock for new classes of Series A-3 and A-4 Preferred Stock, Michael Gorzynski, a director of the Company and executive chairman of Continental, increased his beneficial ownership of the Company's outstanding common stock to 10.8%.
On July 14, 2021, HC2 Broadcasting had entered into an Asset Purchase Agreement for $6.5 million to sell its non-core channel share agreement. On August 2, 2021, HC2 Broadcasting finalized the sale of two of its non-core full power stations for $4.0 million.
On July 21, 2021, the Company provided an additional $15.0 million in Series C funding to R2 Technologies Inc. at a post-money valuation of $150.0 million. The investment was made through HC2’s Life Sciences subsidiary, Pansend Life Sciences, LLC, increasing the Company's fully diluted ownership to 50.4%.
F-34

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
You should read the following discussion and analysis of our financial condition and results of operations together with the information in our consolidated annual audited financial statements and the notes thereto, each of which are contained in Item 8 entitled "Financial Statements and Supplementary Data," and other financial information included herein. Some of the information contained in this discussion and analysis includes forward-looking statements that involve risks and uncertainties. You should review the "Risk Factors" section in our Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 10, 2021, as well as the section below entitled "Special Note Regarding Forward-Looking Statements" for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.
Unless the context otherwise requires, in this Quarterly Report on Form 10-Q, "HC2" means HC2 Holdings, Inc. and the "Company," "we" and "our" mean HC2 together with its consolidated subsidiaries. "U.S. GAAP" means accounting principles accepted in the United States of America.
Our Business
We are a diversified holding company with principal operations conducted through four operating platforms or reportable segments: Infrastructure ("DBMG"), Life Sciences ("Pansend"), Spectrum, and Insurance ("CIG"), plus our Other segment, which includes businesses that do not meet the separately reportable segment thresholds.
Certain previous year amounts have been reclassified to conform with current year presentations, including:
•The recast of Beyond6, ICS, and CIG's results to discontinued operations. Further, the reclassification of prior period assets and liabilities have been classified as held for sale. See Note 3. Discontinued Operations for further information;
•As a result of the sale of ICS, and in accordance with ASC 280, the Company no longer considers the results of operations and Balance Sheets of ICS as a separate segment. Formerly the Telecommunications segment, this entity has been reclassified to the Other segment. See Note 17. Operating Segment and Related Information for further information; and
•As a result of the sale of Beyond6, and in accordance with ASC 280, the Company no longer considers the results of operations and Balance Sheets of Beyond6 as a separate segment. Formerly the Clean Energy segment, this entity has been reclassified to the Other segment. See Note 17. Operating Segment and Related Information for further information;
•The recast of prior year earnings per share as a result of the discontinued operations noted above. This includes presenting EPS for Net (loss) income from continuing operations, Net (loss) income from discontinuing operations, and Net (loss) income. See Note 18. Basic and Diluted Income (Loss) Per Common Share for further details.
Our Operations
Refer to Note 1. Organization and Business to our Condensed Consolidated Financial Statements for additional information.
Cyclical Patterns
Our segments' operations can be highly cyclical. Our volume of business in our Infrastructure segment may be adversely affected by declines or delays in projects, which may vary by geographic region. Project schedules, particularly in connection with large, complex, and longer-term projects can also create fluctuations in the services provided, which may adversely affect us in a given period.
For example, in connection with larger, more complicated projects, the timing of obtaining permits and other approvals may be delayed, and we may need to maintain a portion of our workforce and equipment in an underutilized capacity to ensure we are strategically positioned to deliver on such projects when they move forward.
Examples of other items that may cause our results or demand for our services to fluctuate materially from quarter to quarter include: weather or project site conditions, financial condition of our customers and their access to capital; margins of projects performed during any particular period; economic, and political and market conditions on a regional, national or global scale.
Accordingly, our operating results in any particular period may not be indicative of the results that can be expected for any other period.
35

Recent Developments
COVID-19 Impact on our Business
On March 11, 2020, the World Health Organization declared the outbreak of a novel coronavirus ("COVID-19") as a pandemic, and on March 13, 2020, the United States declared the pandemic to be a national emergency. As COVID-19 spread throughout the country, the situation has continued to evolve, including, more recently, the increasing adoption of the COVID-19 vaccine and the reopening of state economies, although increasing rates of infection with recently identified variants of COVID-19, including the "Delta" variant, have prompted some authorities to reintroduce mask mandates and other restrictions.
The Company’s top priority has been to protect its employees and their families, and those of the Company’s customers. The Company continues to take precautionary measures as directed by health authorities and local governments, including changing operational procedures as necessary, providing additional protective gear and cleaning to protect personnel and customers, which has resulted and may continue to result in disruptions to and increased costs of the Company’s operations. We may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, customers, partners, vendors, and suppliers. Work-from-home and other measures introduce additional operational risks, including cybersecurity risks, and have affected the way we conduct our operations. As the vaccine rollout has commenced, certain employees have begun to return to the office, either full-time or part-time. There is no certainty that such measures will be sufficient to mitigate the risks posed by the virus, including any new strains of the virus, and illness and workforce disruptions could lead to unavailability of key personnel and harm our ability to perform critical functions.
The extent of the impact of COVID-19 on our operational and financial performance will depend on future developments, including, but not limited to, the duration and spread of the outbreak, the effectiveness of the vaccine program, the outbreak of any new strains of the coronavirus, and related travel advisories and restrictions, and its impact to the U.S. and global financial markets, all of which are highly uncertain and cannot be predicted. Preventing the effects from and responding to this market disruption if any other public health threat, related or otherwise, may further increase costs of our business and may have a material adverse effect on our business, financial condition, and results of operations.
We continue to monitor the evolving situation and guidance from authorities, including federal, state and local public health departments, and may take additional actions based on their recommendations. In these circumstances, there may be developments outside our control requiring us to adjust our plans. As such, given the dynamic nature of this situation, we cannot reasonably estimate the impact of COVID-19 on our results of operations, financial condition, or cash flows in the future, but it could have a material adverse impact on our future revenue growth as well as our overall profitability and may lead to revised payment terms with certain of our customers.
During the six months ended June 30, 2021, the effects of COVID-19 and the related actions undertaken in the U.S. to attempt to control its spread, specifically impacted certain of our segments as follows:
Infrastructure
DBMG is dependent on its workforce to carry out its services. Developments resulting from governmental responses to COVID-19 such as social distancing and shelter-in-place directives have impacted, and will continue to impact, DBMG’s ability to deploy its workforce in its facilities and project sites efficiently. The nature of DBMG’s business does not permit alternative workforce arrangements in its facilities and project sites such as remote work schemes to be implemented effectively, and as a result of potential workforce disruptions, DBMG may continue to experience delays or suspensions of projects. DBMG has incurred significant costs related to additional procedures to maintain COVID-19 related safety measures. During the three and six months ended June 30, 2021, $4.0 million and $7.9 million of COVID-19 related expenses were incurred, respectively. DBMG may also experience disruptions in the supply chain depending on the spread of COVID-19 and related governmental orders. These delays, suspensions, and impacts to supply chain may negatively impact DBMG’s results of operations, cash flows or financial condition. While this could cause the timing of revenue to be delayed and possibly impact earnings, as the vaccination program within the U.S. continues to progress, DBMG has more recently seen increases in its backlog position as companies re-engage on previously delayed or postponed projects and could see decreases in COVID-19 related expenses.
Spectrum
As a result of COVID-19, our Spectrum segment has experienced adverse effects on its advertising business because of weakness in the advertising market as advertisers sought to reduce their own costs in response to the pandemic’s impact on their businesses. While we are not able to predict when or whether advertising budgets and the advertising market generally will return or be comparable to historical levels, our Spectrum segment's advertising business appears to have begun to stabilize as the vaccination program within the U.S. progresses and additional businesses begin to reopen.
In addition, COVID-19 could impact our Spectrum segment’s business, financial condition and results of operations in a number of other ways, including, but not limited to:
•negative impact on our broadcast station revenue, as many of our customers also rely on advertising revenues and might be negatively affected by COVID-19;
36

•slow-down of our ability to build out additional broadcast television stations, as illness, social distancing, and other pandemic-related precautions may result in equipment delivery delays and labor shortages, including the availability of tower crews, an already limited, highly-specialized work force necessary to install broadcast equipment;
•negative impact on our network distribution revenues, as consumers may seek to reduce discretionary spending by cutting back or foregoing subscriptions to cable television or other multichannel video programming distributors;
•negative impact on our financial condition or our ability to fund operations or future investment opportunities due to an increase in the cost or difficulty in obtaining debt or equity financing, or refinancing our debt in the future, or our ability to comply with our covenants;
•impairments of our programming inventory, goodwill and other indefinite-lived intangible assets, and other long-lived assets; and
•increased cyber and payment fraud risk, as cybercriminals attempt to profit from the disruption, given increased online activity.
The magnitude of the impact on our Spectrum segment will depend on numerous evolving factors that we may not be able to accurately predict, including the duration and extent of the pandemic, the impact of federal, state, local and foreign governmental actions, consumer behavior in response to the pandemic and such governmental actions, and the economic and operating conditions that we may face in the aftermath of COVID-19. Even after COVID-19 has subsided, we may experience materially adverse impacts to our business as a result of its global economic impact, including any recession that has occurred or may occur in the future.
For further discussion regarding the potential future impacts of COVID-19 and related economic conditions on the Company's liquidity and capital resources, see "Part II-Item 1A-Risk Factors."
Acquisitions and Dispositions
Infrastructure
Banker Steel Acquisition
On March 15, 2021, the Company announced that DBMG entered into an agreement to acquire 100% of Banker Steel Holdco LLC ("Banker Steel") for $145.0 million, which closed on May 27, 2021. The acquisition was financed with $64.1 million from a partial draw on the new $110.0 million revolving credit facility, $49.6 million of sellers' notes, $6.3 million of assumed debt of Banker Steel, and $25.0 million in cash received from HC2 in the settlement of certain intercompany balances.
Banker Steel provides fabricated structural steel and erection services primarily for the East Cost and Southeast commercial and industrial construction market. Banker Steel consists of six operating companies: Banker Steel Co., LLC; NYC Constructors, LLC; Memco LLC; Derr & Isbell Construction LLC; Innovative detailing and Engineering Solutions; and Lynchburg Freight and Specialty LLC.
Insurance
Sale of CGI
On March 29, 2021, the Company announced the entry into a definitive agreement (the "Stock Purchase Agreement") to sell its Insurance segment to Continental General Holdings LLC, an entity controlled by Michael Gorzynski, a director of the Company and, as of June 30, 2021, a beneficial owner of approximately 6.6% of the Company's outstanding common stock who has also served as executive chairman of Continental since October 2020. The transaction value is approximately $90.0 million, inclusive of $65.0 million in cash plus certain assets of CGI. The sale closed on July 1, 2021, subsequent to quarter end.
Other
Sale of Beyond6
On December 31, 2020, the Company announced a plan to sell Beyond6 to an affiliate of Mercuria Investments US, Inc., pursuant to an Agreement and Plan of Merger (the "Merger Agreement") among Beyond6, Greenfill, Inc., a Delaware Corporation ("Parent"), Greenfill Merger Inc., a newly-formed Delaware corporation and wholly-owned subsidiary of Parent, and an affiliate of HC2 as the Stockholder Representative for the Beyond6 stockholders. The sale closed on January 15, 2021. The Company recognized a $39.2 million gain on the sale.
Debt Obligations
Non-Operating Corporate
On February 1, 2021, HC2 repaid its 11.5% senior secured notes due 2021 (the "2021 Senior Secured Notes"), and issued $330.0 million aggregate principal amount of 8.5% senior secured notes due 2026 (the "2026 Senior Secured Notes"). In addition, the Company entered into exchange agreements with certain holders of approximately $51.8 million aggregate principal amount of its existing $55.0 million 7.5% convertible senior notes due 2022 (the "2022 Convertible Notes"), pursuant to which the Company exchanged such holders' 2022 Convertible Notes for newly issued convertible notes due 2026 (the "2026 Convertible Notes"). The 2026 Senior Secured Notes were issued in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
37

On February 23, 2021, the Company entered into a third amendment for the line of credit with MSD PCOF Partners IX, LLC ("Revolving Credit Agreement"), increasing the aggregate principal amount to $20.0 million and extending the maturity to February 23, 2024. In May 2021, HC2 drew $5.0 million of the Revolving Credit Agreement. The Company used the proceeds to fund the redemption of the Company's Series A and A-2 Preferred Stock.
On July 1, 2021 the Company completed the previously announced sale of its insurance segment, comprised of CIG and its wholly-owned subsidiaries, Continental General Insurance Company and Continental LTC Inc. (collectively, “Continental”), to Continental General Holdings LLC, an entity controlled by Michael Gorzynski, a director of the Company and, as of June 30, 2021, a beneficial owner of approximately 6.6% of the Company's outstanding common stock who has also served as executive chairman of Continental since October 2020. The total transaction value of approximately $90.0 million consists of a combination of $65.0 million in cash plus securities held by CGI.
On July 1, 2021, CGI exchanged their Series A and Series A-2 Preferred Stock for new classes of Series A-3 and A-4 Preferred Stock with an extended maturity of July 1, 2026, with other terms substantially unchanged.
Other
On February 3, 2021 the Company announced that R2 received $10.0 million in funding from Huadong Medicine Company Limited (“Huadong”), a leading publicly traded Chinese pharmaceutical company. Huadong’s investment will be used to fund the launch of R2 Technologies’ first-to-market innovations Glacial Rx and Glacial Spa. As part of its equity investment in R2, Huadong receives exclusive distribution rights for R2’s products in the China and selected Asia-Pacific markets.
On July 21, 2021 the Company provided an additional $15.0 million in Series C funding to R2 at a post-money valuation of $150.0 million. The investment was made through HC2’s Life Sciences subsidiary, Pansend Life Sciences, LLC.
Financial Presentation Background
In the below section within this Management’s Discussion and Analysis of Financial Condition and Results of Operations, we compare, pursuant to U.S. GAAP and SEC disclosure rules, the Company’s results of operations for the three and six months ended June 30, 2021 as compared to the three and six months ended June 30, 2020.
38

Results of Operations
The following table summarizes our results of operations and a comparison of the change between the periods (in millions):

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | Increase / (Decrease) |  | 2021 |  | 2020 |  | Increase / (Decrease)
Revenue |  |  |  |  |  |  |  |  |  |  |  |
Infrastructure |  | $ | 232.0 |  |  | $ | 172.3 |  |  | $ | 59.7 |  |  | $ | 393.3 |  |  | $ | 348.8 |  |  | $ | 44.5 |
Life Sciences |  | 1.2 |  |  | — |  |  | 1.2 |  |  | 1.2 |  |  | — |  |  | 1.2 |
Spectrum |  | 10.6 |  |  | 9.5 |  |  | 1.1 |  |  | 21.1 |  |  | 19.6 |  |  | 1.5 |
Total revenue |  | 243.8 |  |  | 181.8 |  |  | 62.0 |  |  | 415.6 |  |  | 368.4 |  |  | 47.2 |
Income (loss) from operations |  |  |  |  |  |  |  |  |  |  |  |
Infrastructure |  | $ | 2.2 |  |  | $ | 4.5 |  |  | $ | (2.3) |  |  | $ | 4.4 |  |  | $ | 7.1 |  |  | $ | (2.7) |
Life Sciences |  | (4.5) |  |  | (3.5) |  |  | (1.0) |  |  | (9.3) |  |  | (6.7) |  |  | (2.6) |
Spectrum |  | 1.4 |  |  | (1.2) |  |  | 2.6 |  |  | 0.2 |  |  | (4.1) |  |  | 4.3 |
Other |  | (0.2) |  |  | (0.7) |  |  | 0.5 |  |  | (0.6) |  |  | (1.7) |  |  | 1.1 |
Non-operating Corporate |  | (6.6) |  |  | (8.0) |  |  | 1.4 |  |  | (13.3) |  |  | (17.1) |  |  | 3.8 |
Total loss from operations |  | (7.7) |  |  | (8.9) |  |  | 1.2 |  |  | (18.6) |  |  | (22.5) |  |  | 3.9 |
Interest expense |  | (12.4) |  |  | (19.1) |  |  | 6.7 |  |  | (33.8) |  |  | (38.3) |  |  | 4.5 |
Loss on early extinguishment or restructuring of debt |  | (1.6) |  |  | (3.4) |  |  | 1.8 |  |  | (12.4) |  |  | (9.2) |  |  | (3.2) |
Income (loss) from equity investees |  | 0.2 |  |  | (0.2) |  |  | 0.4 |  |  | (1.9) |  |  | (2.7) |  |  | 0.8 |
Other income |  | 0.4 |  |  | 64.6 |  |  | (64.2) |  |  | 3.8 |  |  | 66.1 |  |  | (62.3) |
(Loss) income from continuing operations |  | (21.1) |  |  | 33.0 |  |  | (54.1) |  |  | (62.9) |  |  | (6.6) |  |  | (56.3) |
Income tax expense |  | (2.6) |  |  | (12.0) |  |  | 9.4 |  |  | (3.7) |  |  | (2.3) |  |  | (1.4) |
(Loss) income from continuing operations |  | (23.7) |  |  | 21.0 |  |  | (44.7) |  |  | (66.6) |  |  | (8.9) |  |  | (57.7) |
(Loss) income from discontinued operations (including gain on disposal of $40.4 million and loss on disposal of $39.3 million for the six months ended June 30, 2021 and 2020, respectively) |  | (1.5) |  |  | 7.5 |  |  | (9.0) |  |  | 50.4 |  |  | (63.6) |  |  | 114.0 |
Net (loss) income |  | (25.2) |  |  | 28.5 |  |  | (53.7) |  |  | (16.2) |  |  | (72.5) |  |  | 56.3 |
Net income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest |  | 1.7 |  |  | (15.4) |  |  | 17.1 |  |  | 5.3 |  |  | 2.5 |  |  | 2.8 |
Net (loss) income attributable to HC2 Holdings, Inc. |  | (23.5) |  |  | 13.1 |  |  | (36.6) |  |  | (10.9) |  |  | (70.0) |  |  | 59.1 |
Less: Preferred dividends, deemed dividends, and repurchase gains |  | 0.2 |  |  | 0.4 |  |  | (0.2) |  |  | 0.6 |  |  | 0.8 |  |  | (0.2) |
Net (loss) income attributable to common stock and participating preferred stockholders |  | $ | (23.7) |  |  | $ | 12.7 |  |  | $ | (36.4) |  |  | $ | (11.5) |  |  | $ | (70.8) |  |  | $ | 59.3 |

Revenue: Revenue for the three months ended June 30, 2021 increased $62.0 million to $243.8 million from $181.8 million for the three months ended June 30, 2020. Revenue for the six months ended June 30, 2021 increased $47.2 million to $415.6 million from $368.4 million for the six months ended June 30, 2020. The increase in revenue was primarily due to the Infrastructure segment, which acquired Banker Steel in the second quarter of 2021.
Loss from operations: Loss from operations for the three months ended June 30, 2021 decreased $1.2 million to a loss of $7.7 million from a loss of $8.9 million for the three months ended June 30, 2020. Loss from operations for the six months ended June 30, 2021 decreased $3.9 million to a loss of $18.6 million from a loss of $22.5 million for the six months ended June 30, 2020. The decrease is attributable to our Spectrum segment, driven by significant efforts to improve operations and reduce costs across the platform, the sale of high-cost non-core stations in the second half of 2020, and growth in station group OTA revenues, which can be attributed to the expansion in covered markets with new and existing customers and greater number of stations in operation and Non-operating Corporate, driven by unrepeated costs related to the proxy contest in the comparable period and additional cost saving measures implemented. This was partially offset by our Infrastructure segment due primarily to the timing of project work under execution and changes in backlog mix, and our Life Sciences segment driven by R2, which increased spending in the comparable period to support commercialization efforts and further develop its product platform.
39

Interest expense: Interest expense for the three months ended June 30, 2021 decreased $6.7 million to $12.4 million from $19.1 million for the three months ended June 30, 2020. Interest expense for the six months ended June 30, 2021 decreased $4.5 million to $33.8 million from $38.3 million for the six months ended June 30, 2020. The decrease was attributable to the refinancing of the 2021 Senior Secured Notes at Non-operating Corporate in the first quarter of 2021.
Loss on early extinguishment or restructuring of debt: Loss on early extinguishment or restructuring of debt for the three months ended June 30, 2021 decreased $1.8 million to $1.6 million from $3.4 million for the three months ended June 30, 2020. The decrease was related to a partial pay down of the 2021 Senior Secured Notes in the prior year, partially offset by an increase related to the refinancing of Infrastructure debt in conjunction with the Banker Steel acquisition.
Loss on early extinguishment or restructuring of debt for the six months ended June 30, 2021 increased $3.2 million to $12.4 million from $9.2 million for the six months ended June 30, 2020. This was driven by the write-off of deferred financing costs and original issuance discount related to the refinancing of the 2021 Senior Secured Notes and the 2022 Convertible Notes in the first quarter of 2021 and the refinancing of Infrastructure debt in conjunction with the Banker Steel acquisition in the second quarter of 2021, partially offset by the partial pay down of the 2021 Senior Secured Notes in the comparable period.
Income (loss) from equity investees: Income (loss) from equity investees for the three months ended June 30, 2021 increased $0.4 million to income of $0.2 million from a loss of $0.2 million for the three months ended June 30, 2020. Income (loss) from equity investees for the six months ended June 30, 2021 improved $0.8 million to a loss of $1.9 million from a loss of $2.7 million for the six months ended June 30, 2020. The change was driven by the equity investment in HMN, as the joint venture produced higher profits than in the comparable period, which is generally attributable to the timing of turnkey project work. This was partially offset by a reduction in HC2's ownership in HMN in the second quarter of 2020 and increases in losses recorded from our investment in MediBeacon due to the timing of clinical trials.
Other income: Other income for the three months ended June 30, 2021 decreased $64.2 million to $0.4 million from $64.6 million for the three months ended June 30, 2020. Other income for the six months ended June 30, 2021 decreased $62.3 million to $3.8 million from $66.1 million for the six months ended June 30, 2020. The decrease was predominantly driven by the gain on the sale of a portion of HMN in the comparable period, which closed during the second quarter of 2020.
Income tax expense: Income tax expense was an expense of $2.6 million and $12.0 million for the three months ended June 30, 2021 and 2020, respectively. The income tax expense recorded for the three months ended June 30, 2021 primarily relates to the projected expense as calculated under ASC 740 for tax paying entities. Additionally, the tax benefits associated with losses generated by the HC2 Holdings, Inc. U.S. consolidated income tax return and certain other businesses have been reduced by a full valuation allowance as we do not believe it is more-likely-than-not that the losses will be utilized prior to expiration. The income tax expense recorded for the three months ended June 30, 2020 primarily relates to tax expense incurred in China from the partial sale of HMN and projected expense as calculated under ASC 740 for tax paying entities.
Income tax expense was an expense of $3.7 million and $2.3 million for the six months ended June 30, 2021 and 2020, respectively. The income tax benefit recorded for the six months ended June 30, 2021 primarily relates to the projected expense as calculated under ASC 740 for tax paying entities. Additionally, the tax benefits associated with losses generated by the HC2 Holdings, Inc. U.S. consolidated income tax return and certain other businesses have been reduced by a full valuation allowance as we do not believe it is more-likely-than-not that the losses will be utilized prior to expiration. The income tax expense recorded for the six months ended June 30, 2020 primarily relates to tax expense incurred in China from the partial sale of HMN and projected expense as calculated under ASC 740 for tax paying entities which was mostly offset by a tax benefit from the carryback of net operating losses at the Insurance segment as a result of the enactment of the CARES Act.
Segment Results of Operations
In the Company's Condensed Consolidated Financial Statements, other operating (income) expense includes (i) (gain) loss on sale or disposal of assets, (ii) lease termination costs, (iii) asset impairment expense, (iv) accretion of asset retirement obligations, and (v) FCC reimbursements. Each table summarizes the results of operations of our operating segments and compares the amount of the change between the periods presented (in millions).
40

Infrastructure Segment

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | Increase / (Decrease) |  | 2021 |  | 2020 |  | Increase / (Decrease)
Revenue |  | $ | 232.0 |  |  | $ | 172.3 |  |  | $ | 59.7 |  |  | $ | 393.3 |  |  | $ | 348.8 |  |  | $ | 44.5 |
Cost of revenue |  | 202.7 |  |  | 146.6 |  |  | 56.1 |  |  | 339.7 |  |  | 297.8 |  |  | 41.9 |
Selling, general and administrative |  | 23.8 |  |  | 18.6 |  |  | 5.2 |  |  | 43.5 |  |  | 38.5 |  |  | 5.0 |
Depreciation and amortization |  | 3.3 |  |  | 2.7 |  |  | 0.6 |  |  | 5.7 |  |  | 5.3 |  |  | 0.4 |
Other operating expense (income) |  | — |  |  | (0.1) |  |  | 0.1 |  |  | — |  |  | 0.1 |  |  | (0.1) |
Income from operations |  | $ | 2.2 |  |  | $ | 4.5 |  |  | $ | (2.3) |  |  | $ | 4.4 |  |  | $ | 7.1 |  |  | $ | (2.7) |

Revenue: Revenue from our Infrastructure segment for the three months ended June 30, 2021 increased $59.7 million to $232.0 million from $172.3 million for the three months ended June 30, 2020. The increase was primarily driven by DBMG’s acquisition of Banker Steel, which was acquired in the second quarter of 2021 and contributed an incremental $39.5 million of revenue. The increase was also attributable to increased revenues from our structural steel fabrication and erection, industrial maintenance and repair, and modeling and detailing businesses due primarily to the timing of project work under execution and changes in backlog mix.
Revenue from our Infrastructure segment for the six months ended June 30, 2021 increased $44.5 million to $393.3 million from $348.8 million for the six months ended June 30, 2020. The increase was primarily driven by DBMG’s acquisition of Banker Steel, which was acquired in the second quarter of 2021 and contributed an incremental $39.5 million of revenue as well as an increase from our construction modeling and detailing business and in power and industrial maintenance and repair work performed. The increase was partially offset by lower revenues from our structural steel fabrication and erection business, driven by timing of project work under execution and changes in backlog mix.
Cost of revenue: Cost of revenue from our Infrastructure segment for the three months ended June 30, 2021 increased $56.1 million to $202.7 million from $146.6 million for the three months ended June 30, 2020. Cost of revenue from our Infrastructure segment for the six months ended June 30, 2021 increased $41.9 million to $339.7 million from $297.8 million for the six months ended June 30, 2020. The increase was primarily driven by DBMG’s acquisition of Banker Steel, which was acquired in the second quarter of 2021 and contributed an incremental $33.6 million of cost of revenue, and timing of project work under execution and change in backlog mix.
Selling, general and administrative: Selling, general and administrative expense from our Infrastructure segment for the three months ended June 30, 2021 increased $5.2 million to $23.8 million from $18.6 million for the three months ended June 30, 2020. Selling, general and administrative expense from our Infrastructure segment for the six months ended June 30, 2021 increased $5.0 million to $43.5 million from $38.5 million for the six months ended June 30, 2020. The increases were primarily due to headcount-driven increases in salary and benefits as a result of the acquisition of Banker Steel, which was acquired the second quarter of 2021 and contributed an incremental $3.7 million of selling, general and administrative expenses.
Depreciation and amortization: Depreciation and amortization from our Infrastructure segment for the three months ended June 30, 2021 increased $0.6 million to $3.3 million from $2.7 million for the three months ended June 30, 2020. Depreciation and amortization from our Infrastructure segment for the six months ended June 30, 2021 increased $0.4 million to $5.7 million from $5.3 million for the six months ended June 30, 2020. The increase was largely due to the additional amortization and depreciation of assets obtained in the acquisition of Banker Steel in the second quarter of 2021, which contributed an additional $0.9 million of depreciation and amortization expense.
41

Life Sciences Segment

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | Increase / (Decrease) |  | 2021 |  | 2020 |  | Increase / (Decrease)
Revenue |  | $ | 1.2 |  |  | $ | — |  |  | $ | 1.2 |  |  | $ | 1.2 |  |  | $ | — |  |  | $ | 1.2 |
|  |  |  |  |  |  |  |  |  |  |  | — |
Cost of revenue |  | 0.6 |  |  | — |  |  | 0.6 |  |  | 0.6 |  |  | — |  |  | 0.6 |
Selling, general and administrative |  | 5.0 |  |  | 3.4 |  |  | 1.6 |  |  | 9.8 |  |  | 6.6 |  |  | 3.2 |
Depreciation and amortization |  | 0.1 |  |  | 0.1 |  |  | — |  |  | 0.1 |  |  | 0.1 |  |  | — |
Loss from operations |  | $ | (4.5) |  |  | $ | (3.5) |  |  | $ | (1.0) |  |  | $ | (9.3) |  |  | $ | (6.7) |  |  | $ | (2.6) |

Revenue: Revenue from our Life Sciences segment for the three months ended June 30, 2021 increased $1.2 million to $1.2 million from zero for the three months ended June 30, 2020. Revenue from our Life Sciences segment for the six months ended June 30, 2021 increased $1.2 million to $1.2 million from zero for the six months ended June 30, 2020. The increase in revenue was attributable to R2, which began the sale of its Glacial Rx products in the current period.
Cost of revenue: Cost of revenue from our Life Sciences segment for the three months ended June 30, 2021 increased $0.6 million to $0.6 million from zero for the three months ended June 30, 2020. Cost of revenue from our Life Sciences segment for the six months ended June 30, 2021 increased $0.6 million to $0.6 million from zero for the six months ended June 30, 2020. The increase in cost of revenue was attributable to R2, which began the sale of its Glacial Rx products in the current period.
Selling, general and administrative: Selling, general and administrative expenses from our Life Sciences segment for the three months ended June 30, 2021 increased $1.6 million to $5.0 million from $3.4 million for the three months ended June 30, 2020. Selling, general and administrative expenses from our Life Sciences segment for the six months ended June 30, 2021 increased $3.2 million to $9.8 million from $6.6 million for the six months ended June 30, 2020. The increase was driven by higher expenses at R2, which increased spending from the comparable period to ramp up operations to support commercialization efforts and further develop its product platform.
Spectrum Segment

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | Increase / (Decrease) |  | 2021 |  | 2020 |  | Increase / (Decrease)
Revenue |  | $ | 10.6 |  |  | $ | 9.5 |  |  | $ | 1.1 |  |  | $ | 21.1 |  |  | $ | 19.6 |  |  | $ | 1.5 |
Cost of revenue |  | 4.1 |  |  | 5.5 |  |  | (1.4) |  |  | 8.4 |  |  | 11.1 |  |  | (2.7) |
Selling, general and administrative |  | 3.9 |  |  | 5.6 |  |  | (1.7) |  |  | 9.4 |  |  | 11.3 |  |  | (1.9) |
Depreciation and amortization |  | 1.4 |  |  | 1.7 |  |  | (0.3) |  |  | 2.9 |  |  | 3.4 |  |  | (0.5) |
Other operating expense (income) |  | (0.2) |  |  | (2.1) |  |  | 1.9 |  |  | 0.2 |  |  | (2.1) |  |  | 2.3 |
Income (loss) from operations |  | $ | 1.4 |  |  | $ | (1.2) |  |  | $ | 2.6 |  |  | $ | 0.2 |  |  | $ | (4.1) |  |  | $ | 4.3 |

Revenue: Revenue from our Spectrum segment for the three months ended June 30, 2021 increased $1.1 million to $10.6 million from $9.5 million for the three months ended June 30, 2020. Revenue from our Spectrum segment for the six months ended June 30, 2021 increased $1.5 million to $21.1 million from $19.6 million for the six months ended June 30, 2020. The increase was primarily driven by higher station group revenues, which can be attributed to the expansion in coverage market with new and existing customers and the greater number of OTA stations in operation. Stations group revenue increases were partially offset by lost revenues attributable to the sale of non-core stations in the second half of 2020.
Cost of revenue: Cost of revenue from our Spectrum segment for the three months ended June 30, 2021 decreased $1.4 million to $4.1 million from $5.5 million for the three months ended June 30, 2020. Cost of revenue from our Spectrum segment for the six months ended June 30, 2021 decreased $2.7 million to $8.4 million from $11.1 million for the six months ended June 30, 2020. The overall decrease was primarily driven by cost reductions at Network as well as a reduction in operating expenses for certain non-core station that were sold in the second half of 2020.
Selling, general and administrative: Selling, general and administrative expense from our Spectrum segment for the three months ended June 30, 2021 decreased $1.7 million to $3.9 million from $5.6 million for the three months ended June 30, 2020. Selling, general and administrative expense from our Spectrum segment for the six months ended June 30, 2021 decreased $1.9 million to $9.4 million from $11.3 million for the six months ended June 30, 2020. The overall decrease was primarily driven by headcount reductions, decreased consulting fees, decreased office rent, and decreased legal fees in the current year. This was partially offset by severance costs incurred in the current period.
42

Depreciation and amortization: Depreciation and amortization from our Spectrum segment for the three months ended June 30, 2021 decreased $0.3 million to $1.4 million from $1.7 million for the three months ended June 30, 2020. Depreciation and amortization from our Spectrum segment for the six months ended June 30, 2021 decreased $0.5 million to $2.9 million from $3.4 million for the six months ended June 30, 2020. The decrease in depreciation was primarily related to recent disposals of non-core assets.
Other operating expense (income): Other operating expense (income) from our Spectrum segment for the three months ended June 30, 2021 decreased $1.9 million to income of $0.2 million from $2.1 million for the three months ended June 30, 2020. The decrease in other operating expense (income) was primarily related to a reduction in FCC reimbursements.
Other operating expense (income) from our Spectrum segment for the six months ended June 30, 2021 decreased $2.3 million to loss of $0.2 million from income of $2.1 million for the six months ended June 30, 2020. The decrease in other operating expense (income) was primarily related to a reduction in FCC reimbursements and an impairment of certain right-of-use assets as a result of subletting office space in the current period.
Non-operating Corporate

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | Increase / (Decrease) |  | 2021 |  | 2020 |  | Increase / (Decrease)
Selling, general and administrative |  | $ | 6.6 |  |  | $ | 8.0 |  |  | $ | (1.4) |  |  | $ | 13.3 |  |  | $ | 17.1 |  |  | $ | (3.8) |
Loss from operations |  | $ | (6.6) |  |  | $ | (8.0) |  |  | $ | 1.4 |  |  | $ | (13.3) |  |  | $ | (17.1) |  |  | $ | 3.8 |

Selling, general and administrative: Selling, general and administrative expenses from our Non-operating Corporate segment for the three months ended June 30, 2021 decreased $1.4 million to $6.6 million from $8.0 million for the three months ended June 30, 2020. Selling, general and administrative expenses from our Non-operating Corporate segment for the six months ended June 30, 2021 decreased $3.8 million to $13.3 million from $17.1 million for the six months ended June 30, 2020. The decrease was driven by unrepeated costs related to the proxy contest in the comparable period as well as decreases in stock compensation expense, rent expense and various consulting expenses in the current period, partially offset by increased legal expenses and additional expenses incurred as a result of settlement discussions with the Company's former CEO.
Income (Loss) from Equity Investees

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | Increase / (Decrease) |  | 2021 |  | 2020 |  | Increase / (Decrease)
Life Sciences |  | $ | (1.7) |  |  | $ | (1.1) |  |  | $ | (0.6) |  |  | $ | (3.2) |  |  | $ | (2.1) |  |  | $ | (1.1) |
Other |  | 1.9 |  |  | 0.9 |  |  | 1.0 |  |  | 1.3 |  |  | (0.6) |  |  | 1.9 |
Income (loss) from equity investees |  | $ | 0.2 |  |  | $ | (0.2) |  |  | $ | 0.4 |  |  | $ | (1.9) |  |  | $ | (2.7) |  |  | $ | 0.8 |

Life Sciences: Loss from equity investees within our Life Sciences segment for the three months ended June 30, 2021 increased $0.6 million to $1.7 million from $1.1 million for the three months ended June 30, 2020. Loss from equity investees within our Life Sciences segment for the six months ended June 30, 2021 increased $1.1 million to $3.2 million from $2.1 million for the six months ended June 30, 2020. The increase in loss was largely due to higher equity method losses recorded from our investment in MediBeacon due to the timing of clinical trials.
Other: Income from equity investees within our Other segment for the three months ended June 30, 2021 increased $1.0 million to $1.9 million from $0.9 million for the three months ended June 30, 2020. Income (loss) from equity investees within our Other segment for the six months ended June 30, 2021 increased $1.9 million to income of $1.3 million from a loss of $0.6 million for the six months ended June 30, 2020. The increases in both periods were driven by the equity investment in HMN, as the joint venture produced higher income than in the comparable period, which is generally attributable to the timing of turnkey project work, partially offset by a reduction in ownership from 49% to 19% as a result of the partial sale of HC2's investment in the second quarter of 2020.
43

Non-GAAP Financial Measures and Other Information
Adjusted EBITDA
Adjusted EBITDA is not a measurement recognized under U.S. GAAP. In addition, other companies may define Adjusted EBITDA differently than we do, which could limit its usefulness.
Management believes that Adjusted EBITDA provides investors with meaningful information for gaining an understanding of our results as it is frequently used by the financial community to provide insight into an organization’s operating trends and facilitates comparisons between peer companies, since interest, taxes, depreciation, amortization and the other items listed in the definition of Adjusted EBITDA below can differ greatly between organizations as a result of differing capital structures and tax strategies. Adjusted EBITDA can also be a useful measure of a company’s ability to service debt. While management believes that non-U.S. GAAP measurements are useful supplemental information, such adjusted results are not intended to replace our U.S. GAAP financial results. Using Adjusted EBITDA as a performance measure has inherent limitations as an analytical tool as compared to net income (loss) or other U.S. GAAP financial measures, as this non-GAAP measure excludes certain items, including items that are recurring in nature, which may be meaningful to investors. As a result of the exclusions, Adjusted EBITDA should not be considered in isolation and does not purport to be an alternative to net income (loss) or other U.S. GAAP financial measures as a measure of our operating performance. Adjusted EBITDA excludes the results of operations and any consolidating eliminations of our Insurance segment.
The calculation of Adjusted EBITDA, as defined by us, consists of Net income (loss) as adjusted for discontinued operations; depreciation and amortization; Other operating (income) expense, which is inclusive of (gain) loss on sale or disposal of assets, lease termination costs, asset impairment expense and FCC reimbursements; interest expense; other (income) expense, net; net gain (loss) on contingent consideration; loss on early extinguishment or restructuring of debt; foreign currency transaction (gain) loss included in cost of revenue; income tax (benefit) expense; noncontrolling interest; bonus to be settled in equity; share-based compensation
expense; non-recurring items; costs associated with the COVID-19 pandemic; and acquisition and disposition costs.

(in millions) |  | Three months ended June 30, 2021
|  | Infrastructure |  | Life Sciences |  | Spectrum |  | Non-operating Corporate |  | Other and Eliminations |  | HC2
Net (loss) attributable to HC2 Holdings, Inc. |  |  |  |  |  |  |  |  |  |  |  | $ | (23.5) |
Less: Discontinued operations |  |  |  |  |  |  |  |  |  |  |  | (1.5) |
Net Income (loss) attributable to HC2 Holdings, Inc., excluding discontinued operations |  | $ | 1.4 |  |  | $ | (4.3) |  |  | $ | (1.1) |  |  | $ | (19.2) |  |  | $ | 1.2 |  |  | $ | (22.0) |
Adjustments to reconcile net income (loss) to Adjusted EBITDA: |  |  |  |  |  |  |  |  |  |  |  |
Depreciation and amortization |  | 3.3 |  |  | 0.1 |  |  | 1.4 |  |  | — |  |  | — |  |  | 4.8 |
Depreciation and amortization (included in cost of revenue) |  | 2.7 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2.7 |
Other operating (income) |  | — |  |  | — |  |  | (0.2) |  |  | — |  |  | — |  |  | (0.2) |
Interest expense |  | 2.2 |  |  | — |  |  | 2.4 |  |  | 7.8 |  |  | — |  |  | 12.4 |
Other (income) expense, net |  | (4.1) |  |  | — |  |  | 0.4 |  |  | 3.3 |  |  | — |  |  | (0.4) |
Loss on early extinguishment or restructuring of debt |  | 1.5 |  |  | — |  |  | — |  |  | 0.1 |  |  | — |  |  | 1.6 |
Income tax expense |  | 1.2 |  |  | — |  |  | — |  |  | 1.4 |  |  | — |  |  | 2.6 |
Noncontrolling interest |  | 0.1 |  |  | (1.9) |  |  | (0.5) |  |  | — |  |  | 0.6 |  |  | (1.7) |
Share-based compensation expense |  | — |  |  | — |  |  | 0.2 |  |  | 0.5 |  |  | — |  |  | 0.7 |
Nonrecurring Items |  | 0.2 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 0.2 |
COVID-19 Costs |  | 4.0 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 4.0 |
Acquisition and disposition costs |  | 1.4 |  |  | — |  |  | 0.1 |  |  | 0.4 |  |  | (0.1) |  |  | 1.8 |
Adjusted EBITDA |  | $ | 13.9 |  |  | $ | (6.1) |  |  | $ | 2.7 |  |  | $ | (5.7) |  |  | $ | 1.7 |  |  | $ | 6.5 |

44

(in millions) |  | Three months ended June 30, 2020
|  | Infrastructure |  | Life Sciences |  | Spectrum |  | Non-operating Corporate |  | Other and Eliminations |  | HC2
Net income attributable to HC2 Holdings, Inc. |  |  |  |  |  |  |  |  |  |  |  | $ | 13.1 |
Less: Discontinued operations |  |  |  |  |  |  |  |  |  |  |  | 7.5 |
Net Income (loss) attributable to HC2 Holdings, Inc., excluding discontinued operations |  | $ | 1.7 |  |  | $ | (1.2) |  |  | $ | (3.7) |  |  | $ | (38.2) |  |  | $ | 47.0 |  |  | $ | 5.6 |
Adjustments to reconcile net income (loss) to Adjusted EBITDA: |  |  |  |  |  |  |  |  |  |  |  |
Depreciation and amortization |  | 2.7 |  |  | 0.1 |  |  | 1.7 |  |  | — |  |  | — |  |  | 4.5 |
Depreciation and amortization (included in cost of revenue) |  | 2.3 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 2.3 |
Other operating (income) |  | (0.1) |  |  | — |  |  | (2.2) |  |  | — |  |  | — |  |  | (2.3) |
Interest expense |  | 2.2 |  |  | — |  |  | 3.5 |  |  | 13.4 |  |  | — |  |  | 19.1 |
Loss on early extinguishment or restructuring of debt |  | — |  |  | — |  |  | — |  |  | 3.4 |  |  | — |  |  | 3.4 |
Other (income) expense, net |  | (0.1) |  |  | (2.3) |  |  | 0.4 |  |  | 8.8 |  |  | (71.3) |  |  | (64.5) |
Income tax expense |  | 0.8 |  |  | — |  |  | — |  |  | 4.3 |  |  | 6.9 |  |  | 12.0 |
Noncontrolling interest |  | 0.1 |  |  | (1.2) |  |  | (1.3) |  |  | — |  |  | 17.7 |  |  | 15.3 |
Bonus to be settled in equity |  | — |  |  | — |  |  | — |  |  | (0.3) |  |  | — |  |  | (0.3) |
Share-based compensation expense |  | — |  |  | 0.1 |  |  | — |  |  | 0.1 |  |  | — |  |  | 0.2 |
Nonrecurring Items |  | 0.9 |  |  | — |  |  | — |  |  | 3.8 |  |  | — |  |  | 4.7 |
COVID-19 Costs |  | 8.4 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 8.4 |
Acquisition and disposition costs |  | 0.2 |  |  | — |  |  | 0.4 |  |  | 1.1 |  |  | 0.5 |  |  | 2.2 |
Adjusted EBITDA |  | $ | 19.1 |  |  | $ | (4.5) |  |  | $ | (1.2) |  |  | $ | (3.6) |  |  | $ | 0.8 |  |  | $ | 10.6 |

Infrastructure: Net income from our Infrastructure segment for the three months ended June 30, 2021 decreased $0.3 million to $1.4 million from $1.7 million for the three months ended June 30, 2020. Adjusted EBITDA from our Infrastructure segment for the three months ended June 30, 2021 decreased $5.2 million to $13.9 million from $19.1 million for the three months ended June 30, 2020. The decrease in Adjusted EBITDA can be attributed to the timing of project work under execution and change in backlog mix, including a reduction in large commercial construction projects in the current period, as well as a decline in power and industrial repair and maintenance work performed, partially offset by increased contribution from Banker Steel, which was acquired in the second quarter of 2021.
Life Sciences: Net loss from our Life Sciences segment for the three months ended June 30, 2021 increased $3.1 million to $4.3 million from $1.2 million for the three months ended June 30, 2020. Adjusted EBITDA loss from our Life Sciences segment for the three months ended June 30, 2021 increased $1.6 million to $6.1 million from $4.5 million for the three months ended June 30, 2020. The increase in Adjusted EBITDA loss was primarily driven by higher expenses at R2, which increased spending from the comparable period to support commercialization efforts and further develop its product platform, and higher equity method losses recorded from our investment in MediBeacon due to the timing of clinical trials. This was partially offset by increased profit contribution from R2, which launched its Glacial Rx product in the second quarter of 2021.
Spectrum: Net loss from our Spectrum segment for the three months ended June 30, 2021 decreased $2.6 million to $1.1 million from $3.7 million for the three months ended June 30, 2020. Adjusted EBITDA from our Spectrum segment for the three months ended June 30, 2021 increased $3.9 million to income of $2.7 million from a loss of $1.2 million for the three months ended June 30, 2020. The overall increase in Adjusted EBITDA to income was primarily driven significant efforts to improve operations and reduce costs across the platform, the sale of high-cost non-core stations in the second half of 2020, and growth in station group OTA revenues, which can be attributed to the expansion in covered markets with new and existing customers and greater number of stations in operation.
Non-operating Corporate: Net loss from our Non-operating Corporate segment for the three months ended June 30, 2021 decreased $19.0 million to $19.2 million from $38.2 million for the three months ended June 30, 2020. Adjusted EBITDA loss from our Non-operating Corporate segment for the three months ended June 30, 2021 increased $2.1 million to $5.7 million from $3.6 million for the three months ended June 30, 2020. The increase in Adjusted EBITDA loss was driven by additional expenses incurred as a result of settlement discussions with the Company's former CEO and changes to the executive compensation plan that went into effect in the comparable period which reduced executive and employee bonus accruals, partially offset by a reduction in rent expense.
Other and Elimination: Net income from our Other segment for the three months ended June 30, 2021 decreased $45.8 million to $1.2 million from $47.0 million for the three months ended June 30, 2020. Adjusted EBITDA from our Other segment for the three months ended June 30, 2021 increased $0.9 million to $1.7 million from $0.8 million for the three months ended June 30, 2020. The increase in Adjusted EBITDA for Other and Eliminations was driven by the equity investment in HMN, as it produced higher income than in the comparable period, which is generally attributable to the timing of turnkey project work, and partially offset by a reduction in ownership from 49% to 19% as a result of the partial sale of HC2's investment in the second quarter of 2020.
45

(in millions) |  | Six months ended June 30, 2021
|  | Infrastructure |  | Life Sciences |  | Spectrum |  | Non-operating Corporate |  | Other and Eliminations |  | HC2
Net (loss) attributable to HC2 Holdings, Inc. |  |  |  |  |  |  |  |  |  |  |  | $ | (10.9) |
Less: Discontinued operations |  |  |  |  |  |  |  |  |  |  |  | 50.4 |
Net Income (loss) attributable to HC2 Holdings, Inc., excluding discontinued operations |  | $ | 1.4 |  |  | $ | (8.5) |  |  | $ | (5.5) |  |  | $ | (50.0) |  |  | $ | 1.3 |  |  | $ | (61.3) |
Adjustments to reconcile net income (loss) to Adjusted EBITDA: |  |  |  |  |  |  |  |  |  |  |  |
Depreciation and amortization |  | 5.7 |  |  | 0.1 |  |  | 2.9 |  |  | — |  |  | — |  |  | 8.7 |
Depreciation and amortization (included in cost of revenue) |  | 5.0 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 5.0 |
Other operating expenses |  | — |  |  | — |  |  | 0.2 |  |  | — |  |  | — |  |  | 0.2 |
Interest expense |  | 4.1 |  |  | — |  |  | 4.7 |  |  | 25.0 |  |  | — |  |  | 33.8 |
Other (income) expense, net |  | (3.9) |  |  | — |  |  | 0.8 |  |  | (0.7) |  |  | — |  |  | (3.8) |
Loss on early extinguishment or restructuring of debt |  | 1.5 |  |  | — |  |  | 0.9 |  |  | 10.0 |  |  | — |  |  | 12.4 |
Income tax expense |  | 1.2 |  |  | — |  |  | — |  |  | 2.5 |  |  | — |  |  | 3.7 |
Noncontrolling interest |  | 0.1 |  |  | (4.0) |  |  | (1.0) |  |  | — |  |  | (0.5) |  |  | (5.4) |
Share-based compensation expense |  | — |  |  | 0.1 |  |  | 0.3 |  |  | 0.9 |  |  | — |  |  | 1.3 |
Nonrecurring Items |  | 0.4 |  |  | — |  |  | — |  |  | 0.5 |  |  | — |  |  | 0.9 |
COVID-19 Costs |  | 7.9 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 7.9 |
Acquisition and disposition costs |  | 1.8 |  |  | — |  |  | 0.2 |  |  | 2.1 |  |  | — |  |  | 4.1 |
Adjusted EBITDA |  | $ | 25.2 |  |  | $ | (12.3) |  |  | $ | 3.5 |  |  | $ | (9.7) |  |  | $ | 0.8 |  |  | $ | 7.5 |

(in millions) |  | Six months ended June 30, 2020
|  | Infrastructure |  | Life Sciences |  | Spectrum |  | Non-operating Corporate |  | Other and Eliminations |  | HC2
Net (loss) attributable to HC2 Holdings, Inc. |  |  |  |  |  |  |  |  |  |  |  | $ | (70.0) |
Less: Discontinued operations |  |  |  |  |  |  |  |  |  |  |  | (63.6) |
Net Income (loss) attributable to HC2 Holdings, Inc., excluding discontinued operations |  | $ | 1.6 |  |  | $ | (4.4) |  |  | $ | (9.2) |  |  | $ | (64.0) |  |  | $ | 69.6 |  |  | $ | (6.4) |
Adjustments to reconcile net income (loss) to Adjusted EBITDA: |  |  |  |  |  |  |  |  |  |  |  |
Depreciation and amortization |  | 5.3 |  |  | 0.1 |  |  | 3.4 |  |  | — |  |  | — |  |  | 8.8 |
Depreciation and amortization (included in cost of revenue) |  | 4.6 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 4.6 |
Other operating (income) expenses |  | 0.1 |  |  | — |  |  | (2.2) |  |  | — |  |  | — |  |  | (2.1) |
Interest expense |  | 4.4 |  |  | — |  |  | 6.7 |  |  | 27.2 |  |  | — |  |  | 38.3 |
Loss on early extinguishment or restructuring of debt |  | — |  |  | — |  |  | — |  |  | 9.2 |  |  | — |  |  | 9.2 |
Other (income) expense, net |  | 0.1 |  |  | (2.3) |  |  | 1.0 |  |  | 6.4 |  |  | (71.3) |  |  | (66.1) |
Income tax (benefit) expense |  | 1.0 |  |  | — |  |  | — |  |  | 3.9 |  |  | (2.6) |  |  | 2.3 |
Noncontrolling interest |  | 0.1 |  |  | (2.2) |  |  | (2.4) |  |  | — |  |  | 2.0 |  |  | (2.5) |
Bonus to be settled in equity |  | — |  |  | — |  |  | — |  |  | (0.3) |  |  | — |  |  | (0.3) |
Share-based compensation expense |  | — |  |  | 0.1 |  |  | 0.1 |  |  | 1.5 |  |  | — |  |  | 1.7 |
Nonrecurring Items |  | 1.8 |  |  | — |  |  | — |  |  | 5.2 |  |  | — |  |  | 7.0 |
COVID-19 Costs |  | 8.8 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 8.8 |
Acquisition and disposition costs |  | 0.3 |  |  | — |  |  | 0.4 |  |  | 2.3 |  |  | 1.4 |  |  | 4.4 |
Adjusted EBITDA |  | $ | 28.1 |  |  | $ | (8.7) |  |  | $ | (2.2) |  |  | $ | (8.6) |  |  | $ | (0.9) |  |  | $ | 7.7 |

Infrastructure: Net income from our Infrastructure segment for the six months ended June 30, 2021 decreased $0.2 million to $1.4 million from $1.6 million for the six months ended June 30, 2020. Adjusted EBITDA from our Infrastructure segment for the six months ended June 30, 2021 decreased $2.9 million to $25.2 million from $28.1 million for the six months ended June 30, 2020. The decrease in Adjusted EBITDA can be attributed to the timing of project work under execution and change in backlog mix, including a reduction in large commercial construction projects in the current period, as well as a decline in power and industrial repair and maintenance work performed. This was partially offset by increased contribution from Banker Steel, which was acquired in the second quarter of 2021.
Life Sciences: Net loss from our Life Sciences segment for the six months ended June 30, 2021 increased $4.1 million to $8.5 million from $4.4 million for the six months ended June 30, 2020. Adjusted EBITDA loss from our Life Sciences segment for the six months ended June 30, 2021 increased $3.6 million to $12.3 million from $8.7 million for the six months ended June 30, 2020. The increase in Adjusted EBITDA loss was primarily driven by higher expenses at R2, which increased spending from the comparable period to support commercialization efforts and further develop its product platform which launched its Glacial Rx product in the second quarter 2021, and higher equity method losses recorded from our investment in MediBeacon due to the timing of clinical trials.
46

Spectrum: Net loss from our Spectrum segment for the six months ended June 30, 2021 decreased $3.7 million to $5.5 million from $9.2 million for the six months ended June 30, 2020. Adjusted EBITDA from our Spectrum segment for the six months ended June 30, 2021 increased $5.7 million to income of $3.5 million from an Adjusted EBITDA loss of $2.2 million for the six months ended June 30, 2020. The overall increase in Adjusted EBITDA to income primarily driven by significant efforts to improve operations and reduce costs across the platform, the sale of high-cost non-core stations in the second half of 2020 and the growth in OTA revenues, which can be attributed to the expansion in covered markets with new and existing customers and a greater number of stations in operation. This was partially offset by severance costs incurred in the current period.
Non-operating Corporate: Net loss from our Non-operating Corporate segment for the six months ended June 30, 2021 decreased $14.0 million to $50.0 million from $64.0 million for the six months ended June 30, 2020. Adjusted EBITDA loss from our Non-operating Corporate segment for the six months ended June 30, 2021 increased $1.1 million to $9.7 million from $8.6 million for the six months ended June 30, 2020. The increase in Adjusted EBITDA loss was driven by additional expenses incurred as a result of negotiations around a settlement with the Company's former CEO. The Company's remaining selling, general and administrative costs were mostly flat as decreases in discretionary bonus and a general reduction in overhead expenses, including professional fees, travel and entertainment expenses, and rent expense, were mostly offset by increases in legal fees resulting from an increase in activity resulting from employment and litigation matters in the current period.
Other and Eliminations: Net income from our Other and Eliminations segment for the six months ended June 30, 2021 decreased $68.3 million to income of $1.3 million from income of $69.6 million for the six months ended June 30, 2020. Adjusted EBITDA from our Other segment for the six months ended June 30, 2021 increased $1.7 million to income of $0.8 million from a loss of $0.9 million for the six months ended June 30, 2020. The increase in Adjusted EBITDA for our Other and Eliminations segment was driven by the equity investment in HMN, as it produced higher income than in the comparable period, which is generally attributable to the timing of turnkey project work, partially offset by and a reduction in ownership from 49% to 19% as a result of the partial sale of HC2's investment in the second quarter of 2020.

(in millions): |  | Three Months Ended June 30, |  | Six months ended June 30,
|  | 2021 |  | 2020 |  | Increase / (Decrease) |  | 2021 |  | 2020 |  | Increase / (Decrease)
Infrastructure |  | $ | 13.9 |  |  | $ | 19.1 |  |  | $ | (5.2) |  |  | $ | 25.2 |  |  | $ | 28.1 |  |  | $ | (2.9) |
Life Sciences |  | (6.1) |  |  | (4.5) |  |  | (1.6) |  |  | (12.3) |  |  | (8.7) |  |  | (3.6) |
Spectrum |  | 2.7 |  |  | (1.2) |  |  | 3.9 |  |  | 3.5 |  |  | (2.2) |  |  | 5.7 |
Non-Operating Corporate |  | (5.7) |  |  | (3.6) |  |  | (2.1) |  |  | (9.7) |  |  | (8.6) |  |  | (1.1) |
Other and Eliminations |  | 1.7 |  |  | 0.8 |  |  | 0.9 |  |  | 0.8 |  |  | (0.9) |  |  | 1.7 |
Adjusted EBITDA |  | $ | 6.5 |  |  | $ | 10.6 |  |  | $ | (4.1) |  |  | $ | 7.5 |  |  | $ | 7.7 |  |  | $ | (0.2) |

Backlog
Projects in backlog consist of awarded contracts, letters of intent, notices to proceed, change orders, and purchase orders obtained. Backlog increases as contract commitments are obtained, decreases as revenues are recognized and increases or decreases to reflect modifications in the work to be performed under the contracts. Backlog is converted to sales in future periods as work is performed or projects are completed. Backlog can be significantly affected by the receipt or loss of individual contracts.
Infrastructure Segment
At June 30, 2021, DBMG's backlog was $1,634.4 million, consisting of $1,323.1 million under contracts or purchase orders and $311.3 million under letters of intent or notices to proceed. Approximately $1,022.1 million, representing 62.5% of DBMG’s backlog at June 30, 2021, was attributable to five contracts, letters of intent, notices to proceed or purchase orders. If one or more of these projects terminate or reduce their scope, DBMG’s backlog could decrease substantially.
47

Liquidity and Capital Resources
Short- and Long-Term Liquidity Considerations and Risks
Our Non-Operating Corporate segment consists of holding companies, and its liquidity needs are primarily for interest payments on its 2026 Senior Secured Notes, 2022 Convertible Notes and 2026 Convertible Notes, and its Revolving Credit Agreement, dividend payments on its Preferred Stock and recurring operational expenses.
As of June 30, 2021, the Company had $18.1 million of cash and cash equivalents compared to $43.8 million as of December 31, 2020. On a stand-alone basis, as of June 30, 2021, the Non-Operating Corporate segment had cash and cash equivalents of $2.0 million compared to $27.5 million at December 31, 2020.
Our subsidiaries' principal liquidity requirements arise from cash used in operating activities, debt service, and capital expenditures, including purchases of steel construction equipment, OTA broadcast station equipment, liabilities associated with insurance products, development of back-office systems, operating costs and expenses, and income taxes.
As of June 30, 2021, the Company had $679.6 million of indebtedness on a consolidated basis compared to $576.6 million as of December 31, 2020. On a stand-alone basis, as of June 30, 2021 and December 31, 2020, HC2 had indebtedness of $390.0 million and $410.4 million, respectively.
HC2's stand-alone debt consists of the $330.0 million aggregate principal amount of 2026 Senior Secured Notes, the $3.2 million aggregate principal amount of 2022 Convertible Notes, and the $51.8 million aggregate principal amount of 2026 Convertible Notes. HC2 is required to make semi-annual interest payments on its 2026 Senior Secured Notes, 2022 Convertible Notes and 2026 Convertible Notes, and quarterly interest payments, if applicable, on its 2024 Revolving Credit Agreement.
HC2 received $0.8 million and $2.1 million in net management fees from its Insurance segment during the three months ended June 30, 2021 and six months ended June 30, 2021, respectively.
HC2 is required to make dividend payments on its outstanding Preferred Stock on January 15 th, April 15 th, July 15 th, and October 15 th of each year.
On May 29, 2021, pursuant to the Certificate of Designation, holders of the Series A and A-2 Preferred Stock caused the Company to redeem the Series A and A-2 Preferred Stock at the accrued value per share plus accrued but unpaid dividends (to the extent not included in the accrued value of Series A and A-2 Preferred Stock), of which $10.4 million was paid in cash to holders of the Series A and A-2 Preferred Stock. Each share of Series A and A-2 Preferred Stock that was not so redeemed was automatically converted into shares of common stock at the conversion price then in effect, of which 50,410 shares of the Company's common stock were issued in lieu of cash to holders of the Series A Preferred Stock.
In connection with the Stock Purchase Agreement, CGI, a wholly owned subsidiary of the Company, entered into a letter agreement with Continental General Holdings, LLC to not redeem at maturity or seek redemption of the $16.1 million Preferred Stock. On July 1, 2021, subsequent to quarter end, CGI exchanged their Series A and Series A-2 Preferred Stock for new classes of Series A-3 and Series A-4 Preferred Stock with an extended maturity of July 1, 2026, with other terms substantially unchanged from the terms in the Series A and Series A-2 Preferred Stock.
We have financed our growth and operations to date, and expect to finance our future growth and operations, through public offerings and private placements of debt and equity securities, credit facilities, vendor financing, capital lease financing and other financing arrangements, as well as cash generated from the operations of our subsidiaries. In the future, we may also choose to sell assets or certain investments to generate cash.
48

At this time, we believe that we will be able to continue to meet our liquidity requirements and fund our fixed obligations (such as debt service and operating leases) and other cash needs for our operations for at least the next twelve months through a combination of cash on hand, distributions from our subsidiaries, and/or the sale of assets and certain investments. Historically, we have chosen to reinvest cash and receivables into the growth of our various businesses, and therefore have not kept a large amount of cash on hand at the holding company level. The ability of HC2’s subsidiaries to make distributions to HC2 is subject to numerous factors, including restrictions contained in each subsidiary’s financing agreements, regulatory requirements, availability of sufficient funds at each subsidiary and the approval of such payment by each subsidiary’s board of directors, which must consider various factors, including general economic and business conditions, tax considerations, strategic plans, financial results and condition, expansion plans, any contractual, legal or regulatory restrictions on the payment of dividends, and such other factors each subsidiary’s board of directors considers relevant. Although the Company believes that it will be able to raise additional equity capital, refinance or renegotiate terms of our indebtedness or preferred stock, enter into other financing arrangements or engage in asset sales and sales of certain investments sufficient to fund any cash needs that we are not able to satisfy with the funds on hand or expected to be provided by our subsidiaries, there can be no assurance that it will be able to do so on terms satisfactory to the Company if at all. Such financing options, if pursued, may also ultimately have the effect of negatively impacting our liquidity profile and prospects over the long-term. Our ability to sell assets and certain of our investments to meet our existing financing needs may also be limited by our existing financing instruments. In addition, the sale of assets or the Company’s investments may also make the Company less attractive to potential investors or future financing partners.
We have seen significant cost increases, primarily at our Infrastructure segment, driven by expenses associated with maintaining a safe work environment, and while executing on its projects. During the three and six months ended June 30, 2021, $4.0 million and $7.9 million of COVID-19 costs were incurred. Although the COVID-19 pandemic did not have a material impact on the HC2’s liquidity for the six months ended June 30, 2021, management believes the continuation of the pandemic and its related effect on the U.S. and global economies could introduce added pressure on the Company’s liquidity position and financial performance. Our sources of liquidity are primarily from the dividends and tax sharing agreement with DBMG, cash proceeds from completed and anticipated monetization’s and other arrangements.
Capital Expenditures
Capital expenditures for the periods ended June 30, 2021 and 2020 are set forth in the table below (in millions):

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2021 |  | 2020 |  | 2021 |  | 2020
Infrastructure |  | $ | 3.9 |  |  | $ | 1.1 |  |  | $ | 5.5 |  |  | $ | 3.4 |
Life Sciences |  | 0.3 |  |  | 0.1 |  |  | 0.5 |  |  | 0.1 |
Spectrum |  | 0.6 |  |  | 3.7 |  |  | 2.0 |  |  | 6.4 |
Non-operating Corporate |  | — |  |  | 0.1 |  |  | — |  |  | 0.1 |
Total |  | $ | 4.8 |  |  | $ | 5.0 |  |  | $ | 8.0 |  |  | $ | 10.0 |

Indebtedness
2026 Senior Secured Notes Terms and Conditions
Maturity. The 2026 Senior Secured Notes mature on August 1, 2026.
Interest. The 2026 Senior Secured Notes accrue interest at a rate of 8.50% per year. Interest on the 2026 Senior Secured Notes is paid semi-annually on February 1 and August 1 of each year.
Issue Price. The issue price of the 2026 Senior Secured Notes was 100% of par.
Ranking. The notes and the note guarantees are the Company’s and certain of its direct and indirect domestic subsidiaries’ (the "Subsidiary Guarantors") general senior secured obligations. The notes and the note guarantees will rank: (i) senior in right of payment to all of the Company’s and the Subsidiary Guarantors’ future subordinated debt; (ii) equal in right of payment, subject to the priority of any First-Out Obligations (as defined in the Secured Indenture), with all of the Company’s and the Subsidiary Guarantors’ existing and future senior debt and effectively senior to all of its and the Subsidiary Guarantor’s unsecured debt to the extent of the value of the collateral; and (iii) effectively subordinated to all liabilities of its non-guarantor subsidiaries. The notes and the note guarantees are secured on a first-priority basis by substantially all of the Company’s assets and the assets of the Subsidiary Guarantors, subject to certain exceptions and permitted liens.
Collateral. The 2026 Senior Secured Notes are secured by a first priority lien on substantially all of the Company’s assets (except for certain "Excluded Assets," and subject to certain "Permitted Liens," each as defined in the Secured Indenture), including, without limitation:
•all equity interests owned by the Company or a Subsidiary Guarantor (which, in the case of any equity interest in a foreign subsidiary, will be limited to 100% of the non-voting stock (if any) and 65% of the voting stock of such foreign subsidiary) and the related rights and privileges associated therewith (but excluding Equity Interests of Insurance Subsidiaries (as defined in the Secured Indenture), to the extent the pledge thereof is deemed a "change of control" under applicable insurance regulations);
49

•all equipment, goods and inventory owned by the Company or a Subsidiary Guarantor;
•all cash and investment securities owned by the Company or a Subsidiary Guarantor;
•all documents, books and records, instruments and chattel paper owned by the Company or a Subsidiary Guarantor;
•all general intangibles owned by the Company or a Subsidiary Guarantor; and
•any proceeds and supporting obligations thereof.
The Secured Indenture permits the Company, under specified circumstances, to incur additional debt in the future that could equally and ratably share in the collateral. The amount of such debt is limited by the covenants contained in the Secured Indenture.
Events of Default. The Secured Indenture contains customary events of default which could, subject to certain conditions, cause the 2026 Senior Secured Notes to become immediately due and payable.
2022 Convertible Notes Terms and Conditions
Maturity. The 2022 Convertible Notes mature on June 1, 2022 unless earlier converted, redeemed or purchased.
Interest. The 2022 Convertible Notes accrue interest at a rate of 7.5% per year. Interest on the 2022 Convertible Notes is paid semi-annually on December 1 and June 1 of each year.
Issue Price. The issue price of the Convertible Notes was 100% of par.
Ranking. The notes are the Company’s general unsecured and unsubordinated obligations and will rank equally in right of payment with all of the Company’s existing and future unsecured and unsubordinated indebtedness, and senior in right of payment to any of the Company’s future indebtedness that is expressly subordinated to the notes. The notes will be effectively subordinated to all of the Company’s existing and future secured indebtedness, including the Company’s Secured Notes, to the extent of the value of the collateral securing that indebtedness, and structurally subordinated to all indebtedness and other liabilities of the Company’s subsidiaries, including trade credit.
Optional Redemption. The Company could not redeem the notes prior to June 1, 2020. From or after June 1, 2020, the Company may redeem for cash all of the notes if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (which need not be consecutive trading days) during any 30 consecutive trading-day period ending within five trading days prior to the date on which the Company provides notice of redemption. The redemption price will equal 100% of the principal amount of the notes being redeemed, plus accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date.
Conversion Rights. The 2022 Convertible Notes are convertible into shares of the Company’s common stock based on a conversion rate of 234.2971 shares of common stock per $1,000 principal amount of Convertible Notes (equivalent to an initial conversion price of approximately $4.27 per share of the Company’s common stock), at any time prior to the close of business on the business day immediately preceding the maturity date, in principal amounts of $1,000 or an integral multiple of $1,000 in excess thereof. In addition, following a Make-Whole Fundamental Change (as defined in the indenture governing the 2022 Convertible Notes) or the Company’s delivery of a notice of redemption for the 2022 Convertible Notes, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its 2022 Convertible Notes in connection with (i) such Make-Whole Fundamental Change or (ii) such notice of redemption. However, to comply with certain listing standards of The New York Stock Exchange, the Company will settle in cash its obligation to increase the conversion rate in connection with a Make-Whole Fundamental Change or redemption until it has obtained the requisite stockholder approval.
Events of Default. The indenture governing the 2022 Convertible Notes contains customary events of default which could, subject to certain conditions, cause the 2022 Convertible Notes to become immediately due and payable.
2026 Convertible Notes Terms and Conditions
Maturity. The 2026 Convertible Notes mature on August 1, 2026 unless earlier converted, redeemed or purchased.
Interest. The 2026 Convertible Notes accrue interest at a rate of 7.5% per year. Interest on the 2026 Convertible Notes is paid semi-annually on February 1 and August 1 of each year.
Issue Price. The issue price of the 2026 Convertible Notes was 100% of par.
Ranking. The notes are the Company’s general unsecured and unsubordinated obligations and will rank equally in right of payment with all of the Company’s existing and future unsecured and unsubordinated indebtedness, and senior in right of payment to any of the Company’s future indebtedness that is expressly subordinated to the notes. The notes will be effectively subordinated to all of the Company’s existing and future secured indebtedness, including the Company’s 2026 Senior Secured Notes, to the extent of the value of the collateral securing that indebtedness, and structurally subordinated to all indebtedness and other liabilities of the Company’s subsidiaries, including trade credit.
50

Optional Redemption. The Company may not redeem the notes prior to August 1, 2023. On or after August 1, 2023, the Company may redeem for cash all of the notes if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (which need not be consecutive trading days) during any 30 consecutive trading-day period ending within five trading days prior to the date on which the Company provides notice of redemption. The redemption price will equal 100% of the principal amount of the notes being redeemed, plus accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date.
Conversion Rights. The 2026 Convertible Notes are convertible into shares of the Company’s common stock based on an initial conversion rate of 234.2971 shares of common stock per $1,000 principal amount of Convertible Notes (equivalent to an initial conversion price of approximately $4.27 per share of the Company’s common stock), at any time prior to the close of business on the business day immediately preceding the maturity date, in principal amounts of $1,000 or an integral multiple of $1,000 in excess thereof. In addition, following a Make-Whole Fundamental Change (as defined in the Convertible Indenture) or the Company’s delivery of a notice of redemption for the 2026 Convertible Notes, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its 2026 Convertible Notes in connection with (i) such Make-Whole Fundamental Change or (ii) such notice of redemption. However, to comply with certain listing standards of The New York Stock Exchange, the Company will settle in cash its obligation to increase the conversion rate in connection with a Make-Whole Fundamental Change or redemption until it has obtained the requisite stockholder approval.
Events of Default. The Convertible Indenture contains customary events of default which could, subject to certain conditions, cause the Convertible Notes to become immediately due and payable.
Revolving Credit Agreement
Lender. MSD PCOF Partners IX, LLC (“MSD”)
Ranking. Obligations under the Revolving Credit Agreement constitute a First-Out Debt, as defined in the Senior Secured Indenture, and are secured on a pari passu basis with the 2026 Senior Secured Notes with a maturity date of February 23, 2024.
Collateral: As provided under a Collateral Trust Joinder, the lender was added as a secured party to the Collateral Trust Agreement, and accordingly the pari passu obligations and commitments under the Revolving Credit Agreement are secured equally and ratably by the collateral of the Secured Notes.
Infrastructure
The UMB Term Loan and UMB Revolving Line associated with our Infrastructure segment contains customary restrictive and financial covenants related to debt levels and performance. As of June 30, 2021, DBMG was in compliance with all of the financial covenants to its debt agreements.
See Note 9. Debt Obligations to the Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report on Form 10-Q for additional details regarding the Company's indebtedness.
Restrictive Covenants
The indenture governing the 2026 Senior Secured Notes dated February 1, 2021, by and among HC2, the guarantors party thereto and U.S. Bank National Association, a national banking association ("U.S. Bank"), as trustee (the "Senior Secured Indenture"), contains certain affirmative and negative covenants limiting, among other things, the ability of the Company, and, in certain cases, the Company’s subsidiaries, to incur additional indebtedness; create liens; engage in sale-leaseback transactions; pay dividends or make distributions in respect of capital stock; make certain restricted payments; sell assets; engage in transactions with affiliates; or consolidate or merge with, or sell substantially all of its assets to, another person. These covenants are subject to a number of important exceptions and qualifications.
The Company is also required to comply with certain financial maintenance covenants, which are similarly subject to a number of important exceptions and qualifications. These covenants include maintenance of (1) liquidity and (2) collateral coverage.
The maintenance of liquidity covenant provides that the Company will not permit the aggregate amount of (i) all unrestricted cash and Cash Equivalents of the Company and the Subsidiary Guarantors, (ii) amounts available for drawing under revolving credit facilities and undrawn letters of credit of the Company and the Subsidiary Guarantors and (iii) dividends, distributions or payments that are immediately available to be paid to the Company by any of its Restricted Subsidiaries to be less than the Company’s obligation to pay interest on the 2026 Senior Secured Notes and all other Debt, including Convertible Preferred Stock mandatory cash dividends or any other mandatory cash pay Preferred Stock but excluding any obligation to pay interest on Convertible Preferred Stock or any other mandatory cash pay Preferred Stock which, in each case, may be paid by accretion or in-kind in accordance with its terms of the Company and its Subsidiary Guarantors for the next six months. As of June 30, 2021, the Company was in compliance with this covenant.
The maintenance of collateral coverage provides that the certain subsidiaries' Collateral Coverage Ratio (as defined in the Secured Indenture as the ratio of (i) the Loan Collateral to (ii) Consolidated Secured Debt (each as defined therein)) calculated on a pro forma basis as of the last day of each fiscal quarter may not be less than 1.50 to 1.00. As of June 30, 2021, the Company was in compliance with this covenant.
51

The instruments governing the Company’s Preferred Stock also limit the Company’s and its subsidiaries ability to take certain actions, including, among other things, to incur additional indebtedness; issue additional Preferred Stock; engage in transactions with affiliates; and make certain restricted payments. These limitations are subject to a number of important exceptions and qualifications.
The Company conducted its operations in a manner that resulted in compliance with the prior Secured Indenture; however, compliance with certain financial covenants for future periods may depend on the Company or one or more of the Company’s subsidiaries undertaking one or more non-operational transactions, such as the management of operating cash outflows, a monetization of assets, a debt incurrence or refinancing, the raising of equity capital, or similar transactions. If the Company is unable to remain in compliance and does not make alternate arrangements, an event of default would occur under the Company’s Secured Indenture which, among other remedies, could result in the outstanding obligations under the indenture becoming immediately due and payable and permitting the exercise of remedies with respect to the collateral. There is no assurance the Company will be able to complete any non-operational transaction it may undertake to maintain compliance with covenants under the Secured Indenture or, even if the Company completes any such transaction, that it will be able to maintain compliance for any subsequent period.
Summary of Consolidated Cash Flows
The below table summarizes the cash provided or used in our activities and the amount of the respective changes between the periods (in millions):

|  | Six Months Ended June 30, | Increase / (Decrease)
|  | 2021 |  | 2020 |
Operating activities from Continuing Operations |  | $ | (34.7) |  |  | $ | (8.1) |  |  | $ | (26.6) |
Investing activities from Continuing Operations |  | (62.8) |  |  | 223.6 |  |  | (286.4) |
Financing activities from Continuing Operations |  | 73.6 |  |  | (211.2) |  |  | 284.8 |
Effect of exchange rate changes on cash and cash equivalents |  | (0.7) |  |  | 0.6 |  |  | (1.3) |
Cash flows from discontinued operations |  | 58.3 |  |  | (40.2) |  |  | 98.5 |
Net increase (decrease) in cash, cash equivalents and restricted cash |  | $ | 33.7 |  |  | $ | (35.3) |  |  | $ | 69.0 |
Less: Net increase (decrease) in cash and cash equivalents from discontinued operations |  | 58.3 |  |  | (35.7) |  |  | 94.0 |
Net change in cash, cash equivalents and restricted cash |  | $ | (24.6) |  |  | $ | 0.4 |  |  | $ | (25.0) |

Operating Activities
Cash used in operating activities was $34.7 million for the six months ended June 30, 2021 as compared to cash used in operating activities of $8.1 million for the six months ended June 30, 2020. The $26.6 million change was primarily related to the increase in working capital uses resulting from project timing at our Infrastructure segment, ramp up of product launch at R2, and payment of certain accounts payable and increases in accounts receivable at our Spectrum segment. This was partially offset by an increase in working capital at Non-operating Corporate due to the timing of interest payments as a result of the refinancing.
Investing Activities
Cash used in investing activities was $62.8 million for the six months ended June 30, 2021 as compared to cash provided by investing activities of $223.6 million for the six months ended June 30, 2020. The $286.4 million change was due to the acquisition of Banker Steel at our Infrastructure segment in the second quarter of 2021 and from the reduction in proceeds from the sale of subsidiaries. Beyond6 was sold in first quarter of 2021 for net proceeds of $70.0 million compared to GMSL sold in the prior year for net proceeds of $144.0 million.
Financing Activities
Cash provided by financing activities was $73.6 million for the six months ended June 30, 2021 as compared to cash used in financing activities of $211.2 million for the six months ended June 30, 2020. The $284.8 million change was primarily due to proceeds received on debt obligations at our Infrastructure segment as a result of the refinancing in the second quarter of 2021. The change was also driven by the refinancing of debt obligations at our Non-Operating Corporate segment in the comparable period and payments to minority stockholders at our Other segment for the portion of the proceeds received from the sale of GMSL and the partial sale of HMN in the comparable period.
52

Discontinued Operations
Cash provided by discontinued operations was $58.3 million for the six months ended June 30, 2021 as compared to cash used by discontinued operations of $40.2 million for the six months ended June 30, 2020. The $98.5 million increase was largely due to a decline in net investment purchases at our Insurance segment compared to the prior year.
Reclassifications
Certain 2021 statement of cash flow items have been reclassified to conform to the current financial statement presentation. These reclassifications have no effect on previously reported net income.
Infrastructure
Cash Flows
Cash flows from operating activities are the principal source of cash used to fund DBMG’s operating expenses, interest payments on debt, and capital expenditures. DBMG's short-term cash needs are primarily for working capital to support operations including receivables, inventories, and other costs incurred in performing its contracts. DBMG attempts to structure the payment arrangements under its contracts to match costs incurred under the project. To the extent it is able to bill in advance of costs incurred, DBMG generates working capital through billings in excess of costs and recognized earnings on uncompleted contracts. DBMG relies on its credit facilities to meet its working capital needs. DBMG believes that its existing borrowing availability together with cash from operations will be adequate to meet all funding requirements for its operating expenses, interest payments on debt and capital expenditures for the foreseeable future.
DBMG is required to make monthly or quarterly interest payments on all of its debt. Based upon the June 30, 2021 debt balance, DBMG anticipates that its interest payments will be approximately $2.1 million each quarter of 2021.
DBMG believes that its available funds, cash generated by operating activities and funds available under its bank credit facilities will be sufficient to fund its capital expenditures and its working capital needs. However, DBMG may expand its operations through future acquisitions and may require additional equity or debt financing.
Discontinued Operations
We have reclassified several entities as discontinued operations for the three and six months ended June 30, 2021 and 2020. Accordingly, revenue, costs, and expenses of the discontinued operations have been excluded from continuing operations. The entities reported in discontinued operations are as follows:
•The sale of GMSL closed on February 28, 2020. At the time of the sale, the Company recorded a $39.3 million loss on the sale and recognized $31.3 million Accumulated other comprehensive loss. During the fourth quarter of 2020, the Company recognized a gain of $2.4 million as a result of bonding releases related to projects which existed prior to sale. During the first quarter of 2021, the Company recognized a gain of $1.2 million as a result of indemnity release.
•The sale of ICS and its subsidiary, Go2 Tel, Inc., closed on October 31, 2020. The Company recorded a $0.9 million gain on the sale and recognized $8.2 million of Accumulated other comprehensive loss related to the foreign currency translation of PTGi International Carrier Services Ltd., which was essentially liquidated in conjunction with the sale. The proceeds were used for general corporate purposes.
•On December 31, 2020, the Company signed the Merger Agreement to sell Beyond6. The sale closed on January 15, 2021. The Company recognized a $39.2 million gain on the sale.
•On March 29, 2021, the Company announced the entry into the Stock Purchase Agreement to sell its Insurance segment to Continental General Holdings LLC, an entity controlled by Michael Gorzynski, a director of the Company and, as of June 30, 2021, a beneficial owner of approximately 6.6% of the Company's outstanding common stock who has also served as executive chairman of Continental since October 2020. On July 1, 2021, subsequent to quarter end, the Company closed on the sale.
Cash flows from discontinued operations are reported in the Statement of Cash Flows as a separate line item within the Operations, Investing and Financing activities sections for each year presented.
In the absence of cash flows from the discontinued operations, the Company does not expect there to be an impact on liquidity at the Company.
53

Off-Balance Sheet Arrangements
In September 2018, the Company entered into a 75-month lease for office space. As part of the agreement, HC2 was able to pay a lower security deposit and lease payments, and received favorable lease terms as consideration for landlord required cross default language in the event of default of the shared space leased by Harbinger Capital Partners, formerly a related party, in the same building. With the adoption of ASC 842, as of January 1, 2019, this lease was recognized as a right of use asset and lease liability on the Condensed Consolidated Balance Sheets.
DBMG’s off-balance sheet arrangements at June 30, 2021 included letters of credit of $13.4 million under Credit and Security Agreements and performance bonds of $921.1 million. DBMG’s contract arrangements with customers sometimes require DBMG to provide performance bonds to partially secure its obligations under its contracts. Bonding requirements typically arise in connection with public works projects and sometimes with respect to certain private contracts. DBMG’s performance bonds are obtained through surety companies and typically cover the entire project price.
New Accounting Pronouncements
For a discussion of our New Accounting Pronouncements, refer to Note 2. Summary of Significant Accounting Policies to our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.
Critical Accounting Policies
There have been no material changes in the Company’s critical accounting policies during the quarter ended June 30, 2021. For information about critical accounting policies, refer to “Critical Accounting Policies” under Item 7 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 10, 2021.
Related Party Transactions
For a discussion of our Related Party Transactions, refer to Note 16. Related Parties to our Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report on Form 10-Q.
Corporate Information
HC2, a Delaware corporation, was incorporated in 1994. The Company’s executive offices are located at 295 Madison Avenue, 12th Floor, New York, NY, 10017. The Company’s telephone number is (212) 235-2690. Our Internet address is www.hc2.com. We make available free of charge through our Internet website our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The information on or accessible through our website is not a part of this Quarterly Report on Form 10-Q.
54

Special Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q contains or incorporates a number of "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are based on current expectations, and are not strictly historical statements. In some cases, you can identify forward-looking statements by terminology such as "if," "may," "should," "believe," "anticipate," "future," "forward," "potential," "estimate," "opportunity," "goal," "objective," "growth," "outcome," "could," "expect," "intend," "plan," "strategy," "provide," "commitment," "result," "seek," "pursue," "ongoing," "include" or in the negative of such terms or comparable terminology. These forward-looking statements inherently involve certain risks and uncertainties and are not guarantees of performance, results, or the creation of stockholder value, although they are based on our current plans or assessments which we believe to be reasonable as of the date hereof.
Factors that could cause actual results, events and developments to differ include, without limitation: the ability of our subsidiaries (including, target businesses following their acquisition) to generate sufficient net income and cash flows to make upstream cash distributions, capital market conditions, our and our subsidiaries’ ability to identify any suitable future acquisition opportunities, efficiencies/cost avoidance, cost savings, income and margins, growth, economies of scale, combined operations, future economic performance, conditions to, and the timetable for, completing the integration of financial reporting of acquired or target businesses with HC2 or the applicable subsidiary of HC2, completing future acquisitions and dispositions, litigation, potential and contingent liabilities, management’s plans, changes in regulations and taxes.
We claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 for all forward-looking statements.
Forward-looking statements are not guarantees of performance. You should understand that the following important factors, in addition to those discussed under the section entitled "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2020 and in the documents incorporated by reference, could affect our future results and could cause those results or other outcomes to differ materially from those expressed or implied in the forward-looking statements. You should also understand that many factors described under one heading below may apply to more than one section in which we have grouped them for the purpose of this presentation. As a result, you should consider all of the following factors, together with all of the other information presented herein, in evaluating our business and that of our subsidiaries.
HC2 Holdings, Inc. and Subsidiaries
Our actual results or other outcomes may differ from those expressed or implied by forward-looking statements contained herein due to a variety of important factors, including, without limitation, the following:
•the effect of the novel coronavirus (“COVID-19”) pandemic and related governmental responses on our business, financial condition and results of operations;
•limitations on our ability to successfully identify any strategic acquisitions or business opportunities and to compete for these opportunities with others who have greater resources;
•our possible inability to generate sufficient liquidity, margins, earnings per share, cash flow and working capital from our operating segments;
•the impact of catastrophic events including natural disasters, pandemic illness and the outbreak of war or acts of terrorism;
•our dependence on distributions from our subsidiaries to fund our operations and payments on our obligations;
•the impact on our business and financial condition of our substantial indebtedness and the significant additional indebtedness and other financing obligations we may incur;
•the impact of covenants in the Indenture governing HC2’s new notes, the Certificates of Designation governing HC2’s Preferred Stock and all other subsidiary debt obligations as summarized in Note 9. Debt Obligations and future financing agreements on our ability to operate our business and finance our pursuit of acquisition opportunities;
•our dependence on certain key personnel;
•uncertain global economic conditions in the markets in which our operating segments conduct their businesses;
•the ability of our operating segments to attract and retain customers;
•increased competition in the markets in which our operating segments conduct their businesses;
•our expectations regarding the timing, extent and effectiveness of our cost reduction initiatives and management’s ability to moderate or control discretionary spending;
•management’s plans, goals, forecasts, expectations, guidance, objectives, strategies and timing for future operations, acquisitions, synergies, asset dispositions, fixed asset and goodwill impairment charges, tax and withholding expense, selling, general and administrative expenses, product plans, performance and results;
•management’s assessment of market factors and competitive developments, including pricing actions and regulatory rulings;
•the impact of additional material charges associated with our oversight of acquired or target businesses and the integration of our financial reporting;
•the impact of expending significant resources in considering acquisition targets or business opportunities that are not consummated;
•our expectations and timing with respect to our ordinary course acquisition activity and whether such acquisitions are accretive or dilutive to stockholders;
55

•our expectations and timing with respect to any strategic dispositions and sales of our operating subsidiaries, or businesses that we may make in the future and the effect of any such dispositions or sales on our results of operations;
•the possibility of indemnification claims arising out of divestitures of businesses;
•tax consequences associated with our acquisition, holding and disposition of target companies and assets;
•the effect any interests our officers, directors, stockholders and their respective affiliates may have in certain transactions in which we are involved;
•our ability to effectively increase the size of our organization, if needed, and manage our growth;
•the potential for, and our ability to, remediate future material weaknesses in our internal controls over financial reporting;
•our possible inability to raise additional capital when needed or refinance our existing debt, on attractive terms, or at all; and
•our possible inability to hire and retain qualified executive management, sales, technical and other personnel.
Infrastructure / DBM Global Inc.
Our actual results or other outcomes of DBM Global, Inc. and its wholly-owned subsidiaries ("DBMG"), and, thus, our Infrastructure segment, may differ from those expressed or implied by forward-looking statements contained herein due to a variety of important factors, including, without limitation, the following:
•our ability to maintain efficient staffing and productivity as well as delays and cancellations as a result of the COVID-19 pandemic;
•its ability to realize cost savings from expected performance of contracts, whether as a result of improper estimates, performance, or otherwise;
•potential impediments and limitations on our ability to complete ordinary course acquisitions in anticipated time frames or at all;
•uncertain timing and funding of new contract awards, as well as project cancellations;
•cost overruns on fixed-price or similar contracts or failure to receive timely or proper payments on cost-reimbursable contracts, whether as a result of improper estimates, performance, disputes, or otherwise;
•risks associated with labor productivity, including performance of subcontractors that DBMG hires to complete projects;
•its ability to settle or negotiate unapproved change orders and claims;
•changes in the costs or availability of, or delivery schedule for, equipment, components, materials, labor or subcontractors;
•adverse impacts from weather affecting DBMG’s performance and timeliness of completion of projects, which could lead to increased costs and affect the quality, costs or availability of, or delivery schedule for, equipment, components, materials, labor or subcontractors;
•fluctuating revenue resulting from a number of factors, including the cyclical nature of the individual markets in which our customers operate;
•adverse outcomes of pending claims or litigation or the possibility of new claims or litigation, and the potential effect of such claims or litigation on DBMG’s business, financial condition, results of operations or cash flow; and
•lack of necessary liquidity to provide bid, performance, advance payment and retention bonds, guarantees, or letters of credit securing DBMG’s obligations under bids and contracts or to finance expenditures prior to the receipt of payment for the performance of contracts.
Life Sciences / Pansend Life Sciences, LLC
Our actual results or other outcomes of Pansend Life Sciences, LLC, and, thus, our Life Sciences segment, may differ from those expressed or implied by forward-looking statements contained herein due to a variety of important factors, including, without limitation, the following:
•our Life Sciences segment’s ability to invest in development stage companies;
•our Life Sciences segment’s ability to develop products and treatments related to its portfolio companies;
•medical advances in healthcare and biotechnology; and
•governmental regulation in the healthcare industry.
Spectrum / HC2 Broadcasting Holdings Inc.
Our actual results or other outcomes of HC2 Broadcasting Holdings Inc., and, thus, our Spectrum segment, may differ from those expressed or implied by forward-looking statements contained herein due to a variety of important factors, including, without limitation, the following:
•our ability to attract advertisers during the COVID-19 pandemic;
•our Spectrum segment’s ability to operate in highly competitive markets and maintain market share;
•our Spectrum segment’s ability to effectively implement its business strategy or be successful in the operation of its business;
•new and growing sources of competition in the broadcasting industry; and
•FCC regulation of the television broadcasting industry.
56

Other
Our actual results or other outcomes of our Other segment may differ from those expressed or implied by forward-looking statements contained herein due to a variety of important factors, including, without limitation, the following:
•risks associated with our equity method investment that operates in China (i.e., HMN International Co., Ltd F/K/A Huawei Marine Systems Co. Limited, a Hong Kong holding company with a Chinese operating subsidiary)
We caution the reader that undue reliance should not be placed on any forward-looking statements, which speak only as of the date of this document. Neither we nor any of our subsidiaries undertake any duty or responsibility to update any of these forward-looking statements to reflect events or circumstances after the date of this document or to reflect actual outcomes, except as required by applicable law.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 as amended (the "Exchange Act") as of the end of the period covered by this report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of June 30, 2021, our disclosure controls and procedures were effective. Disclosure controls and procedures mean our controls and other procedures that are designed to ensure that information required to be disclosed by us in our reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in our reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There have been no changes in our internal control over financial reporting that occurred during the fiscal quarter ended June 30, 2021, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
57

PART II
ITEM 1. LEGAL PROCEEDINGS
The Company is subject to claims and legal proceedings that arise in the ordinary course of business. Such matters are inherently uncertain, and there can be no guarantee that the outcome of any such matter will be decided favorably to the Company or that the resolution of any such matter will not have a material adverse effect upon the Company’s Condensed Consolidated Financial Statements. The Company does not believe that any of such pending claims and legal proceedings will have a material adverse effect on its Condensed Consolidated Financial Statements. The Company records a liability in its Condensed Consolidated Financial Statements for these matters when a loss is known or considered probable and the amount can be reasonably estimated. The Company reviews these estimates each accounting period as additional information is known and adjusts the loss provision when appropriate. If a matter is both probable to result in a liability and the amounts of loss can be reasonably estimated, the Company estimates and discloses the possible loss or range of loss to the extent necessary for the Condensed Consolidated Financial Statements not to be misleading. If the loss is not probable or cannot be reasonably estimated, a liability is not recorded in its Condensed Consolidated Financial Statements. See Note 13. Commitments and Contingencies to our unaudited financial statements included elsewhere in this Quarterly Report on Form 10-Q.
ITEM 1A. RISK FACTORS
There have been no material changes to the risk factors disclosed in "Item 1A. Risk Factors" of our Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 10, 2021.
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.
ITEM 3. Defaults upon Senior Securities
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
None.
ITEM 6. EXHIBITS
(a) Exhibits
Please note that the agreements included as exhibits to this Form 10-Q are included to provide information regarding their terms and are not intended to provide any other factual or disclosure information about HC2 Holdings, Inc. or the other parties to the agreements. The agreements may contain representations and warranties by each of the parties to the applicable agreement that have been made solely for the benefit of the other parties to the applicable agreement and may not describe the actual state of affairs as of the date they were made or at any other time.
58

Exhibit Number |  | Description
2.1 |  | First Amendment to Membership Interest Purchase Agreement, dated May 25, 2021 by and among DBM Global Inc., Bridge Fabrication Banker Holdings LLC, The Banker Family Irrevocable Trust #3 U/A/D December 22, 2009, Chesley F. McPhatter, III, Richard Plant and Bridge Fabrication Banker Holdings LLC (incorporated by reference to Exhibit 2.2 to the Current Report on Form 8-K filed by HC2 on May 27, 2021) (File No. 021-35210)
4.1 |  | Certificate of Designation of Series A-3 Convertible Participating Preferred Stock of HC2 Holdings, Inc. (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed by HC2 Holdings, Inc. ("HC2") on July 7, 2021) (File No. 021-35210)
4.2 |  | Certificate of Designation of Series A-4 Convertible Participating Preferred Stock of HC2 Holdings, Inc. (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed by HC2 Holdings, Inc. ("HC2") on July 7, 2021) (File No. 021-35210)
4.3 |  | Amended and Restated Certificate of Designation of Series A Fixed-to-Floating Rate Perpetual Preferred Stock of DBM Global Intermediate Holdco Inc. (incorporated by reference to Exhibit 4.3 to the Current Report on Form 8-K filed by HC2 Holdings, Inc. ("HC2") on July 7, 2021) (File No. 021-35210)
10.1 |  | Credit Agreement, dated as of May 27, 2021, by and among DBM Global Inc., the other Borrowers listed on Schedule 1.1 thereto, the Lenders, which are party thereto from time to time and UMB Bank, n.a., a national banking association, as Letter of Credit Issuer and as Administrative Agent (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by HC2 Holdings, Inc. ("HC2") on May 27, 2021) (File No. 021-35210),
10.2 |  | H C2 Preferred Sup port Agreement, dated July 1, 2021, by and among HC2 Holdings, Inc., Continental General Insurance Company and Continental General Holdings LLC (incorporated by referen ce to Exhibit 10.1 to the Current Report on Form 8-K filed by HC2 on July 1, 2021) (File No. 021-35210)
10.3 |  | DBM Common Support Agreement, dated July 1, 2021, by and among HC2 Holdings, Inc., Continental General Insurance Company and Continental General Holdings LLC (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed by HC2 on July 1, 2021 (File No. 021-35210),
10.4 |  | Form of Exchange Agreement, dated July 1, 2021, by and among HC2 Holdings, Inc. and the investors party thereto (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by HC2 Holdings, Inc. ("HC2") on July 7, 2021) (File No. 021-35210)
10.5 |  | Letter Agreement dated March 26, 2021 by and between HC2 Holdings, Inc. and Continental General Insurance Compan y (filed herewith)
31.1 |  | Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer (filed herewith)
31.2 |  | Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer (filed herewith)
32.1* |  | Section 1350 Certification of Chief Executive Officer and Chief Financial Officer
101 |  | The following materials from the registrant’s Quarterly Report on Form 10-Q for the three months ended June 30, 2021, formatted in extensible business reporting language (XBRL); (i) Condensed Consolidated Statements of Operations for the three months ended June 30, 2021 and 2020, (ii) Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended June 30, 2021 and 2020, (iii) Condensed Consolidated Balance Sheets at June 30, 2021 and December 31, 2020, (iv) Condensed Consolidated Statements of Stockholders’ Equity for the three and six months ended June 30, 2021 and 2020, (v) Condensed Consolidated Statements of Cash Flows for the three and six months ended June 30, 2021 and 2020, and (vi) Notes to Condensed Consolidated Financial Statements (filed herewith).

* | These certifications are being "furnished" and will not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Such certifications will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates it by reference.

59

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  | HC2 Holdings, Inc.
Date: | August 6, 2021 | By: | /S/ Michael J. Sena
|  |  | Michael J. Sena
|  |  | Chief Financial Officer
|  |  | (Duly Authorized Officer and Principal Financial and Accounting Officer)

60